10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

__________________________

FORM 10-Q

S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

or

£ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from _________ to ________

Commission File Number: None

GWG HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-2222607
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

220 South Sixth Street, Suite 1200

Minneapolis, MN 55402

(Address of principal executive offices, including zip code)

(612) 746-1944

(Registrant’s telephone number, including area code)

________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒  Yes    ☐  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒  Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer  ☐	Accelerated filer   ☐
Non-accelerated filer    ☐	Smaller reporting company   ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐  Yes   ☒  No

As of May 14, 2015, GWG Holdings, Inc. had 5,870,193 shares of common stock outstanding.

GWG HOLDINGS, INC.

Index to Form 10-Q

for the Quarter Ended March 31, 2015

		Page No.
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of March 31, 2015, and December 31, 2014	1
	Condensed Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014	2
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014	3
	Notes to Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 4.	Controls and Procedures	46
PART II.	OTHER INFORMATION
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 6.	Exhibits	49
SIGNATURES		50

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2015 (unaudited)			December 31, 2014
A S S E T S
Cash and cash equivalents	$	36,190,527		$	30,662,704
Restricted cash		11,333,617			4,296,053
Policy benefits receivable		19,640,000			1,750,000
Investment in life settlements, at fair value		278,395,047			282,883,010
Other assets		5,753,383			3,478,762
TOTAL ASSETS	$	351,312,574		$	323,070,529
L I A B I L I T I E S  &  S T O C K H O L D E R S’  E Q U I T Y
LIABILITIES
Revolving credit facility	$	72,161,048		$	72,161,048
Series I Secured Notes payable		26,498,511			27,616,578
L Bonds		205,038,330			182,782,884
Interest payable		11,404,195			11,128,519
Accounts payable and accrued expenses		2,886,070			1,718,009
Deferred taxes, net		7,455,806			5,273,555
TOTAL LIABILITIES		325,443,960			300,680,593
STOCKHOLDERS’ EQUITY
CONVERTIBLE PREFERRED STOCK
(par value $0.001; shares authorized 40,000,000; shares outstanding 2,765,281 and 2,738,966; liquidation preference of $20,740,000 and $20,542,000, respectively)		20,712,073			20,527,866
COMMON STOCK
Common stock (par value $0.001: shares authorized 210,000,000; shares issued and outstanding is 5,870,193 on both March 31, 2015 and December 31, 2014)		5,870			5,870
Additional paid-in capital		16,290,266			16,257,686
Accumulated deficit		(11,139,595	)		(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		25,868,614			22,389,936
TOTAL LIABILITIES & EQUITY	$	351,312,574		$	323,070,529

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

- 1 -

GWG HOLDINGS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended
	March 31, 2015			March 31, 2014
REVENUE
Gain on life settlements, net	$	16,783,409		$	5,516,205
Interest and other income		49,296			7,367
TOTAL REVENUE		16,832,705			5,523,572
EXPENSES
Employee compensation and benefits		1,727,917			968,746
Legal and professional fees		578,144			325,298
Interest expense		7,176,534			6,326,548
Other expenses		1,478,848			759,008
TOTAL EXPENSES		10,961,443			8,379,600
INCOME (LOSS) BEFORE INCOME TAXES		5,871,262			(2,856,028	)
INCOME TAX EXPENSE (BENEFIT)		2,609,371			(954,858	)
NET INCOME (LOSS)		3,261,891			(1,901,170	)
Loss attributable to preferred shareholders		(353,155	)		(125,714	)
INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	3,615,046		$	(2,026,884	)
NET INCOME (LOSS) PER COMMON SHARE
Basic	$	0.62		$	(0.44	)
Diluted		0.46			(0.44	)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic		5,870,193			4,562,000
Diluted		7,940,645			4,562,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

- 2 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

	Three Months Ended
	March 31, 2015			March 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	3,261,891		$	(1,901,170	)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Gain on life settlements		1,893,845			(11,358,913	)
Amortization of deferred financing and issuance costs		(549,030	)		353,657
Deferred income taxes		2,182,251			(954,858	)
Convertible, redeemable preferred stock dividends payable		188,812			192,340
Increase in operating assets:
Policy benefits receivable		(17,890,000	)		-
Other assets		(131,173	)		(251,846	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		2,635,687			1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(8,407,717	)		(12,642,964	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		(2,446,477	)		(8,271,203	)
Proceeds from settlement of life settlements		3,610,595			-
NET CASH FLOWS USED IN INVESTING ACTIVITIES		1,164,118			(8,271,203	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		(1,273,189	)		(868,303	)
Proceeds from issuance of L Bonds		27,960,297			18,365,657
Payments for issuance and redemption of L Bonds		(6,878,122	)		(4,928,888	)
Proceeds (payments) from restricted cash		(7,037,564	)		2,979,207
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		12,771,422			15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		5,527,823			(5,366,494	)
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR		30,662,704			33,449,793
END OF YEAR	$	36,190,527		$	28,083,299

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

- 3 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS – CONTINUED

(unaudited)

	Three Months Ended
	March 31, 2015		March 31, 2014
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and preferred dividends paid	$	6,102,000	$	4,250,000
NON-CASH INVESTING AND FINANCING ACTIVITIES
Series I Secured Notes:
Accrued interest and commissions payable added to principal	$	41,000	$	65,000
L Bonds:
Accrued interest and commissions payable added to principal	$	218,000		119,000
Convertible, Redeemable Preferred Stock:
Accretion of Convertible, Redeemable Preferred Stock to redemption value	$	-	$	126,000
Conversion of dividends payable	$	184,000	$	188,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

- 4 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(1)       Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (GWG Holdings) and subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life, LLC (GWG Life), and GWG Life’s own subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II), and GWG DLP Funding III, LLC (DLP III). All of these entities are legally organized in Delaware. Unless the context otherwise requires or we specifically so indicate, all references in this report to "we", "us", "our", "our Company", "GWG", or the "Company" refer to these entities collectively. References to particular entities, such as “GWG Holdings” or “GWG Life”, are meant to refer only to the particular entity referenced.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1) Receipt of death notice or verified obituary of insured; or

2) Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $1,459,000 and $27,000 at March 31, 2015 and December 31, 2014, respectively.

- 5 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Deferred financing and issuance costs - Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $0 and $89,000 for the three months ended March 31, 2015 and 2014, respectively. As of December 31, 2014 those costs have been fully amortized. The Series I Secured Notes payable, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements - Pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

(2)       Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to fund the acquisition of insurance policies, pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility described in note 5, authorizes the disbursements from these accounts. At March 31, 2015 and December 31, 2014, there were balances of $11,334,000, and $4,296,000, respectively, maintained in these restricted cash accounts.

(3)       Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions. Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy, and our estimate of the risk premium an investor in the policy would require. As a result of management’s analysis, discount rates of 11.38% and 11.43% were applied to the portfolio as of March 31, 2015 and December 31, 2014, respectively.

- 6 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy, is as follows:

		As of March 31, 2015						As of December 31, 2014
Years Ending December 31,		Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015			-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016			8		11,626,000		14,750,000		7		8,144,000		11,550,000
2017			15		14,104,000		20,357,000		17		21,916,000		35,542,000
2018			28		39,094,000		68,717,000		30		41,994,000		76,206,000
2019			43		46,749,000		101,110,000		45		47,303,000		106,973,000
2020			44		45,825,000		103,674,000		41		43,429,000		102,614,000
2021			39		32,011,000		93,970,000		36		29,789,000		90,921,000
Thereafter			116		88,986,000		352,364,000		112		85,245,000		349,293,000
	Totals		293		278,395,000		754,942,000		291	$	282,883,000	$	779,099,000

The Company recognized insurance benefits of $28,625,000 and $0 during the three months ended March 31, 2015 and 2014, respectively, related to policies with a carrying value of $3,611,000 and $0, respectively. The Company recorded realized gains of $25,014,000 and $0 on such policies.

Reconciliation of gain on life settlements:

Three Months Ended:	March 31, 2015			March 31, 2014
Change in fair value	$	(1,894,000	)	$	11,359,000
Premiums and other annual fees		(6,337,000	)		(5,843,000	)
Policy maturities		25,014,000			-
Gain on life settlements, net	$	16,783,000		$	5,516,000

The estimated expected premium payments and servicing fees to maintain the above life insurance policies in force for the next five years, assuming no mortalities, are as follows:

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Nine months ending December 31, 2015	$	18,635,000	$	352,000	$	18,987,000
2016		26,899,000		352,000		27,251,000
2017		30,098,000		352,000		30,450,000
2018		32,813,000		352,000		33,165,000
2019		36,454,000		352,000		36,806,000
2020		40,389,000		352,000		40,741,000
	$	185,288,000	$	2,112,000	$	187,400,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing, as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies.

- 7 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(4)       Fair value definition and hierarchy

ASC 820 establishes a hierarchical disclosure framework which prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace, including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value, which hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an arms-length and orderly transaction between market participants at the measurement date. An “orderly transaction” is a non-distressed transaction in which neither the seller nor the buyer is compelled to engage in the transaction.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.  Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s portfolio of life settlements is determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration changes in discount rate assumptions, estimated premium payments and life expectancy estimate assumptions, as well as any changes in economic and other relevant conditions. These inputs are then used to estimate the discounted cash flows using the Model Actuarial Pricing System (MAPS), probabilistic portfolio price model, which estimates the cash flows using various probabilities and scenarios. The valuation process includes a review by senior management as of each valuation date. Management has also engaged a third party expert to independently test the accuracy of the valuations using the inputs provided by management on a quarterly basis.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three month periods ending March 31, as follows:

	2015			2014
Beginning balance	$	282,883,000		$	234,673,000
Purchases		1,016,000			8,472,000
Maturities (cost basis)		(3,610,000	)		-
Gross unrealized gains (losses)		(1,894,000	)		11,359,000
Ending balance	$	278,395,000		$	254,504,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy estimate assumptions. Life expectancy estimates are obtained from independent, third-party widely accepted life expectancy estimate providers at policy acquisition. The life expectancy values of each insured, as determined at policy acquisition, are rolled down monthly for the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies. The discount rate incorporates current information about discount rate applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the life insurance secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies.

- 8 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

On September 15, 2014, 21st Services announced changes to its mortality tables primarily for insureds age 90 and older, as well as updated adjustment factors designed to better underwrite seniors with multiple impairments. These changes represent small portions of 21st Services’ historical underwritings. We expect medical-actuarial underwriting firms to continue improving and refining their underwriting methodology.

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of  March 31, 2015			As of December 31, 2014
Weighted average age of insured		82.9			82.8
Weighted average life expectancy, months*		77.8			78.4
Average face amount per policy	$	2,577,000		$	2,677,000
Discount rate		11.38	%		11.43	%

* Standard life expectancy as adjusted for insured’s specific circumstances.

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry and include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonably vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables were held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the amounts summarized below:

		Change in life expectancy estimates
		plus 8 months			minus 8 months		plus 4 months			minus  4 months
March 31, 2015	$	(37,287,000	)	$	38,921,000	$	(18,864,000	)	$	19,320,000
December 31, 2014	$	(38,864,000	)	$	40,634,000	$	(19,664,000	)	$	20,130,000

		Change in discount rate
		plus 2%			minus 2%		plus 1%			minus 1%
March 31, 2015	$	(23,373,000	)	$	27,333,000	$	(12,131,000	)	$	13,118,000
December 31, 2014	$	(24,085,000	)	$	28,179,000	$	(12,502,000	)	$	13,522,000

Other Fair Value Considerations

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured Notes payable and L Bonds is approximately $237,950,000 based on a weighted-average market interest rate of 7.17% based on an income approach, the combined face value of these notes is $235,654,000 as of March 31, 2015. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolver approximates fair value. All of the financial instruments are Level 3 fair value measurements.

- 9 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company as permanent equity. The fair value measurements associated with the warrants, measured at issuance, represent Level 3 instruments.

As of March 31, 2015:

Month issued	Warrants issued		Fair value per share		Risk free rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%		5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%		5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%		5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%		5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%		5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%		5 years
		431,954

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date. We compare annual volatility based on this weekly information.

(5)       Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II. DZ Bank AG Deutsche Zentral-Genossenschaftsbank (DZ Bank) acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013. On January 29, 2013, GWG Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014. On May 29, 2014, GWG Holdings, together with GWG Life and DLP II, entered into an Amendment No. 1 to Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank (as committed lender and Agent). The amendment was entered into for the purpose of extending the maturity date for borrowings under the Agreement to December 31, 2016. The amount outstanding under this facility as of both March 31, 2015 and December 31, 2014 was $72,161,000.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 6.22% at March 31, 2015 and 6.24% at December 31, 2014. The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The weighted-average effective interest rate (excluding the unused line fee) was 6.20% and 6.22% for the three months ended March 31, 2015 and 2014, respectively. The note is secured by substantially all of DLP II’s assets, which consist primarily of life insurance policies.

- 10 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

The Agreement has certain financial and non-financial/operational covenants. The Company was in compliance with these covenants at March 31, 2015 and December 31, 2014. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any Series I Secured Notes or L Bonds, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income on a non-GAAP basis (as defined and calculated under the Agreement) for each complete fiscal year; (ii) a tangible net worth on a non-GAAP basis (as defined and calculated under the Agreement) of not less than $15 million; and (iii) maintain a borrowing base surplus or cash cushion sufficient to pay 12 months of premiums and facility fees.

Consolidated tangible net worth and net income as of and for the four quarters ended March 31, 2015, as calculated under the agreement, was $98,775,000 and $45,553,000 respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors which may limit availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at March 31, 2015 and December 31, 2014, were $3,751,000 and $20,585,000 respectively.

On July 15, 2008, GWG Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents. In January 2013 and May 2014 in connection with the Amended and Restated Credit and Security Agreement and Amendment No. 1 to Amended and Restated Credit and Security Agreement, GWG Holdings delivered a reaffirmation of its performance guaranty. The obligations of GWG Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II as the borrower under the credit facility. 

(6)       Series I Secured Notes payable

Series I Secured Notes are secured by assets of GWG Life and are subordinate to our revolving credit facility (see note 5). On June 14, 2011, the Company closed the offering to additional investors; however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option to repay such notes. Series I Secured Notes have maturity dates ranging from six months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At March 31, 2015 and December 31, 2014, the weighted-average interest rate of Series I Secured Notes was 8.39% and 8.37%, respectively. The notes are secured by assets of GWG Life. The principal amount outstanding under these Series I Secured Notes was $26,926,000 and $28,047,000 at March 31, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the Series I Secured Notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $130,000 and $167,000 for the three months ended March 31, 2015 and 2014, respectively. Future expected amortization of deferred financing costs is $427,000 in total over the next six years.

- 11 -

Future contractual maturities of Series I Secured Notes payable and future amortization of their deferred financing costs at March 31, 2015 are as follows: 

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	9,426,000	$	51,000
2016		10,060,000		168,000
2017		5,873,000		158,000
2018		802,000		30,000
2019		347,000		8,000
Thereafter		418,000		12,000
	$	26,926,000	$	427,000

(7)       L Bonds (formerly Renewable Secured Debentures)

The Company registered with the SEC, effective January of 2012, the offer and sale of $250,000,000 of Renewable Secured Debentures (subsequently renamed “L Bonds”). The debentures are secured by assets of GWG Holdings and GWG Life and are subordinate to our revolving credit facility (see note 5). L Bonds have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.25% to 9.50% depending on the term of the note. Interest is payable monthly, annually or at maturity depending on the terms of the debenture. Effective January 9, 2015, The Company launched a $1 billion follow-on to our publicly registered L Bond offering. The Company is offering L Bonds on a continuous basis and there is no minimum amount of L Bonds that must be sold before The Company can use proceeds from the sale of L Bonds. The Company plans to use the net proceeds from the offering of the L Bonds primarily to purchase and finance additional life insurance assets, and to service and retire other outstanding debt obligations. Emerson Equity LLC is serving as the managing broker-dealer for the offering, which is being sold through a network of participating dealers and licensed financial advisors and representatives in minimum increments of $25,000. At March 31, 2015 and December 31, 2014, the weighted-average interest rate of L Bonds was 7.32% and 7.45%, respectively. The amount outstanding under these L Bonds was $208,729,000 and $186,377,000 at March 31, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the L Bonds and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process. Amortization of deferred issuance costs was $974,000 and $847,000 for the three months ended March 31, 2015 and 2014, respectively. Future expected amortization of deferred financing costs as of March 31, 2015 is $6,268,000 in total over the next seven years.

The use of proceeds from the issuances of L Bonds is limited to the following: (1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.

Future contractual maturities of L Bonds and future amortization of their deferred financing costs at March 31, 2015 are as follows: 

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	56,626,000	$	611,000
2016		59,311,000		1,487,000
2017		36,939,000		1,434,000
2018		23,355,000		1,130,000
2019		14,342,000		639,000
Thereafter		18,156,000		967,000
	$	208,729,000	$	6,268,000

The Company entered into an Indenture effective October 19, 2011 with Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the debenture holders. The Indenture has certain financial and non-financial covenants. The Company was in compliance with these covenants at December 31, 2014 and 2013.  

- 12 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(8)       Convertible, Redeemable Preferred Stock

The Company offered 3,333,333 shares of convertible redeemable preferred stock (Series A Preferred Stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A Preferred Stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of March 31, 2015, 303,000 shares have been issued as a result of the payment of $2,121,000 in dividends in the form of shares of Series A Preferred Stock and 678,000 shares have been converted to 508,000 shares of the Company’s common stock. The Series A Preferred Stock was sold at an offering price of $7.50 per share. Series A Preferred Stock has a preferred yield of 10% per annum, and each share has the right to convert into 0.75 shares of the Company’s common stock. Series A preferred shareholders also received three-year warrants to purchase, at an exercise price per share of $12.50, one share of common stock for every 40 shares of Series A Preferred Stock purchased. The warrants are exercisable immediately. Upon their original issuance, these warrants had a three-year exercise period. Effective August 1, 2014, the Board of Directors authorized the extension of the warrant exercise period for an additional two years. In the Certificate of Designations for the Series A Preferred Stock dated July 31, 2011, the Company agreed to permit preferred shareholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends, according to the following schedule: 

● Up to 33% of the holder’s unredeemed shares one year after issuance:

● Up to 66% of the holder’s unredeemed shares two years after issuance; and

● Up to 100% of the holder’s unredeemed shares three years after issuance.

The Company’s obligation to redeem its Series A Preferred Stock terminated upon the Company completing a registration of its common stock with the SEC which occurred on September 24, 2014 (See Note 10). As such, the convertible redeemable preferred stock was reclassified from temporary equity to permanent equity. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time. As of March 31, 2015, the Company had redeemed an aggregate of 145,000 shares of Series A Preferred Stock. The Series A Preferred Stock shares (i) were convertible, at the election of the Company, into common stock of the Company in the event of either a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million and at a price equal to or greater than $11.00 per share; (ii) remain convertible at the option of each holder; and (iii) are required to be converted upon the consent of shareholders holding at least a majority of the then-outstanding Series A Preferred Stock. In connection with the Company’s initial public offering, the Company elected to cause the conversion of 678,000 shares of preferred stock into 508,000 shares of common stock. As of March 31, 2015, the Company had 2,765,000 shares of Series A Preferred Stock outstanding with gross consideration of $20,712,000 (including cash proceeds, conversion of Series I Secured Notes and accrued interest on Series I, and conversion of preferred dividends payable). The Company incurred Series A Preferred Stock issuance costs of $2,838,000, all of which was included as a component of additional paid in capital as of December 31, 2014.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A Preferred Stock was $428,000 for warrants outstanding as of March 31, 2015. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.

Total warrants outstanding as of both March 31, 2015 and December 31, 2014, were 431,954 with a weighted-average remaining life of 2.18 and 2.43 years, respectively. As of March 31, 2015, none of these warrants have been exercised.

Dividends on the Series A Preferred Stock may be paid in either cash or additional shares of Series A Preferred Stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations. The Company declared and accrued dividends of $537,000 and $634,000 for the three months ended March 31, 2015 and 2014, respectively, pursuant to a board resolution declaring the dividend. 26,000 and 27,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the three months ended March 31, 2015 and 2014, respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share. As of March 31, 2015, GWG Holdings has $518,000 of accrued preferred dividends which were paid or converted to shares of Series A Preferred Stock on April 15, 2015.

- 13 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(9)       Income taxes

The Company has a $427,000 and $0 of current income tax liability as of March 31, 2015 and December 31, 2014. The components of current and deferred income tax expense for the three month ended March 31, 2015 and income tax benefit for the three month ended March 31, 2014, consisted of the following:

Three months ended:	March 31,			March 31,
	2015			2014
Income tax provision:
Current:
Federal	$	(324,000	)	$	-
State		(103,000	)		-
Total current tax expense		(427,000	)		-
Deferred:
Federal	$	(1,654,000	)	$	802,000
State		(528,000	)		153,000
Total deferred tax expense		(2,182,000	)		955,000
Total income tax expense	$	(2,609,000	)	$	955,000

The primary differences between the Company’s March 31, 2015 effective tax rate and the statutory federal rate are the accrual of nondeductible preferred stock dividend expense of $537,000, state taxes, and other non-deductible expenses. The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

(10)    Common Stock

On September 24, 2014, GWG consummated an initial public offering of its common stock which resulted in the sale of 800,000 shares of common stock at $12.50 per share. The sale resulted in net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. In connection with this offering, the Company listed its common stock on The NASDAQ Capital Market under the ticker symbol “GWGH” effective September 25, 2014. The Company used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, purchase additional life insurance policies in the secondary market, pay premiums on the Company’s life insurance policy assets, fund its portfolio operations, and for working capital purposes.

Stock split— On June 24, 2014, the Company’s Board of Directors and majority stockholders approved a joint resolution to effect an amendment to the Company’s Certificate of Incorporation to effect a reverse split of the issued and outstanding common stock on a 2-for-1 basis. The effective date of the amendment and reverse stock split was June 24, 2014. In lieu of fractional shares, stockholders received cash payments in an amount equal to the fraction to which the stockholder would otherwise be entitled multiplied by the price of the common stock, as determined by the Board of Directors of the Company, but adjusted so as to give effect to the reverse stock split. The par value of the common stock remained at $0.001 per share.

- 14 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(11)     Stock Incentive Plan

The Company adopted the GWG Holdings, Inc. 2013 Stock Incentive Plan on March 27, 2013. The plan was subsequently revised on March 4, 2015. The plan is administered by Compensation Committee of the Board of Directors of the Company. The Company’s Chief Executive Officer may, on a discretionary basis and without committee review or approval, grant incentives to new employees of the Company who are not officers of the Company. Incentives under the plan may be granted in one or a combination of the following forms: (a) incentive stock options and non-statutory stock options; (b) stock appreciation rights; (c) stock awards; (d) restricted stock; (e) restricted stock units; and (f) performance shares. Eligible participants include officers and employees of the company, members of the Board of Directors, and consultants or other independent contractors. 2,000,000 shares are issuable under the plan. No person shall receive grants of stock options and SARs under the plan that exceed, in the aggregate 400,000 shares of common stock in any one year. The term of each stock option shall be determined by the committee but shall not exceed ten years. Vested stock options may be exercised in whole or part by the holder giving notice to the Company. The holder of the option may provide payment for the exercise price or surrender shares equal to the exercise price.

The Company issued stock options for 755,101 shares of common stock to employees, officers, and directors of the Company through December 31, 2014. Options for 363,957 shares have vested, and the remaining options will vest over three years. The options were issued with an exercise price between $8.20 and $9.01 for those owning more than 10% of the Company’s stock and between $7.46 and $10.25 for others, which is equal to the estimated market price of the shares on the date of grant valued using Black-Scholes binomial option pricing model. The expected volatility used in the Black-Scholes model valuation of options issued during the year was 17.03% annualized. The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks. Forfeiture rate of 15% is based on historical Company information and expected future trend. As of March 31, 2015, stock options for 72,583 shares were forfeited and stock options for 4,167 shares were exercised.

In September 2014, we entered into a stock option agreement (the Agreement) with a new management employee (the Employee) granting the Employee the right to purchase up to 318,000 of the Company’s common stock at an exercise price of $12.50. The grant of such rights to purchase the Company’s common stock was treated as an inducement grant and was issued outside the GWG Holdings Inc. 2013 Stock Incentive Plan. The Agreement specifies that, among other things, options to purchase 159,000 shares of the Company’s common stock will vest with the Employee ratably on the first, second and third anniversary of the date of the Agreement. The remaining 159,000 options will vest quarterly using a formula based upon the closing price of the Company’s common stock on the last business day of such quarter. The maximum number of these remaining options that will vest with the Employee is 53,000 in each successive one-year period beginning on the date of the Agreement.

Outstanding stock options:

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the quarter		43,500			42,750			86,250
Vested during the quarter		10,002			(10,002	)		-
Exercised during the quarter		(3,833	)		-			(3,833	)
Forfeited during the quarter		-			(9,417	)		(9,417	)
Balance as of March 31, 2015		363,957			709,144			1,073,101

Compensation expense related to un-vested options not yet recognized is $608,000. We expect to recognize this compensation expense over the next three years ($217,000 in 2015, $217,000 in 2016, $166,000 in 2017, and 8,000 in 2018). The Company issues new common stock for options exercised.

(12)     Net income per common share

The Company began issuing Series A Preferred Stock on September 1, 2011, as described in note 8. The Series A Preferred Stock is dilutive to the net loss per common share calculation at March 31, 2015 and anti-dilutive at March 31, 2014. The Company has also issued warrants to purchase common stock in conjunction with the sale of convertible preferred stock, discussed in note 8. The warrants and vested stock options are anti-dilutive at March 31, 2015 and March 31, 2014 and have not been included in the fully diluted net loss per common share calculation.

- 15 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(13)     Commitments

The Company entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this agreement were $67,000 and $52,000 during the three month ended March 31, 2015 and 2014, respectively. The minimum lease payments for 2015 under the lease agreement are $70,000.

(14)    Contingencies

Litigation - In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes (Company directors and officers), is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may have been deemed preference payments. In addition, Jon Sabes and Steven Sabes are subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments received from Opportunity Finance that may have been deemed preference payments. If the parties are unsuccessful in defending against these claims, their equity ownership in the Company may be sold or transferred to other parties to satisfy such claims. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court.

(15)    Guarantees of secured debt

GWG Holdings has registered with the SEC the offer and sale $250,000,000 of L Bonds, and effective January 9, 2015, launched a $1 billion follow-on to its publicly registered L Bond offering as described in note 7. The L Bonds are secured by the assets of Holdings as described in note 7 and a pledge of all the common stock held by the largest individual shareholders. Obligations under the L Bonds are guaranteed by GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. The payment of principal and interest on the L Bonds is fully and unconditional guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, DLP III and the Trust. The policies held by DLP II are not collateral for the L Bond obligations as such policies serve as collateral for the credit facility.

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II is a borrower under a credit agreement with Autobahn, with DZ Bank AG as agent, as described in note 5. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank AG described in notes 2 and 5. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank AG and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. Distributions are limited to an amount that would result in the borrowers (DLP II, GWG Life and Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by DZ Bank AG. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of March 31, 2015 and December 31, 2014, with respect to the financial position, and for the three months ended March 31, 2015 and 2014 with respect to results of operations and cash flows of Holdings and its subsidiaries. The parent column presents the financial information of Holdings, the primary obligor of the L Bonds. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the L Bonds, presenting its investment in DLP II, DLP III and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II, DLP III and Trust.

- 16 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Balance Sheets

March 31, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	34,762,097		$	1,278,378	$	150,052	$	-		$	36,190,527
Restricted cash		-			1,862,500		9,471,117		-			11,333,617
Policy benefits receivable		-			-		19,640,000		-			19,640,000
Investment in life settlements, at fair value		-			-		278,395,047		-			278,395,047
Other assets		1,814,859			1,756,731		2,181,793		-			5,753,383
Investment in subsidiaries		210,207,072			236,319,121		-		(446,526,193	)		-
TOTAL ASSETS	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			26,498,511		-		-			26,498,511
L Bonds		205,038,330			-		-		-			205,038,330
Interest payable		7,242,071			3,559,004		603,120		-			11,404,195
Accounts payable and other accrued expenses		1,179,207			1,102,196		604,667		-			2,886,070
Deferred taxes		7,455,806			-		-		-			7,455,806
TOTAL LIABILITIES		220,915,414			31,159,711		73,368,835		-			325,443,960
STOCKHOLDERS’ EQUITY
Member capital		-			210,057,019		236,469,174		(446,526,193	)		-
Convertible preferred stock		20,712,073										20,712,073
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,290,266			-		-		-			16,290,266
Accumulated deficit		(11,139,595	)		-		-		-			(11,139,595	)
TOTAL STOCKHOLDERS’ EQUITY		25,868,614			210,057,019		236,496,174		(446,526,193	)		25,868,614
TOTAL LIABILITIES AND EQUITY	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574

- 17 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Balance Sheets (continued)

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		1,777,500		-			5,228,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y  (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Accounts payable		410,895			242,680		550,000		-			1,203,575
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Other accrued expenses		301,098			191,753		21,583		-			514,434
Deferred taxes		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

- 18 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Operations

For the three months ended March 31, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	357,486		$	-	$	(357,486	)	$	-
Gain on life settlements, net		-			-			16,783,409		-			16,783,409
Interest and other income		7,543			6,450			35,303		-			49,296
TOTAL REVENUE		7,453			363,936			16,818,712		(357,486	)		16,832,705
EXPENSES
Origination and servicing fees		-			-			357,486		(357,486	)		-
Employee compensation and benefits		1,305,801			422,116			-		-			1,727,917
Legal and professional fees		477,351			100,793			-		-			578,144
Interest expense		5,249,962			774,086			1,152,486		-			7,176,534
Other expenses		951,362			514,902			12,584		-			1,478,848
TOTAL EXPENSES		7,984,476			1,811,897			1,522,556		(357,486	)		10,961,443
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(7,976,933	)		(1,447,961	)		15,296,156		-			5,871,262
EQUITY IN INCOME OF SUBSIDIARY		13,848,195			15,296,105			-		(29,144,300	)		-
NET INCOME BEFORE INCOME TAXES		5,871,262			13,848,144			15,296,156		(29,144,300	)		5,871,262
INCOME TAX EXPENSE		2,609,371			-			-		-			2,609,371
NET INCOME	$	3,261,891		$	13,848,144		$	15,296,156	$	(29,144,300	)	$	3,261,891

For the three months ended March 31, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	966,056		$	-	$	(966,056	)	$	-
Gain on life settlements, net		-			-			5,516,205		-			5,516,205
Interest and other income		6,929			169,615			44		(169,221	)		7,367
TOTAL REVENUE		6,929			1,135,671			5,516,249		(1,135,277	)		5,523,572
EXPENSES
Origination and servicing fees		-			-			966,056		(966,056	)		-
Employee compensation and benefits		590,584			378,162			-		-			968,746
Legal and professional fees		266,159			59,139			-		-			325,298
Interest expense		4,216,528			778,567			1,331,453		-			6,326,548
Other expenses		421,243			325,255			181,731		(169,221	)		759,008
TOTAL EXPENSES		5,494,514			1,541,123			2,479,240		(1,135,277	)		8,379,600
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,487,585	)		(405,452	)		3,037,009		-			(2,856,028	)
EQUITY IN INCOME OF SUBSIDIARY		2,631,557			3,037,009			-		(5,668,566	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(2,856,028	)		2,631,557			3,037,009		(5,668,566	)		(2,856,028	)
INCOME TAX BENEFIT		(954,858	)		-			-		-			(954,858	)
NET INCOME (LOSS)	$	(1,901,170	)	$	2,631,557		$	3,037,009	$	(5,668,566	)	$	(1,901,170	)

- 19 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Condensed Consolidating Statements of Cash Flows

For the three months ended March 31, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	3,261,891		$	13,848,144		$	15,296,156		$	(29,144,300	)	$	3,261,891
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(13,848,196	)		(15,296,104	)		-			29,144,300			-
Gain on life settlements		-			-			1,893,845			-			1,893,845
Amortization of deferred financing and issuance costs		43,475			130,188			(722,693	)		-			(549,030	)
Deferred income taxes		2,182,251			-			-			-			2,182,251
Preferred stock issued for dividends		188,812			-			-			-			188,812
Increase in operating assets:
Policy benefits receivable		-			-			17,890,000			-			17,890,000
Other assets		(10,874,436	)		(5,877,435	)		-			16,620,698			(131,173	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		2,279,652			738,084			382,049			-			2,635,687
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(16,766,551	)		(6,457,123	)		(1,804,741	)		16,620,698			(8,407,717	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,446,477	)		-			(2,446,477	)
Proceeds from settlement of life settlements		-			-			3,610,595			-			3,610,595
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			1,164,118			-			1,164,118
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(1,273,189	)		-			-			(1,273,189	)
Proceeds from issuance of L Bonds		27,960,297			-			-			-			27,960,297
Payments from issuance of L Bonds		(1,340,583	)		-			-			-			(1,340,583	)
Payments from redemption of L Bonds		(5,537,539	)		-			-			-			(5,537,539	)
Proceeds from restricted cash		-			(1,780,000	)		(5,257,564	)		-			(7,073,564	)
Issuance of member capital		-			10,572,459			6,048,239			(16,620,698	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		21,082,175			7,519,270			790,675			(16,620,698	)		12,771,422
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,315,624			1,062,147			150,052			-			5,527,823
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		30,446,473			216,231			-			-			30,662,704
END OF THE YEAR	$	34,762,097		$	1,278,378		$	150,052		$	-		$	36,190,527

- 20 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Consolidating Statements of Cash Flows (continued)

For the three months ended March 31, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(1,901,170	)	$	2,631,557		$	3,037,009		$	(5,668,566	)	$	(1,901,170	)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(2,631,557	)		(3,037,009	)		-			5,668,566			-
Gain on life settlements		-			-			(11,358,913	)		-			(11,358,913	)
Amortization of deferred financing and issuance costs		847,236			166,946			(660,525	)		-			353,657
Deferred income taxes		(954,858	)		-			-			-			(954,858	)
Preferred stock issued for dividends		192,340			-			-			-			192,340
Increase in operating assets:
Other assets		(15,947,713	)		(15,248,357	)		-			30,944,224			(251,846	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		713,785			229,443			334,598			-			1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(19,681,937	)		(15,257,420	)		(8,647,831	)		30,944,224			(12,642,964	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(8,271,203	)		-			(8,271,203	)
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(8,271,203	)		-			(8,271,203	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(868,303	)		-			-			(868,303	)
Proceeds from issuance of debentures		18,365,657			-			-			-			18,365,657
Payments from issuance of debentures		(1,057,763	)		-			-			-			(1,057,763	)
Payments from redemption of debentures		(3,871,125	)		-			-			-			(3,871,125	)
Proceeds from restricted cash		-			1,070,000			1,909,207			-			2,979,207
Issuance of member capital		-			15,934,397			15,009,827			(30,944,224	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		13,436,769			16,136,094			16,919,034			(30,944,224	)		15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(6,245,168	)		878,674			-			-			(5,366,494	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		32,711,636			738,157			-			-			33,449,793
END OF THE YEAR	$	26,466,468		$	1,616,831		$	-		$	-		$	28,083,299

- 21 -

GWG HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(16)     Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies.  As a result there may be certain concentrations of contracts with life insurance companies.  The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	March 31,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		15.02		14.55
John Hancock		12.03		11.48
Transamerica		10.32		*

* percentage does not exceed 10% of the total face value.

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	March 31,		December 31,
	2015		2014
State of residence	%		%
California		28.33		28.87
Florida		18.77		18.56
New York		9.56		*

* percentage does not exceed 10% of the total face value.

(17) Subsequent events

Subsequent to March 31, 2015, one policy has matured. The insurance benefits of this policy were $750,000 and the carrying value of the policy was 132,000. The Company recorded realized gains of $618,000 on this policy.

Subsequent to March 31, 2015, the Company has issued approximately an additional $9.6 million in principal amount of L Bonds.

Amended and Restated Credit Facility

Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into an Second Amended and Restated Credit and Security Agreement with Autobahn Funding Company LLC, as the conduit lender, and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as the committed lender and as the agent on behalf of secured parties under such agreement.  The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings made by the Company’s subsidiaries, GWG DLP Funding II, LLC and GWG DLP Funding III, LLC, to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance, or at the lender’s cost of borrowing plus 4.75 percent, which is 1.75 percent less than under the previous Credit and Security Agreement executed on January 25, 2013.  In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement also removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

In connection with the Second Amended and Restated Credit and Security Agreement, GWG Holdings and its subsidiaries entered into certain other agreements and amendments and restatements of earlier agreements entered into in connection with the original and renewal Credit and Security Agreements.  Included among these other agreements was an Amended and Restated Performance Guaranty affirming the performance guaranty that GWG Holdings earlier provided in connection with the original and first amended and related Credit and Security Agreements to DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as agent.

- 22 -

ITEM 2.      MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You should read the following discussion in conjunction with the consolidated financial statements and accompanying notes and the information contained in other sections of this report. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The statements in this discussion and analysis concerning expectations regarding our future performance, liquidity and capital resources, as well as other non-historical statements, are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties. Our actual results could differ materially from those suggested or implied by any forward-looking statements. Please see the “Risk Relating to Forward-Looking Statements” caption below.

Overview

We are engaged in the emerging secondary market for life insurance policies. We acquire life insurance policies in the secondary market from policy owners desiring to sell their policies at a discount to the face value of the insurance benefit. Once we purchase a policy, we continue paying the policy premiums to ultimately collect the face value of the insurance benefit. We generally seek to hold the individual policies to maturity, in order to ultimately collect the policy’s face value upon the insured’s mortality. Our strategy is to build a profitable and large portfolio of policies that is diversified in terms of insurance carriers and the medical conditions of insureds. We believe that diversification among insureds, insurers, and medical conditions will lower our overall risk exposure, and that a larger number of individual policies (diversification in overall number) will provide our portfolio with greater  actuarial stability.

In the first three months of 2015, we recognized $25.0 million of revenue from the receipt of $28.6 million in policy benefits. In addition, we recognized an expense from the change in fair value of our life insurance policies, net of premiums and carrying costs, of $8.2 million. In the first three months of 2015, interest expense, including amortization of the deferred financing costs and preferred stock dividends, was $7.2 million, and selling, general and administrative expenses were $3.8 million. Income tax expense for the first three months of 2015 was $2.6 million. Our net income for the first quarter of 2015 was $3.3 million.

In the first three months of 2014, we did not experience any policy maturities. In this period we recognized revenue from the change in fair value of our life insurance policies, net of premiums and carrying costs, of $5.5 million. For the three months ended March 31, 2014, interest expense, including amortization of the deferred financing costs and preferred stock dividends, was $6.3 million, and selling, general and administrative expenses were $2.1 million. Income tax benefit for the three months ended March 31, 2014 was $0.9 million. Our net loss for first quarter of 2014 was $1.9 million.

To date, we have financed our business principally through the issuance of debt, including debt incurred by our subsidiary DLP Funding II under a senior revolving credit facility provided by Autobahn/DZ Bank, Series I Secured Notes issued by our subsidiary GWG Life and our registered public offerings of L Bonds. See the “Liquidity and Capital Resources” caption below.

Critical Accounting Policies

Critical Accounting Estimates

The preparation of our consolidated financial statements in accordance with the Generally Accepted Accounting Principles (GAAP) requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our judgments, estimates, and assumptions on historical experience and on various other factors believed to be reasonable under the circumstances. Actual results could differ materially from these estimates. We evaluate our judgments, estimates, and assumptions on a regular basis and make changes accordingly. We believe that the judgments, estimates, and assumptions involved in the accounting for the valuation of investments in life insurance policies have the greatest potential impact on our consolidated financial statements and accordingly believe these to be our critical accounting estimates. Below we discuss the critical accounting policies associated with these estimates as well as certain other critical accounting policies.

- 23 -

Ownership of Life Insurance Policies—Fair Value Option

Our primary business involves the purchasing and financing of life insurance policies. As such, we account for the purchase of life insurance policies in accordance with Financial Accounting Standards Board’s Accounting Standards Codification (FASB ASC) 325-30, Investments in Insurance Contracts, which requires us to use either the investment method or the fair value method. We have elected to account for these life insurance policies as investments using the fair value method.

We initially record our purchase of life insurance policies at the transaction price, which is the amount paid for the policy, inclusive of all fees and costs associated with the acquisition. The fair value of our investment in the portfolio of insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the portfolio of life insurance policies are based on periodic evaluations and are recorded as changes in fair value of life

insurance policies in our consolidated and combined statement of operations. The fair value is determined as the net present value of the life insurance portfolio’s future expected cash flows that incorporates current life expectancy estimates and discount rate assumptions.

In addition to reporting our results of operations and financial condition based on the fair value of our life insurance policies as required by GAAP, management also makes calculations based on the weighted average expected internal rate of return of the policies. See “Non-GAAP Financial Measures” below.

Valuation of Insurance Policies

Unobservable inputs, as discussed below, are a critical component of our estimate for the fair value of our investments in life insurance policies. We currently use a probabilistic method of estimating and valuing the projected cash flows of our portfolio of life insurance policies, which we believe to be the preferred and most prevalent valuation method in the industry. In this regard, the most significant assumptions we make are the life expectancy estimates of the insureds and the discount rate applied to the projected cash flows to be derived from our portfolio.

In determining life expectancy estimates, we generally use actuarial medical reviews from independent medical underwriters. These medical underwriters evaluate the health of the insured by reviewing historical and current medical records. This evaluation is performed to produce an estimate of the insured’s mortality—a life expectancy report. In the case of a small face policy ($1.0 million face value of policy benefits or less), we may use one life expectancy report or estimate life expectancy based on a modified methodology which does not use actuarial medical reviews from independent medical underwriters. The life expectancy estimate represents a range of probabilities for the insured’s mortality against a group of cohorts with the same age, sex and smoking status. These mortality probabilities represent a mathematical curve known as a mortality curve, which is then used to generate a series of expected cash flows from the life insurance policy over the expected lifespan of the insured. A discount rate is used to calculate the net present value of the expected cash flows. The discount rate represents the internal rate of return we expect to earn on investments in a policy or in the portfolio as a whole at the stated fair value. The discount rate used to calculate fair value of our portfolio incorporates the guidance provided by ASC 820, Fair Value Measurements and Disclosures. Many of our current underwriting review processes, including our policy of obtaining actuarial medical reviews from independent medical underwriters as described above, are undertaken in satisfaction of obligations under our revolving credit facility. As a result, we may in the future modify our underwriting review processes if permitted under our borrowing arrangements.

The table below provides the discount rate used to estimate the fair value of the life insurance policies for the period ending:

March 31, 2015	December 31, 2014
11.38%	11.43%

The change in the discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed by us in the life insurance secondary market, market interest rates, the credit exposure to the issuing insurance companies, and our estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies. Because we use the discount rate to arrive at the fair value of our portfolio, the rate we choose necessarily assumes an orderly and arms-length transaction (i.e., a non-distressed transaction in which neither seller nor buyer is compelled to engage in the transaction).

- 24 -

We engaged a third party, Model Actuarial Pricing Systems (MAPS), to prepare a third-party valuation of our life settlement portfolio. MAPS owns and maintains the portfolio pricing software we use. MAPS processed policy data, future premium data, life expectancy estimate data, and other actuarial information we supplied to calculate a net present value for our portfolio using the specified discount rate of 11.38%. MAPS independently calculated the net present value of our portfolio of 293 policies to be $278.4 million, which is the same fair value estimate we used on the balance sheet as of March 31, 2015, and furnished us with a letter documenting its calculation. A copy of such letter is filed as Exhibit 99.1 to this report.

JOBS Act

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933 for complying with new or revised accounting standards. This means that an “emerging growth company” can make an election to delay the adoption of certain accounting standards until those standards would apply to private companies. We have elected to delay such adoption of new or revised accounting standards and, as a result, we may not comply with new or revised accounting standards at the same time as other public reporting companies that are not “emerging growth companies.” This exemption will apply for a period of five years following our first sale of common equity securities under an effective registration statement or until we no longer qualify as an “emerging growth company” as defined under the JOBS Act, whichever is earlier.

Deferred Income Taxes

FASB ASC 740, Income Taxes, requires us to recognize deferred tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. A valuation allowance is established for any portion of deferred tax assets that is not considered more likely than not to be realized.

We have provided a valuation allowance against the deferred tax asset related to a note receivable, which has been charged-off for financial reporting purposes, because we believe that, when realized for tax purposes, it will result in a capital loss that will not be utilized because we have no expectation of generating a capital gain within the applicable carryforward period. Therefore, we do not believe that it is more likely than not that the deferred tax asset

will be realized.

We have also provided a valuation allowance against the deferred tax asset related to a tax basis capital loss generated with respect to our settlement and subsequent disposal of an earlier investment in Athena Structured Funds PLC (see “Notes to Consolidated Financial Statements” Note 9). As we have no expectation of generating capital gains with the applicable carry-forward period, we do not believe that it is more likely than not that the deferred asset will be realized.

A valuation allowance is required to be recognized to reduce deferred tax assets to an amount that is more likely than not to be realized. Realization of deferred tax assets depends upon having sufficient past or future taxable income in periods to which the deductible temporary differences are expected to be recovered or within any applicable carryback or carryforward periods. We believe that it is more likely than not that we will be able to realize all of our deferred tax assets other than those which are expected to result in a capital loss.

Deferred Financing and Issuance Costs

Financing costs incurred to obtain financing under the revolving credit facility have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. The Series I Secured Note obligations are reported net of issuance costs, sales commissions, and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds are reported net of issuance costs, sales commissions, and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over a three-year redemption period. As of December 31, 2014 these costs have been fully amortized.

- 25 -

Risk Relating to Forward-Looking Statements

Certain matters discussed in this section of this report, and elsewhere in this report, are forward-looking statements.  We have based these forward-looking statements on our current expectations and projections about future events.  Nevertheless, these forward-looking statements are subject to risks, uncertainties and assumptions about our operations and the investments we make, including, among other things, factors discussed in the “Risk Factors” section of this report and the following:

● changes in the secondary market for life insurance;

● our limited operating history;

● the valuation of assets reflected on our financial statements;

● the reliability of assumptions underlying our actuarial models;

● our reliance of debt financing;

● risks relating to the validity and enforceability of the life insurance policies we purchase;

● our reliance on information provided and obtained by third parties;

● Federal, state and FINRA regulatory matters;

● competition in the secondary life insurance market;

● the relative illiquidity of life insurance policies;

● our ability to satisfy our debt obligations if we were to sell our entire portfolio of life insurance policies;

● life insurance company credit exposure;

● general economic outlook, including prevailing interest rates;

● performance of our investments in life insurance policies;

● financing requirements;

● litigation risks; and

● restrictive covenants contained in borrowing agreements.

Forward-looking statements can generally be identified by the use of words like “believes,” “could,” “possibly,” “probably,” “anticipates,” “estimates,” “projects,” “expects,” “may,” “will,” “should,” “seek,” “intend,” “plan,” “expect” or “consider,” or the negative of these expressions or other variations, or by discussions of strategy that involve risks and uncertainties.  All forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual transactions, results, performance or achievements to be materially different from any future transactions, results, performance or achievements expressed or implied by such forward-looking statements.

Principal Revenue and Expense Items

We earn revenues from three primary sources as described below.

● Policy Benefits Realized. We recognize the difference between the death benefits and carrying values of the policy when an insured event has occurred and we determine that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. We generally collect the face value of the life insurance policy from the insurance company within 45 days of the insured’s mortality.

● Change in Fair Value of Life Insurance Policies. We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30, Investments in Life Insurance Contracts. Accordingly, we value our investments in our portfolio of life insurance policies each reporting period in accordance with the fair value principles discussed herein, which includes the expected payment of premiums for future periods.

● Sale of a Life Insurance Policy or a Portfolio of Life Insurance Policies. In an event of a sale of a policy, we recognize gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

- 26 -

Our main components of expense are summarized below.

● Selling, General and Administrative Expenses. We recognize and record expenses incurred in the operations of the purchasing and servicing of life insurance policies. These expenses include professional fees, salaries, and sales and marketing expenditures.

● Interest Expense. We recognize and record interest expenses associated with the costs of financing our life insurance portfolio for the current period. These expenses include interest paid to our senior lender under our revolving credit facility, as well as all interest paid on our debentures and other outstanding indebtedness such as our subsidiary secured notes and dividends on convertible, redeemable preferred stock. When we issue long-term indebtedness, we amortize the issuance costs associated with such indebtedness over the outstanding term of the financing, and classify it as interest expense.

Results of Operations — Three Months Ended March 31, 2015 Compared to the Same Period in 2014

The following is our analysis of the results of operations for the periods indicated below.  This analysis should be read in conjunction with our consolidated financial statements and related notes.

Revenue.

	Three Months Ended March 31,
	2015			2014
Revenue recognized from the receipt of policy benefits (1)	$	25,014,000		$	-
Revenue (expense) recognized from the change in fair value of life insurance policies, net of premiums and carrying costs (2)		(8,231,000	)		5,516,000
Gain on life settlements, net	$	16,783,000		$	5,516,000
The change in fair value related to new policies acquired during the first quarter of 2015	$	612,000		$	4,473,000

(1) In the first three months of 2015, we recognized $25.0 million of revenue from the receipt of $28.6 million in policy benefits. In the first three months of 2014, we did not experience any policy maturities.

(2) The change in the discount rate incorporates current information about discount rates applied by other reporting companies owning portfolios of life insurance policies, discount rates observed by us in the life insurance secondary market, market interest rates, the credit exposure to the issuing insurance companies and our estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurancepolicies. Because we use the discount rate to arrive at the fair value of our portfolio, the rate we choose necessarily assumes an orderly and arms-length transaction (i.e., a non-distressed transaction in which neither seller nor buyer is compelled to engage in the transaction). The discount rate applied to estimate the fair value of the portfolio of life insurance policies we own was 11.38% as of March 31, 2015, compared to 11.69% as of March 31, 2014, and to 11.43% as of December 31, 2014. The decrease in discount rate was due to both an increase in the size of our portfolio and the diversity of policies held in our portfolio of life insurance policies that resulted in a lower anticipated risk premium to a potential buyer. The carrying value of policies acquired during each quarterly reporting period are adjusted to their current fair value using the fair value discount rate applied to the entire portfolio as of that reporting date.

Expenses.

	Three Months Ended March 31,
	2015		2014		Increase
Employee compensation and benefits (1)	$	1,728,000	$	969,000	$	759,000
Interest expense (including amortization of deferred financing costs and preferred stock dividends) (2)		7,176,000		6,327,000		849,000
Legal and professional expenses (3)		578,000		325,000		253,000
Other expenses (4)		1,479,000		759,000		720,000
Total expenses	$	10,961,000	$	8,380,000	$	2,581,000

(1)	The increase in the current period as compared to the first quarter of 2014 resulted primarily from our employment of more staff and additional members to our Business Development and executive teams.
(2)	The increase in the current period was due to the increase in average debt outstanding.
(3)	The increase in the current period is due to increased compliance work and SEC filings related to our L Bonds offering.
(4)	Marketing, recruiting and other expenses increased in the current period due to the implementation of a direct marketing campaign, increased activity related to our public offering of L Bonds and increased expenses from the implementation of a new company operating system.

- 27 -

Income Tax Expense. For the three months ended March 31, 2015, we had $5.9 million of income before income taxes and recorded income tax expense of $2.6 million, or 44.4%. In the same period of 2014, we had $2.9 million of loss before income taxes and recognized an income tax benefit of $0.9 million, or 33.4%. The primary differences between our effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state taxes, and other non-deductible expenses. The primary permanent difference between our effective tax rate and the statutory federal rate are the accrual of preferred stock dividend expense, state income taxes, and other non-deductible expenses. The dividends charged to interest expense were $0.5 million and $0.6 million during the first three month of 2015 and 2014, respectively.

The following table provides a reconciliation of our income tax expense at the statutory federal tax rate to our actual income tax expense:

	Three Months Ended				Three Months Ended
	March 31, 2015				March 31, 2014
Statutory federal income tax (benefit)	$	1,998,000	34.0	%	$	(964,000	)	34.0	%
State income taxes, net of federal benefit		416,000	7.1	%		(141,000	)	5.0	%
Series A Preferred Stock dividends		183,000	3.1	%		216,000		(7.6	)%
Other permanent differences		12,000	0.2	%		(66,000	)	2.0	%
Total income tax expense (benefit)	$	2,609,000	44.4	%	$	(955,000	)	33.4	%

The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

Liquidity and Capital Resources

We finance our business through a combination of policy benefit revenues, origination fees, equity offerings, debt offerings, and a credit facility. We have used our debt offerings and credit facility primarily for policy acquisition, policy servicing, and portfolio related financing expenditures. We charge an intercompany origination fee in the amount of one to four percent of the face value of a life insurance policy’s benefit when we acquire the related life insurance policy. The origination fee we charge is included in the total purchase price we pay for a life insurance policy for purposes of our valuation and expected internal rate of return calculations, but is not netted against the purchase price we pay to a seller of an insurance policy. We generated cash flows of $0.4 million and $1.0 million from origination fees in the first quarter of 2015 and 2014, respectively. Profits from intercompany origination fees for life insurance policies retained by the Company are eliminated from our consolidated statements of operations. As such, the origination fees collected under our life insurance policy financing arrangements are reflected in our consolidated statements of cash flows as cash flows from financing activities as they are received from borrowings used to finance the acquisition of life insurance policies. Our revolving credit facility allows DLP II to borrow the funds necessary to pay origination fees to GWG Life. Our borrowing agreements allow us to use net proceeds of the L Bonds for policy acquisition, which includes origination fees. If the policy acquisition is not financed, no fees are included in the consolidated cash flows. See “Cash Flows” below for further information. We determine the value of life insurance policies in accordance with ASC 325-30, Investments in Insurance Contracts, using the fair value method. Under the fair value method, the initial investment is recorded at the transaction price. Because the origination fees are paid from a wholly owned subsidiary to the parent company, these fees are not included in the transaction price as reflected in our consolidated financial statements. For further discussion on our accounting policies for life settlements, please refer to note 1 to our consolidated financial statements.

As of March 31, 2015 and December 31, 2014, we had approximately $39.9 million and $51.2 million, respectively, in combined available cash and available borrowing base surplus capacity under our revolving credit facility for the purpose of purchasing additional life insurance policies, paying premiums on existing policies, paying portfolio servicing expenses, and paying principal and interest on our outstanding financing obligations.

In September 2012, we concluded a Series A Preferred Stock offering, having received an aggregate $24.6 million in subscriptions for our Series A Preferred Stock. These subscriptions consisted of $14.0 million in conversions of outstanding Series I Secured Notes and $10.6 million of new investments. We have used the proceeds from the sale of our Series A Preferred Stock to fund our operational expenditures.

In June 2011, GWG registered a $250.0 million debt offering of our Renewable Secured Debentures (subsequently renamed L Bonds) with the SEC. The registration became effective on January 31, 2012. Effective January 9, 2015, we launched a $1 billion follow-on to our publicly registered L Bond offering. Through March 31, 2015, the total amount of these L Bonds sold, including renewals, was $288.6 million. As of March 31, 2015, we had approximately $208.7 million in principal amount of L Bonds outstanding.

- 28 -

On September 24, 2014, we consummated an initial public offering of its common stock resulting in the sale of 800,000 shares of common stock at $12.50 per share and net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. We used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, to purchase additional life insurance policies in the secondary market, to pay premiums on our life insurance policy assets, to fund our portfolio operations, and for working capital purposes.

In November 2009, our wholly owned subsidiary GWG Life commenced private placement of Series I Secured Notes to accredited investors only. This offering was closed in November 2011. As of March 31, 2015, we had approximately $26.9 million in principal amount of Series I Secured Notes outstanding.

The weighted-average interest rate of our outstanding Series I Secured Notes as of March 31, 2015 and December 31, 2014 was 8.39% and 8.37%, respectively, and the weighted-average maturity at those dates was 2.11 and 2.01 years, respectively. The Series I Secured Notes have renewal features. Since we first issued our Series I Secured Notes, we have experienced $140.0 million in maturities, of which as of March 31, 2015, $109.2 million has renewed for an additional term. This has provided us with an aggregate renewal rate of approximately 78% for investments in these securities.

The weighted-average interest rate of our outstanding L Bonds as of March 31, 2015 and December 31, 2014 was 7.32% and 7.45%, respectively, and the weighted-average maturity at those dates was 3.32 and 3.45 years, respectively. Our L Bonds have renewal features. Since we first issued our L Bonds, we have experienced $79.9 in maturities, of which as of March 31, 2015, $53.6 million has renewed for an additional term. This has provided us with an aggregate renewal rate of approximately 67% for investments in these securities. Future contractual maturities of Series I Secured Notes and L Bonds at March 31, 2015 are:

Years Ending December 31,	Series I Secured Notes		L Bonds		Total
2015	$	9,426,000	$	56,626,000	$	66,052,000
2016		10,060,000		59,311,000		69,371,000
2017		5,873,000		36,939,000		42,812,000
2018		802,000		23,355,000		24,157,000
2019		347,000		14,342,000		14,689,000
Thereafter		418,000		18,156,000		18,574,000
	$	26,926,000	$	208,729,000	$	235,655,000

The L Bonds and Series I Secured Notes are secured by all our assets, and are subordinate to our revolving credit facility with Autobahn/DZ Bank. The L Bonds and Series I Secured Notes are pari passu with respect to a security interest in our assets pursuant to an intercreditor agreement (see notes 6 and 7 to our consolidated financial statements).

We maintain a $100 million revolving credit facility with Autobahn/DZ Bank through GWG Life’s wholly owned subsidiary DLP II. As of both March 31, 2015 and December 31, 2014, we had $72.2 million outstanding under the revolving credit facility and maintained an available borrowing base surplus of $3.7 million and $20.6 million, respectively (see note 5 to our condensed consolidated financial statements). Effective May 11, 2015, we amended and restated our credit facility (see “- Amended and Restated Credit Facility” below for more information.)

- 29 -

We expect to meet our ongoing operational capital needs through a combination of policy benefit revenues, origination fees, and proceeds from financing transactions. We expect to meet our policy acquisition, servicing, and financing capital needs principally from the receipt of policy benefit revenues from our portfolio of life insurance policies, net proceeds from our offering of L Bonds, and from our revolving credit facility. Because we only receive origination fees when we purchase a policy, our receipt of those fees is contingent upon our consummation of policy purchases, which is, in turn, contingent upon our receipt of external funding. We have demonstrated continued access to credit and financing markets. Furthermore, we expect that policy benefit payments will increase as the average age of the insureds increase and mortality events occur over time which trend we expect to experience more significantly in 2015 with steady increase until 2018. As a result of the foregoing, we estimate that our liquidity and capital resources are sufficient for our current and projected financial needs. Nevertheless, if we are unable to continue our offering of L Bonds for any reason (or if we become unsuccessful in selling L Bonds), and we are unable to obtain capital from other sources, we expect that our business would be materially and adversely affected. In addition, our business would be materially and adversely affected if we did not receive the policy benefits we forecast and if holders of our L Bonds or Series I Secured Notes failed to renew with the frequency we have historically experienced. In such a case, we could be forced to sell our investments in life insurance policies to service or satisfy our debt-related obligations and continue to pay policy premiums.

Capital expenditures have historically not been material and we do not anticipate making material capital expenditures in 2015 or beyond.

Debt Financings Summary

We had the following outstanding debt balances as of March 31, 2015:

Issuer/Borrower	Principal Amount Outstanding		Weighted Average Interest Rate
GWG Holdings, Inc. – L Bonds	$	208,729,000		7.32	%
GWG Life Settlements, LLC - Series I Notes, secured		26,926,000		8.39	%
GWG DLP Funding II, LLC - Revolving credit facility		72,161,000		6.22	%
Total	$	307,816,000		7.16	%

Our total credit facility and other indebtedness balance as of March 31, 2015 and December 31, 2014 was $307.8 million and $286.6 million, respectively. At March 31, 2015, the total outstanding face amount under our Series I Secured Notes outstanding was $26.9 million, less unamortized selling costs of $0.4 million, resulting in a carrying amount of $26.5 million. At December 31, 2014, the total outstanding face amount under our Series I Secured Notes outstanding was $28.0 million, less unamortized selling costs of $0.4 million, resulting in a carrying amount of $27.6 million. At March 31, 2015, the total outstanding face amount of L Bonds was $208.7 million plus $2.6 million of subscriptions in process, less unamortized selling costs of $6.3 million resulting in a carrying amount of $205.0 million. At December 31, 2014, the total outstanding face amount of L Bonds was $186.4 million plus $2.3 million of subscriptions in process, less unamortized selling costs of $5.9 million resulting in a carrying amount of $182.8 million. At March 31, 2015, the fair value of our investments in life insurance policies of $278.4 million plus our cash balance of $36.2 million and our restricted cash balance of $11.3 million, totaled $325.9 million, representing an excess of portfolio assets over secured indebtedness of $18.1 million. At December 31, 2014, the fair value of our investments in life insurance policies of $282.8 million plus our cash balance of $30.7 million and our restricted cash balance of $4.3 million, totaled $317.8 million, representing an excess of portfolio assets over secured indebtedness of $31.2 million. At March 31, 2015 our weighted average cost of capital was approximately 7.16%. The L Bonds and Series I Secured Notes are secured by all our assets and are subordinate to our revolving credit facility with Autobahn/DZ Bank. The L Bonds and Series I Secured Notes are pari passu with respect to a security interest in our asset pursuant to an intercreditor agreement.

- 30 -

The following forward-looking table seeks to illustrate the impact of a hypothetical sale of our portfolio of life insurance assets at various discount rates in order to satisfy our debt obligations as of March 31, 2015. In all cases, the sale of the life insurance assets owned by DLP II will be used first to satisfy all amounts owing under the revolving credit facility with Autobahn/ DZ Bank. The net sale proceeds remaining after satisfying all obligations under the revolving credit facility would be applied to L Bonds and Series I Secured Notes on a pari passu basis.

Portfolio Discount Rate	10%		11%		12%		13%
Value of portfolio	$	296,779,000	$	283,258,000	$	270,763,833	$	259,195,000
Cash and cash equivalents		47,524,000		47,524,000		47,524,000		47,524,000
Total assets		344,303,000		330,782,000		318,287,833		306,719,000
Revolving credit facility Autobahn/DZ Bank		72,161,000		72,161,000		72,161,000		72,161,000
Net after revolving credit facility		272,142,000		258,621,000		246,127,000		234,558,000
Series I Secured Notes and L Bonds		235,652,000		235,652,000		235,652,000		235,652,000
Net after Series I Secured Notes and L Bonds		36,490,000		22,969,000		10,475,000		(1,094,000	)
Impairment to Series I Secured Notes and L Bonds	No impairment		No impairment		No impairment		impairment

The table illustrates that our ability to fully satisfy amounts owing under the L Bonds and Series I Secured Notes would likely be impaired upon the sale of all our life insurance assets at a price equivalent to a discount rate of approximately 12.90% or higher. At December 31, 2014 the impairment occurred at discount rate of approximately 14.09% or higher. The discount rates used to calculate the fair value of our portfolio for mark-to-market accounting were 11.38% and 11.43% as of March 31, 2015 and December 31, 2014, respectively.

The table does not include any allowance for transactional fees and expenses associated with a portfolio sale (which expenses and fees could be substantial), and is provided to demonstrate how various discount rates used to value our portfolio could affect our ability to satisfy amounts owing under our debt obligations, in light of our senior secured lender’s right to priority payments. You should read the above table in conjunction with the information contained in other sections of this report, including our discussion of discount rates included under the “— Critical Accounting Policies — Valuation of Insurance Policies” caption above. This discussion and analysis is based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. The forward-looking presentation above is subject to numerous risks and uncertainties. Our actual results could differ materially from those suggested or implied by the above table. Please see the caption “Risk Relating to Forward-Looking Statements” above.

Amended and Restated Credit Facility

Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into an Second Amended and Restated Credit and Security Agreement with Autobahn Funding Company LLC, as the conduit lender, and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as the committed lender and as the agent on behalf of secured parties under such agreement.  The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings made by the Company’s subsidiaries, GWG DLP Funding II, LLC and GWG DLP Funding III, LLC, to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance, or at the lender’s cost of borrowing plus 4.75 percent, which is 1.75 percent less than under the previous Credit and Security Agreement executed on January 25, 2013.  In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement also removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

In connection with the Second Amended and Restated Credit and Security Agreement, GWG Holdings and its subsidiaries entered into certain other agreements and amendments and restatements of earlier agreements entered into in connection with the original and renewal Credit and Security Agreements.  Included among these other agreements was an Amended and Restated Performance Guaranty affirming the performance guaranty that GWG Holdings earlier provided in connection with the original and first amended and related Credit and Security Agreements to DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as agent.

Cash Flows

The payment of premiums and servicing costs to maintain life insurance policies represents our most significant requirement for cash disbursement. When a policy is purchased, we are able to calculate the minimum premium payments required to maintain the policy in-force. Over time as the insured age, premium payments will increase; however, the probability of actually needing to pay the premiums decreases since mortality becomes more likely. These scheduled premiums and associated probabilities are factored into our expected internal rate of return and cash-flow modeling described herein. Beyond premiums, we incur policy servicing costs, including annual trustee and tracking costs, and debt servicing costs, including principal and interest payments. Until we receive a stable amount of proceeds from the policy benefits, we intend to pay these costs from our credit facility, when permitted, and through the issuance of debt securities, including the L Bonds.

The amount of payments for anticipated premiums and servicing costs that we will be required to make over the next five years to maintain our current portfolio, assuming no mortalities, is set forth in the table below.

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Nine months ending December 31 ,2015	$	18,635,000	$	352,000	$	18,987,000
2016		26,899,000		352,000		27,251,000
2017		30,098,000		352,000		30,450,000
2018		32,813,000		352,000		33,165,000
2019		36,454,000		352,000		36,806,000
2020		40,389,000		352,000		40,741,000
	$	185,288,000	$	2,112,000	$	187,400,000

- 31 -

For the quarter end dates set forth below, the following table illustrates the total amount of face value of policy benefits owned, and the trailing 12 months of life insurance policy benefits collected and premiums paid on our portfolio. The trailing 12-month benefits/premium coverage ratio indicates the ratio of policy benefits received to premiums paid over the trailing 12-month period from our portfolio of life insurance policies.

Quarter End Date	Portfolio Face Amount		12-Month Trailing Benefits Collected		12-Month Trailing Premiums Paid		12-Month Trailing Benefits/Premium Coverage Ratio
March 31, 2012	$	482,455,000	$	4,203,000	$	14,977,000		28.06	%
June 30, 2012		489,255,000		8,703,000		15,412,000		56.47	%
September 30, 2012		515,661,000		7,833,000		15,837,000		49.46	%
December 31, 2012		572,245,000		7,350,000		16,597,000		44.28	%
March 31, 2013		639,755,000		11,350,000		18,044,000		62.90	%
June 30, 2013		650,655,000		13,450,000		19,182,000		70.11	%
September 30, 2013		705,069,000		18,450,000		20,279,000		90.98	%
December 31, 2013		740,648,000		16,600,000		21,733,000		76.38	%
March 31, 2014		771,940,000		12,600,000		21,930,000		57.46	%
June 30, 2014		784,652,000		6,300,000		22,598,000		27.88	%
September 30, 2014		787,964,000		4,300,000		23,121,000		18.60	%
December 31, 2014		779,099,000		18,050,000		23,265,000		77.58	%
March 31, 2015		754,942,000		46,675,000		23,786,000		196.23	%

We believe that the portfolio cash flow results set forth above are consistent with our general investment thesis: that the life insurance policy benefits we receive will continue to increase over time in relation to the premiums we are required to pay on the remaining polices in the portfolio. Nevertheless, we expect that our portfolio cash flow results on a period-to-period basis will remain inconsistent until such time as we achieve our goal of acquiring a larger, more diversified portfolio of life insurance policies in order to obtain more normalized actuarial results. As our receipt of life insurance policy benefits increases, we expect to begin servicing and paying down our outstanding indebtedness, or alternatively purchasing additional life insurance policies, from these cash flows.

The life insurance policies owned by DLP II are subject to a collateral arrangement with the agent to our revolving credit lender, as described in note 5 to the consolidated financial statements. Under this arrangement, collection and escrow accounts are used to fund purchases and premiums of the insurance policies and to pay interest and other charges under our revolving credit facility. The lender and its agent must authorize all disbursements from these accounts, including any distributions to GWG Life or Holdings. Distributions are limited to an amount that would result in the borrowers (DLP II, GWG Life, and Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by the agent. After such amount is reached, the credit agreement requires that excess funds be used to fund repayments or a reserve account in a certain amount before any additional distributions may be made. In the future, these arrangements may restrict the cash flows available for payment of principal and interest on our debt obligations.

- 32 -

Inflation

Changes in inflation do not necessarily correlate with changes in interest rates. We presently do not foresee any material impact of inflation on our results of operations in the periods presented in our consolidated financial statements.

Off-Balance Sheet Arrangements

Operating Lease - We entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. We are obligated to pay base rent plus common area maintenance and a share of the building operating costs. The minimum lease payment under the lease agreement is $0.1 million in 2015.

Credit Risk

We review the credit risk associated with our portfolio of life insurance policies when estimating its fair value. In evaluating the policies’ credit risk we consider insurance company solvency, credit risk indicators, economic conditions, ongoing credit evaluations, and company positions. We attempt to manage our credit risk related to life insurance policies typically by purchasing policies issued only from companies with an investment grade credit rating by either Standard & Poor’s, Moody’s, or A.M. Best Company. As of March 31, 2015, 97.81% of our life insurance policies, by face value benefits, were issued by companies that maintained an investment grade rating (BBB or better) by Standard & Poor’s.

Interest Rate Risk

Our credit facility is floating-rate financing. In addition, our ability to offer interest rates that attract capital (including in our continuous offering of L Bonds) is generally impacted by prevailing interest rates. Furthermore, while our other indebtedness provides us with fixed-rate financing, our debt coverage ratio is calculated in relation to our total cost of financing. Therefore, fluctuations in interest rates impact our business by increasing our borrowing costs, and reducing availability under our debt financing arrangements. Furthermore, we calculate our portfolio earnings based upon the spread generated between the return on our life insurance portfolio and the cost of our financing. As a result, increases in interest rates will reduce the earnings we expect to achieve from our investments in life insurance policies.

Non-GAAP Financial Measures

We use non-GAAP financial measures when evaluating our financial results, for planning and forecasting purposes, and for maintaining compliance with covenants contained in our borrowing agreements. Non-GAAP financial measures disclosed by management are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results. These non-GAAP financial measures are not in accordance with GAAP and may be different from non-GAAP measures used by other companies, including other companies within our industry. This presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for comparable amounts prepared in accordance with GAAP. See the notes to our consolidated financial statements and our audited financial statements contained herein.

We have elected to carry our investments in life insurance policies at fair value in accordance with ASC 325-30, Investments in Life Insurance Contracts. Accordingly, we value our investments in life insurance policies at the conclusion of each reporting period in accordance with GAAP fair value accounting principles. In addition to GAAP, we are required to report non-GAAP financial measures to Autobahn/DZ Bank under certain financial covenants made to that lender under our revolving credit facility. As indicated above, we also use non-GAAP financial reporting to manage and evaluate the financial performance of our business.

- 33 -

GAAP-based fair value requires us to mark-to-market our investments in life insurance policies, which by its nature, is based upon Level 3 measurements that are unobservable. As a result, this accounting treatment imports financial market volatility and subjective inputs into our financial reporting. We believe this type of reporting is at odds with one of the key attractions for purchasing and owning a portfolio life insurance policies: the non-correlated nature of the returns to be derived from such policies. Therefore, in contrast to a GAAP-based fair valuation, we seek to measure the accrual of the actuarial gain occurring within the portfolio of life insurance policies at their expected internal rate of return based on statistical mortality probabilities for the insureds (using primarily the insured’s age, sex, health and smoking status). The expected internal rate of return tracks actuarial gain occurring within the policies according to a mortality table as the insureds’ age increases. By comparing the actuarial gain accruing within our portfolio of life insurance policies against our costs during the same period, we can estimate, manage and evaluate the overall financial profitability of our business without regard to mark-to-market volatility. We use this information to balance our life insurance policy purchasing and manage our capital structure, including the issuance of debt and utilization of our other sources of capital, and to monitor our compliance with borrowing covenants. We believe that these non-GAAP financial measures provide information that is useful for investors to understand period-over-period operating results separate and apart from fair value items that may, or could, have a disproportionately positive or negative impact on results in any particular period. 

Our credit facility requires us to maintain a “positive net income” and “tangible net worth” each of which are calculated on an adjusted non-GAAP basis on the method described above, without regard to GAAP-based fair value measures. In addition, our revolving credit facility requires us to maintain an “excess spread,” which is the difference between (i) the weighted average of our expected internal rate of return of our portfolio of life insurance policies and (ii) the weighted average of our credit facility’s interest rate. These calculations are made using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

In addition, the indenture under which our L Bonds were and continue to be issued, and the note issuance and security agreement under which our Series I Secured Notes were issued, require us to maintain a “debt coverage ratio” designed to ensure that the expected cash flows from our portfolio of life insurance policies is able to adequately service our total outstanding indebtedness. In addition, our L Bond indenture requires us to maintain a “subordination ratio” limiting the total amount of indebtedness that can be issued senior in rank to the L Bonds and Series I Secured Notes. These ratios are calculated using non-GAAP measures in the method described below, without regard to GAAP-based fair value measures.

Adjusted Non-GAAP Net Income. Our credit facility requires us to maintain a positive net income calculated on an adjusted non-GAAP basis. We calculate the adjusted net income by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value. We net this actuarial gain against our costs during the same period to calculate our net income on a non-GAAP basis.

Three months ended March 31,	2015		2014
GAAP net gain (loss)	$	3,262,000	$	(1,901,000	)
Unrealized fair value (gain) loss (1)		1,894,000		(11,359,000	)
Adjusted cost basis increase (2)		12,229,000		11,397,000
Accrual of unrealized actuarial gain (3)		4,241,000		7,305,000
Total adjusted non-GAAP income (4)	$	21,626,000	$	5,442,000

(1)	Reversal of unrealized fair value gain or loss of life insurance policies for current period.
(2)	Adjusted cost basis is increased to include those acquisition and servicing expenses which are not capitalized under GAAP.

(3)	Accrual of actuarial gain at expected internal rate of return based on investment cost basis for the period.
(4)	We must maintain an annual positive consolidated net income, calculated on a non-GAAP basis, to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

- 34 -

Adjusted Non-GAAP Tangible Net Worth. Our revolving credit facility requires us to maintain a tangible net worth in excess of $15 million calculated on an adjusted non-GAAP basis. We calculate the adjusted tangible net worth by recognizing the actuarial gain accruing within our life insurance policies at the expected internal rate of return of the policies we own without regard to fair value. We net this actuarial gain against our costs during the same period

to calculate our tangible net worth on a non-GAAP basis.

	As of March 31, 2015			As of December 31, 2014
GAAP net worth	$	25,869,000		$	22,390,000
Less intangible assets (1)		(9,276,000	)		(8,132,000	)
GAAP tangible net worth		16,593,000			14,258,000
Unrealized fair value gain (2)		(152,778,000	)		(154,672,000	)
Adjusted cost basis increase (3)		150,930,000			147,673,000
Accrual of unrealized actuarial gain (4)		84,030,000			80,122,000
Total adjusted non-GAAP tangible net worth (5)	$	98,775,000		$	87,381,000

(1)	Unamortized portion of deferred financing costs and pre-paid insurance.
(2)	Reversal of cumulative unrealized fair value gain or loss of life insurance policies.
(3)	Adjusted cost basis is increased by acquisition and servicing expenses which are not capitalized under GAAP.
(4)	Accrual of cumulative actuarial gain at expected internal rate of return based on investment cost basis.
(5)	We must maintain a total adjusted non-GAAP tangible net worth of $15 million to maintain compliance with our revolving credit facility with DZ Bank/Autobahn.

Excess Spread. Our revolving credit facility requires us to maintain a 2.00% “excess spread” between our weighted-average expected internal rate of return of our portfolio of life insurance policies and the credit facility’s interest rate. A presentation of our excess spread and our total excess spread is set forth below. Management uses the “total excess spread” to gauge expected profitability of our investments, and uses the “excess spread” to monitor compliance with our borrowing.

	As of March 31, 2015			As of December 31, 2014
Weighted-average expected IRR (1)		11.33	%		11.78	%
Weighted-average revolving credit facility interest rate (2)		6.22	%		6.24	%
Excess spread (3)		5.11	%		5.54	%
Total weighted-average interest rate on indebtedness for borrowed money (4)		7.16	%		7.24	%
Total excess spread		4.17	%		4.54	%

(1) This represents the weighted-average expected internal rate of return of the life insurance policies as of the measurement date based upon our investment cost basis of the insurance policies and the expected cash flows from the life insurance portfolio. Our investment cost basis is calculated as our cash investment in the life insurance policies, without regard to GAAP-based fair value measurements, and is set forth below:

Investment Cost Basis	As of March 31, 2015			As of December 31, 2014
GAAP fair value	$	278,395,000		$	282,883,000
Unrealized fair value gain (A)		(152,778,000	)		(154,672,000	)
Adjusted cost basis increase (B)		150,930,000			147,673,000
Investment cost basis (C)	$	276,547,000		$	275,884,000

(A) This represents the reversal of cumulative unrealized GAAP fair value gain of life insurance policies.

(B)	Adjusted cost basis is increased to include those acquisition and servicing expenses that are not capitalized under GAAP.
(C)	This is the full cash investment cost basis in life insurance policies from which our expected internal rate of return is calculated.

- 35 -

(2)	This is the weighted-average revolving credit relating to our revolving credit facility interest rate as of the measurement date.
(3)	We must maintain an excess spread of 2.00% relating to our revolving credit facility to maintain compliance under such facility.
(4)	Represents the weighted-average interest rate paid on all outstanding indebtedness as of the measurement date, determined as follows:

Outstanding Indebtedness	As of March 31, 2015		As of December 31, 2014
Revolving credit facility	$	72,161,000	$	72,161,000
Series I Secured Notes		26,926,000		28,047,000
L Bonds		208,729,000		186,377,000
Total	$	307,816,000	$	286,585,000

Interest Rates on Indebtedness
Revolving credit facility	6.22	%	6.19	%
Series I Secured Notes	8.39	%	8.35	%
L Bond	7.32	%	7.53	%
Weighted-average interest rates on indebtedness	7.16	%	7.20	%

(5) Calculated as the weighted-average expected IRR (1) minus the weighted-average interest rate on indebtedness for borrowed money (4).

Debt Coverage Ratio and Subordination Ratio. Our L Bond and Series I Secured Notes borrowing covenants require us to maintain a “debt coverage ratio” of less than 90%. The “debt coverage ratio” is calculated by dividing the sum of our total indebtedness by the sum of our cash and cash equivalents and the net present value of the life insurance portfolio. The “subordination ratio” for our L Bonds is calculated by dividing the total indebtedness that is senior to L Bonds and Series I Secured Notes by the sum of the company’s cash and cash equivalents and the net present value of the life insurance portfolio. The “subordination ratio” must be less than 50%. For purposes of both ratio calculations, the net present value of the life insurance portfolio is calculated using a discount rate equal to the weighted-average interest rate of all indebtedness.

	As of March 31, 2015			As of December 31, 2014
Life insurance portfolio policy benefits	$	754,942,000		$	779,099,000
Discount rate of future cash flows		7.16	%		7.24	%
Net present value of Life insurance portfolio policy benefits	$	341,867,000		$	347,786,000
Cash and cash equivalents		47,524,000			34,959,000
Total Coverage		389,391,000			382,745,000
Revolving credit facility		72,161,000			72,161,000
Series I Secured Notes		26,926,000			28,047,000
Renewable Secured Debentures		208,729,000			186,377,000
Total Indebtedness	$	307,816,000		$	286,585,000
Debt Coverage Ratio		79.04	%		74.88	%
Subordination Ratio		18.53	%		18.85	%

As of March 31, 2015, we were in compliance with both the debt coverage ratio and the subordination ratio as required under our financing agreements for L Bonds and Series I Secured Notes.

- 36 -

Our Portfolio

Our portfolio of life insurance policies, owned by our subsidiaries as of March 31, 2015, is summarized below:

Life Insurance Portfolio Summary 

Total portfolio face value of policy benefits	$	754,942,000
Average face value per policy	$	2,577,000
Average face value per insured life	$	2,817,000
Average age of insured (yrs.) *		82.9
Average life expectancy estimate (yrs.) *		6.48
Total number of policies		293
Number of unique lives		268
Gender		68% Males; 32% Females
Number of smokers		3
Largest policy as % of total portfolio		1.32	%
Average policy as % of total portfolio		0.34	%
Average Annual Premium as % of face value		3.35	%

*  Averages presented in the table are weighted averages.

Our portfolio of life insurance policies, owned by our subsidiaries as of March 31, 2015, organized by the insured’s current age and the associated policy benefits, is summarized below:

Distribution of Policy Benefits by Current Age of Insured

Min Age		Max Age		Policy Benefits		Weighted Average Life Expectancy (yrs.)		Percentage of Total Policy Benefits
	90		94		35,497,000		3.06		4.70	%
	85		89		227,191,000		4.92		30.09	%
	80		84		275,133,000		6.90		36.44	%
	75		79		175,198,000		8.02		23.21	%
	70		74		31,767,000		9.27		4.21	%
	65		69	$	10,156,000		7.06		1.35	%
	Total			$	754,942,000		6.48		100.00	%

Our portfolio of life insurance policies, owned by our subsidiaries as of March 31, 2015, organized by the insured’s current age and number of policies owned, is summarized below:

Distribution of Policies by Current Age of Insured

Min Age		Max Age		Policies		Weighted Average Life Expectancy (yrs.)		Percentage of Total Policies
	90		94		16		3.06		5.46	%
	85		89		95		4.92		32.42	%
	80		84		98		6.90		33.45	%
	75		79		58		8.02		19.80	%
	70		74		18		9.27		6.14	%
	65		69		8		7.06		2.73	%
	Total				293		6.48		100.00	%

- 37 -

Our portfolio of life insurance policies, owned by our subsidiaries as of March 31, 2015, organized by the insured’s estimated life expectancy estimates and associated policy benefits, is summarized below:

Distribution of Policies by Current Life Expectancies of Insured

Min LE (Months)		Max LE (Months)		Policy Benefits		Distribution
	10		47	$	121,539,000		16.10	%
	48		71		199,233,000		26.39	%
	72		95		227,107,000		30.08	%
	96		119		141,111,000		18.69	%
	120		143		54,200,000		7.18	%
	144		159		11,752,000		1.56	%
	Total			$	754,942,000		100.00	%

We track concentrations of pre-existing medical conditions among insured individuals within our portfolio based on information contained in life expectancy reports. We track these medical conditions within the following ten primary disease categories: (1) cancer, (2) cardiovascular, (3) cerebrovascular, (4) dementia, (5) diabetes, (6) multiple, (7) neurological disorders, (8) no disease, (9) other, and (10) respiratory diseases. Our primary disease categories are summary generalizations based on the ICD-9 codes we track on each insured individuals within our portfolio. ICD-9 codes, published by the World Health Organization, are used worldwide for medical diagnoses and treatment systems, as well as morbidity and mortality statistics. Currently, cardiovascular is the only primary disease category within our portfolio that represents a concentration of over 10%.

Our portfolio of life insurance policies, owned by our subsidiaries as of March 31, 2015, organized by the primary disease categories of the insured and associated policy benefits, is summarized below:

Distribution of Policy Benefits by Primary Disease Category

Primary Disease Category	Policy Benefits		Distribution
Cancer	$	59,750,000		7.91	%
Cardiovascular		131,874,000		17.47	%
Cerebrovascular		24,462,000		3.24	%
Dementia		60,449,000		8.01	%
Diabetes		63,617,000		8.43	%
Multiple		176,585,000		23.39	%
Neurological Disorders		16,104,000		2.13	%
No Disease		94,718,000		12.55	%
Other		85,933,000		11.38	%
Respiratory Diseases		41,450,000		5.49	%
Total Policy Benefits	$	754,942,000		100.00	%

The primary disease category represents a general category of impairment. Within the primary disease category, there are a multitude of subcategorizations defined more specifically by ICD-9 codes. For example, a primary disease category of cardiovascular includes subcategorizations such as atrial fibrillation, heart valve replacement, coronary atherosclerosis, etc. In addition, individuals may have more than one ICD-9 code describing multiple medical conditions within one or more primary disease categories. Where an individual’s ICD-9 codes indicate medical conditions in more than one primary disease categories, we categorize the individual as having multiple primary disease categories. We expect to continue to develop and refine our identification and tracking on the insured individuals medical conditions as we manage our portfolio of life insurance policies.

Portfolio Credit Risk Management

The life insurance assets in which we invest represent obligations of third-party life insurance companies to pay the benefits under the relevant policy. We rely on the payment of policy benefits by life insurance companies as our sole source of revenue collection. Accordingly, the possible insolvency of a life insurance company is a significant risk to our business. To manage this risk, we seek to invest in life insurance assets that are issued by insurance companies with investment-grade ratings from either A.M. Best, Moody’s or Standard & Poor’s. To further mitigate risk, we seek to have no more than 20% of our aggregate face value of policy benefits in our portfolio issued by any one life insurance company. In addition, to assure diversity and stability in our portfolio, we regularly review the various metrics of our portfolio relating to credit risk. We track industry rating agency reports and industry journals and articles in order to gain insight into possible financial problems of life insurance companies. Finally, we only invest in those life insurance policies that meet the underwriting standards established in the indenture governing our debt securities, as applicable.

- 38 -

As of March 31, 2015, 93.2% of insurance companies in our portfolio hold an investment-grade rating by Standard & Poor’s (BBB- or better), and the highest percentage of face value of policy benefits issued by one life insurance company within our portfolio was 15.02%. Of the 44 insurance companies that insure the policies we own, ten companies insure approximately 72.50% of total face value of policy benefits and the other 34 insurance companies insure the remaining approximately 27.50% of total face value of policy benefits. The concentration risk of our ten largest insurance company holdings as of March 31, 2015 is set forth in the table below.

Rank		Policy Benefits		Percentage  of Policy Benefit Amt.			Insurance Company	Ins. Co. S&P Rating
	1	$	113,380,000		15.02	%	AXA Equitable Life Insurance Company	A+
	2	$	89,470,000		12.03	%	John Hancock Life Insurance Company (U.S.A)	AA-
	3	$	76,672,000		10.32	%	Transamerica Life Insurance Company	AA-
	4	$	58,769,000		7.78	%	Jefferson-Pilot Life Insurance Company	AA-
	5	$	56,215,000		6.00	%	Voya Retirement and Insurance Company	A
	6	$	42,735,000		5.53	%	Massachusetts Mutual Life Insurance Company	AA+
	7	$	41,750,000		4.47	%	American General Life Insurance Company	A+
	8	$	30,500,000		4.04	%	Pacific Life Insurance Company	A+
	9	$	28,450,000		3.77	%	West Coast Life Insurance Company	AA-
	10	$	26,661,000		3.53	%	Metropolitan Life Insurance Company	AA-

Life Insurance Portfolio Detail

(as of March 31, 2015)

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
1	$	4,000,000	Male		94		36.2	MetLife Investors USA Insurance Company	AA-
2	$	1,100,000	Male		94		30.6	Voya Retirement and Insurance Company	A
3	$	1,500,000	Female		94		34.2	Aviva Life Insurance Company	A-
4	$	1,000,000	Female		93		40.2	Transamerica Life Insurance Company	AA-
5	$	3,200,000	Male		93		28.7	West Coast Life Insurance Company	AA-
6	$	264,000	Female		92		26.3	Lincoln Benefit Life Company	BBB+
7	$	250,000	Male		92		23.6	Transamerica Life Insurance Company	AA-
8	$	3,000,000	Male		91		47.9	West Coast Life Insurance Company	AA-
9	$	500,000	Male		91		16.7	John Hancock Life Insurance Company (U.S.A)	AA-
10	$	5,000,000	Female		91		54.7	American General Life Insurance Company	A+
11	$	2,000,000	Female		91		15.4	Pruco Life Insurance Company	AA-
12	$	1,682,773	Female		90		53.0	Hartford Life and Annuity Insurance Company	BBB+
13	$	5,000,000	Male		90		34.4	John Hancock Life Insurance Company (U.S.A)	AA-
14	$	1,000,000	Male		90		26.9	State Farm Life Insurance Company	AA-
15	$	5,000,000	Female		90		34.4	John Hancock Life Insurance Company (U.S.A)	AA-
16	$	1,000,000	Male		90		10.1	Voya Retirement and Insurance Company	A
17	$	1,000,000	Female		89		53.1	United of Omaha Life Insurance Company	A+
18	$	3,500,000	Female		89		58.7	John Hancock Life Insurance Company (U.S.A)	AA-
19	$	3,100,000	Female		89		36.0	Lincoln Benefit Life Company	BBB+
20	$	1,500,000	Female		89		70.0	Jefferson-Pilot Life Insurance Company	AA-

- 39 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
21	$	2,500,000	Female		89		9.7	AXA Equitable Life Insurance Company	A+
22	$	2,500,000	Female		89		9.7	AXA Equitable Life Insurance Company	A+
23	$	3,000,000	Female		89		35.5	Jefferson-Pilot Life Insurance Company	AA-
24	$	5,000,000	Female		89		42.3	Voya Retirement and Insurance Company	A
25	$	5,000,000	Female		89		20.1	Lincoln National Life Insurance Company	AA-
26	$	715,000	Female		89		62.6	Jefferson-Pilot Life Insurance Company	AA-
27	$	1,203,520	Male		89		46.2	Columbus Life Insurance Company	AA
28	$	1,350,000	Female		89		38.0	Jefferson-Pilot Life Insurance Company	AA-
29	$	600,000	Female		89		23.4	Columbus Life Insurance Company	AA
30	$	5,000,000	Female		88		51.7	Massachusetts Mutual Life Insurance Company	AA+
31	$	2,500,000	Female		88		50.3	American General Life Insurance Company	A+
32	$	2,500,000	Male		88		41.9	Pacific Life Insurance Company	A+
33	$	5,000,000	Male		88		55.6	AXA Equitable Life Insurance Company	A+
34	$	1,103,922	Female		88		64.6	Sun Life Assurance Company of Canada (U.S.)	AA-
35	$	1,500,000	Male		88		44.7	John Hancock Life Insurance Company (U.S.A)	AA-
36	$	1,500,000	Male		88		44.7	John Hancock Life Insurance Company (U.S.A)	AA-
37	$	1,000,000	Female		88		67.7	Transamerica Life Insurance Company	AA-
38	$	250,000	Female		88		67.7	Transamerica Life Insurance Company	AA-
39	$	1,050,000	Male		88		47.4	John Hancock Life Insurance Company (U.S.A)	AA-
40	$	500,000	Male		88		64.0	Lincoln National Life Insurance Company	AA-
41	$	4,785,380	Female		88		46.7	John Hancock Life Insurance Company (U.S.A)	AA-
42	$	1,803,455	Female		88		51.4	Metropolitan Life Insurance Company	AA-
43	$	1,529,270	Female		88		51.4	Metropolitan Life Insurance Company	AA-
44	$	800,000	Male		88		74.4	Lincoln National Life Insurance Company	AA-
45	$	5,000,000	Male		88		54.5	John Hancock Life Insurance Company (U.S.A)	AA-
46	$	2,225,000	Female		88		88.2	Transamerica Life Insurance Company	AA-
47	$	3,000,000	Female		88		84.2	Massachusetts Mutual Life Insurance Company	AA+
48	$	1,500,000	Male		88		48.5	Union Central Life Insurance Company	A+
49	$	3,500,000	Female		88		43.3	Lincoln National Life Insurance Company	AA-
50	$	3,000,000	Male		88		35.1	American General Life Insurance Company	A+
51	$	500,000	Female		87		70.4	Sun Life Assurance Company of Canada (U.S.)	AA-
52	$	5,000,000	Female		87		36.8	Transamerica Life Insurance Company	AA-
53	$	3,000,000	Male		87		53.2	Transamerica Life Insurance Company	AA-
54	$	250,000	Male		87		74.6	Metropolitan Life Insurance Company	AA-
55	$	6,000,000	Female		87		58.5	Sun Life Assurance Company of Canada (U.S.)	AA-
56	$	4,000,000	Female		87		74.6	Transamerica Life Insurance Company	AA-
57	$	1,000,000	Female		87		37.8	New York Life Insurance Company	AA+
58	$	1,000,000	Male		87		57.4	AXA Equitable Life Insurance Company	A+
59	$	10,000,000	Female		87		74.4	West Coast Life Insurance Company	AA-
60	$	2,500,000	Male		87		50.4	Transamerica Life Insurance Company	AA-
61	$	1,000,000	Female		87		53.3	West Coast Life Insurance Company	AA-
62	$	2,000,000	Female		87		53.3	West Coast Life Insurance Company	AA-
63	$	800,000	Male		87		57.8	National Western Life Insurance Company	A

- 40 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
64	$	200,000	Male		87		50.8	Lincoln Benefit Life Company	BBB+
65	$	4,445,467	Male		87		61.0	Penn Mutual Life Insurance Company	A+
66	$	7,500,000	Male		87		52.6	Jefferson-Pilot Life Insurance Company	AA-
67	$	3,600,000	Female		87		60.1	AXA Equitable Life Insurance Company	A+
68	$	1,000,000	Female		87		29.7	John Hancock Life Insurance Company (U.S.A)	AA-
69	$	4,513,823	Female		87		25.5	Aviva Life Insurance Company	A-
70	$	3,000,000	Male		87		45.9	Jefferson-Pilot Life Insurance Company	AA-
71	$	2,000,000	Male		87		49.3	John Hancock Life Insurance Company (U.S.A)	AA-
72	$	100,000	Female		87		59.6	American General Life Insurance Company	A+
73	$	100,000	Female		87		59.6	American General Life Insurance Company	A+
74	$	2,000,000	Female		87		77.6	U.S. Financial Life Insurance Company	A+
75	$	1,000,000	Male		86		63.4	John Hancock Life Insurance Company (U.S.A)	AA-
76	$	2,000,000	Male		86		63.4	John Hancock Life Insurance Company (U.S.A)	AA-
77	$	5,000,000	Male		86		51.4	Jefferson-Pilot Life Insurance Company	AA-
78	$	1,200,000	Male		86		62.6	Transamerica Life Insurance Company	AA-
79	$	1,000,000	Female		86		86.8	Voya Retirement and Insurance Company	A
80	$	200,000	Female		86		89.6	Lincoln National Life Insurance Company	AA-
81	$	3,000,000	Male		86		84.7	AXA Equitable Life Insurance Company	A+
82	$	8,500,000	Male		86		83.5	Massachusetts Mutual Life Insurance Company	AA+
83	$	1,000,000	Male		86		27.7	Transamerica Life Insurance Company	AA-
84	$	500,000	Male		86		84.3	Metropolitan Life Insurance Company	AA-
85	$	347,211	Male		86		46.9	Prudential Life Insurance Company	AA-
86	$	500,000	Female		86		57.4	Beneficial Life Insurance Company	N/A
87	$	5,000,000	Male		86		83.6	Lincoln National Life Insurance Company	AA-
88	$	2,000,000	Male		86		99.7	Voya Retirement and Insurance Company	A
89	$	2,000,000	Male		86		99.7	Voya Retirement and Insurance Company	A
90	$	2,000,000	Male		86		99.7	Voya Retirement and Insurance Company	A
91	$	1,365,000	Female		85		87.2	Transamerica Life Insurance Company	AA-
92	$	1,000,000	Male		85		42.2	Massachusetts Mutual Life Insurance Company	AA+
93	$	3,750,000	Male		85		78.4	AXA Equitable Life Insurance Company	A+
94	$	2,000,000	Male		85		87.0	Transamerica Life Insurance Company	AA-
95	$	1,000,000	Male		85		62.4	John Hancock Life Insurance Company (U.S.A)	AA-
96	$	2,000,000	Female		85		87.1	AXA Equitable Life Insurance Company	A+
97	$	3,000,000	Female		85		85.7	Sun Life Assurance Company of Canada (U.S.)	AA-
98	$	2,328,547	Male		85		46.7	Metropolitan Life Insurance Company	AA-
99	$	2,000,000	Male		85		46.7	Metropolitan Life Insurance Company	AA-
100	$	2,000,000	Male		85		64.1	Jefferson-Pilot Life Insurance Company	AA-
101	$	1,500,000	Male		85		51.4	Voya Retirement and Insurance Company	A
102	$	1,500,000	Male		85		51.4	Voya Retirement and Insurance Company	A
103	$	3,000,000	Female		85		73.3	Transamerica Life Insurance Company	AA-
104	$	5,000,000	Male		85		75.5	Voya Retirement and Insurance Company	A
105	$	1,000,000	Male		85		49.5	John Hancock Life Insurance Company (U.S.A)	AA-
106	$	1,800,000	Male		85		55.0	John Hancock Variable Life Insurance Company	AA-

- 41 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
107	$	5,000,000	Female		85		94.7	American General Life Insurance Company	A+
108	$	2,000,000	Male		85		66.2	AXA Equitable Life Insurance Company	A+
109	$	1,750,000	Male		85		66.2	AXA Equitable Life Insurance Company	A+
110	$	2,000,000	Male		85		37.0	Transamerica Life Insurance Company	AA-
111	$	1,425,000	Male		85		83.2	John Hancock Life Insurance Company (U.S.A)	AA-
112	$	5,000,000	Female		84		99.1	AXA Equitable Life Insurance Company	A+
113	$	1,000,000	Female		84		85.5	John Hancock Life Insurance Company (U.S.A)	AA-
114	$	6,000,000	Female		84		112.8	American General Life Insurance Company	A+
115	$	1,500,000	Male		84		51.5	Transamerica Life Insurance Company	AA-
116	$	1,500,000	Female		84		111.0	Lincoln Benefit Life Company	BBB+
117	$	4,000,000	Male		84		39.3	John Hancock Life Insurance Company (U.S.A)	AA-
118	$	1,000,000	Male		84		80.8	John Hancock Life Insurance Company (U.S.A)	AA-
119	$	2,000,000	Female		84		100.7	Lincoln Benefit Life Company	BBB+
120	$	1,000,000	Male		84		56.5	Voya Retirement and Insurance Company	A
121	$	2,700,000	Male		84		64.0	John Hancock Life Insurance Company (U.S.A)	AA-
122	$	829,022	Female		84		27.0	Hartford Life and Annuity Insurance Company	BBB+
123	$	1,500,000	Male		84		81.6	AXA Equitable Life Insurance Company	A+
124	$	5,000,000	Male		84		91.3	Voya Retirement and Insurance Company	A
125	$	7,600,000	Female		84		101.0	Transamerica Life Insurance Company	AA-
126	$	2,500,000	Female		84		66.6	American General Life Insurance Company	A+
127	$	2,500,000	Male		84		61.8	AXA Equitable Life Insurance Company	A+
128	$	3,000,000	Male		84		61.8	Lincoln National Life Insurance Company	AA-
129	$	500,000	Male		84		43.2	Genworth Life Insurance Company	BBB-
130	$	4,000,000	Female		84		52.4	Voya Retirement and Insurance Company	A
131	$	3,000,000	Female		84		45.8	AXA Equitable Life Insurance Company	A+
132	$	1,703,959	Male		84		69.9	Jefferson-Pilot Life Insurance Company	AA-
133	$	500,000	Male		84		20.6	Great Southern Life Insurance Company	N/A
134	$	1,000,000	Male		84		60.4	Hartford Life and Annuity Insurance Company	BBB+
135	$	3,500,000	Female		84		109.8	Lincoln Benefit Life Company	BBB+
136	$	5,000,000	Male		83		68.1	AXA Equitable Life Insurance Company	A+
137	$	500,000	Male		83		103.2	Metropolitan Life Insurance Company	AA-
138	$	2,000,000	Male		83		42.3	National Life Insurance Company	A
139	$	4,200,000	Female		83		120.9	Transamerica Life Insurance Company	AA-
140	$	750,000	Male		83		91.3	West Coast Life Insurance Company	AA-
141	$	5,000,000	Male		83		76.1	AXA Equitable Life Insurance Company	A+
142	$	5,000,000	Male		83		77.2	Jefferson-Pilot Life Insurance Company	AA-
143	$	1,500,000	Male		83		78.7	Jefferson-Pilot Life Insurance Company	AA-
144	$	3,500,000	Female		83		91.1	AXA Equitable Life Insurance Company	A+
145	$	3,000,000	Female		83		96.4	MetLife Investors USA Insurance Company	AA-
146	$	4,500,000	Male		83		76.6	AXA Equitable Life Insurance Company	A+
147	$	250,000	Male		83		55.2	Transamerica Life Insurance Company	AA-
148	$	2,275,000	Male		83		96.3	Voya Retirement and Insurance Company	A
149	$	2,000,000	Male		83		88.4	Pacific Life Insurance Company	A+

- 42 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
150	$	3,500,000	Male		83		75.2	AXA Equitable Life Insurance Company	A+
151	$	3,000,000	Male		83		63.8	Metropolitan Life Insurance Company	AA-
152	$	1,500,000	Male		83		27.8	Pacific Life Insurance Company	A+
153	$	2,000,000	Female		83		100.6	Jefferson-Pilot Life Insurance Company	AA-
154	$	10,000,000	Female		83		60.9	American National Insurance Company	A
155	$	500,000	Male		83		27.6	West Coast Life Insurance Company	AA-
156	$	3,500,000	Female		82		95.1	Jefferson-Pilot Life Insurance Company	AA-
157	$	1,000,000	Male		82		71.6	Lincoln National Life Insurance Company	AA-
158	$	3,000,000	Male		82		43.2	U.S. Financial Life Insurance Company	A+
159	$	1,500,000	Male		82		60.2	Pacific Life Insurance Company	A+
160	$	5,000,000	Male		82		113.4	American General Life Insurance Company	A+
161	$	1,900,000	Male		82		68.7	American National Insurance Company	A
162	$	500,000	Male		82		48.5	New York Life Insurance Company	AA+
163	$	500,000	Male		82		48.5	New York Life Insurance Company	AA+
164	$	250,000	Male		82		34.9	Jackson National Life Insurance Company	AA
165	$	5,000,000	Female		82		78.7	Sun Life Assurance Company of Canada (U.S.)	AA-
166	$	750,000	Male		82		84.8	John Hancock Life Insurance Company (U.S.A)	AA-
167	$	1,995,000	Female		82		83.3	Transamerica Life Insurance Company	AA-
168	$	4,000,000	Male		82		59.6	Jefferson-Pilot Life Insurance Company	AA-
169	$	1,250,000	Female		82		63.8	Columbus Life Insurance Company	AA
170	$	10,000,000	Male		82		82.0	AXA Equitable Life Insurance Company	A+
171	$	2,300,000	Male		82		23.9	American General Life Insurance Company	A+
172	$	6,217,200	Female		82		108.8	Phoenix Life Insurance Company	B+
173	$	2,500,000	Female		82		74.8	Voya Retirement and Insurance Company	A
174	$	5,000,000	Female		82		59.9	Massachusetts Mutual Life Insurance Company	AA+
175	$	5,000,000	Male		82		78.8	Transamerica Life Insurance Company	AA-
176	$	350,000	Male		82		39.0	Reassure America Life Insurance Company	AA
177	$	5,000,000	Male		82		86.7	Jefferson-Pilot Life Insurance Company	AA-
178	$	3,000,000	Male		81		71.2	Protective Life Insurance Company	AA-
179	$	1,500,000	Male		81		71.2	American General Life Insurance Company	A+
180	$	2,000,000	Female		81		119.7	Transamerica Life Insurance Company	AA-
181	$	5,000,000	Male		81		96.5	AXA Equitable Life Insurance Company	A+
182	$	550,000	Male		81		108.2	Genworth Life Insurance Company	BBB-
183	$	1,680,000	Female		81		72.9	AXA Equitable Life Insurance Company	A+
184	$	1,000,000	Female		81		101.5	Jefferson-Pilot Life Insurance Company	AA-
185	$	250,000	Male		81		153.5	Voya Retirement and Insurance Company	A
186	$	1,250,000	Male		81		105.5	Metropolitan Life Insurance Company	AA-
187	$	1,000,000	Male		81		70.4	AXA Equitable Life Insurance Company	A+
188	$	1,250,000	Female		81		79.4	Principal Life Insurance Company	A+
189	$	2,000,000	Male		81		44.6	Jefferson-Pilot Life Insurance Company	AA-
190	$	10,000,000	Male		81		84.2	New York Life Insurance Company	AA+
191	$	5,000,000	Male		81		77.6	AXA Equitable Life Insurance Company	A+
192	$	300,000	Female		81		78.8	Hartford Life and Annuity Insurance Company	BBB+

- 43 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
193	$	2,502,000	Male		81		157.5	Transamerica Life Insurance Company	AA-
194	$	10,000,000	Male		81		119.0	John Hancock Life Insurance Company (U.S.A)	AA-
195	$	2,000,000	Male		81		74.4	Ohio National Life Assurance Corporation	AA-
196	$	1,000,000	Male		81		74.4	Ohio National Life Assurance Corporation	AA-
197	$	3,000,000	Female		81		111.6	West Coast Life Insurance Company	AA-
198	$	7,000,000	Male		81		91.9	Genworth Life Insurance Company	BBB-
199	$	8,000,000	Male		80		88.7	AXA Equitable Life Insurance Company	A+
200	$	2,000,000	Male		80		32.0	Metropolitan Life Insurance Company	AA-
201	$	320,987	Female		80		111.9	John Hancock Life Insurance Company (U.S.A)	AA-
202	$	1,000,000	Male		80		61.2	AXA Equitable Life Insurance Company	A+
203	$	2,000,000	Female		80		95.0	Pacific Life Insurance Company	A+
204	$	3,000,000	Male		80		103.8	John Hancock Life Insurance Company (U.S.A)	AA-
205	$	1,750,000	Male		80		88.0	AXA Equitable Life Insurance Company	A+
206	$	250,000	Male		80		85.1	American General Life Insurance Company	A+
207	$	2,000,000	Female		80		93.5	Transamerica Life Insurance Company	AA-
208	$	3,000,000	Male		80		117.0	Principal Life Insurance Company	A+
209	$	1,210,000	Male		80		70.9	Lincoln National Life Insurance Company	AA-
210	$	3,000,000	Male		79		47.8	Pacific Life Insurance Company	A+
211	$	3,000,000	Male		79		47.8	Minnesota Life Insurance Company	A+
212	$	3,000,000	Male		79		47.8	Prudential Life Insurance Company	AA-
213	$	3,000,000	Male		79		96.9	Voya Retirement and Insurance Company	A
214	$	5,000,000	Male		79		84.9	Pacific Life Insurance Company	A+
215	$	5,000,000	Male		79		84.9	Pacific Life Insurance Company	A+
216	$	4,000,000	Male		79		86.6	Jefferson-Pilot Life Insurance Company	AA-
217	$	3,601,500	Male		79		100.8	Transamerica Life Insurance Company	AA-
218	$	5,000,000	Male		79		136.6	Principal Life Insurance Company	A+
219	$	5,000,000	Male		79		97.2	John Hancock Life Insurance Company (U.S.A)	AA-
220	$	7,000,000	Male		79		92.7	Lincoln Benefit Life Company	BBB+
221	$	476,574	Male		79		78.6	Transamerica Life Insurance Company	AA-
222	$	6,000,000	Male		79		129.6	AXA Equitable Life Insurance Company	A+
223	$	130,000	Male		79		55.8	Genworth Life Insurance Company	BBB-
224	$	1,000,000	Male		79		130.6	Empire General Life Assurance Corporation	AA-
225	$	4,300,000	Female		79		116.7	American National Insurance Company	A
226	$	6,000,000	Male		79		114.2	AXA Equitable Life Insurance Company	A+
227	$	750,000	Male		79		76.2	Lincoln National Life Insurance Company	AA-
228	$	500,000	Male		79		53.2	Transamerica Life Insurance Company	AA-
229	$	5,000,000	Male		78		85.1	John Hancock Life Insurance Company (U.S.A)	AA-
230	$	1,000,000	Male		78		97.6	Sun Life Assurance Company of Canada (U.S.)	AA-
231	$	5,000,000	Male		78		95.7	John Hancock Life Insurance Company (U.S.A)	AA-
232	$	1,009,467	Male		78		65.4	John Hancock Life Insurance Company (U.S.A)	AA-
233	$	4,000,000	Male		78		55.9	MetLife Investors USA Insurance Company	AA-
234	$	2,500,000	Male		78		94.8	Massachusetts Mutual Life Insurance Company	AA+
235	$	2,500,000	Male		78		94.8	Massachusetts Mutual Life Insurance Company	AA+

- 44 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
236	$	5,000,000	Male		78		62.8	John Hancock Life Insurance Company (U.S.A)	AA-
237	$	2,250,000	Male		78		101.2	Massachusetts Mutual Life Insurance Company	AA+
238	$	1,000,000	Female		78		131.3	John Hancock Life Insurance Company (U.S.A)	AA-
239	$	3,750,000	Male		78		64.9	AXA Equitable Life Insurance Company	A+
240	$	1,000,000	Male		78		117.7	Metropolitan Life Insurance Company	AA-
241	$	5,000,000	Female		78		123.9	Voya Retirement and Insurance Company	A
242	$	3,000,000	Male		78		102.7	Principal Life Insurance Company	A+
243	$	5,000,000	Male		77		126.0	Jefferson-Pilot Life Insurance Company	AA-
244	$	500,000	Male		77		73.5	John Hancock Life Insurance Company (U.S.A)	AA-
245	$	1,000,000	Male		77		122.4	Metropolitan Life Insurance Company	AA-
246	$	2,840,000	Male		77		106.3	Transamerica Life Insurance Company	AA-
247	$	500,000	Female		77		123.9	Columbus Life Insurance Company	AA
248	$	750,000	Male		77		14.5	U.S. Financial Life Insurance Company	A+
249	$	1,000,000	Female		77		82.7	John Hancock Life Insurance Company (U.S.A)	AA-
250	$	1,750,000	Male		77		69.5	John Hancock Life Insurance Company (U.S.A)	AA-
251	$	5,000,000	Male		77		111.3	Transamerica Life Insurance Company	AA-
252	$	2,000,000	Female		77		63.3	Transamerica Life Insurance Company	AA-
253	$	3,000,000	Male		76		112.7	Protective Life Insurance Company	AA-
254	$	4,000,000	Male		76		75.2	Massachusetts Mutual Life Insurance Company	AA+
255	$	7,000,000	Female		76		131.8	Pacific Life Insurance Company	A+
256	$	1,000,000	Male		76		91.7	Pacific Life Insurance Company	A+
257	$	2,000,000	Male		76		128.9	Transamerica Life Insurance Company	AA-
258	$	150,000	Male		76		115.1	Genworth Life Insurance Company	BBB-
259	$	490,620	Male		76		94.9	Ameritas Life Insurance Corporation	A+
260	$	600,000	Male		76		92.2	Protective Life Insurance Company	AA-
261	$	5,000,000	Male		76		67.3	West Coast Life Insurance Company	AA-
262	$	5,000,000	Male		75		158.6	Prudential Life Insurance Company	AA-
263	$	3,000,000	Male		75		63.3	Aviva Life Insurance Company	A-
264	$	8,000,000	Male		75		112.8	Metropolitan Life Insurance Company	AA-
265	$	2,000,000	Female		75		128.8	Aviva Life Insurance Company	A-
266	$	5,000,000	Male		75		39.5	Lincoln Benefit Life Company	BBB+
267	$	850,000	Male		75		75.7	New York Life Insurance Company	AA+
268	$	200,000	Male		74		78.8	Voya Retirement and Insurance Company	A
269	$	4,000,000	Female		74		154.0	American General Life Insurance Company	A+
270	$	300,000	Male		74		22.6	Lincoln National Life Insurance Company	AA-
271	$	3,000,000	Female		74		126.0	General American Life Insurance Company	AA-
272	$	500,000	Male		73		44.3	Midland National Life Insurance Company	A+
273	$	3,000,000	Male		73		84.5	AXA Equitable Life Insurance Company	A+
274	$	2,000,000	Male		73		108.8	American General Life Insurance Company	A+
275	$	2,500,000	Male		72		108.5	American General Life Insurance Company	A+
276	$	1,167,000	Male		72		35.5	Transamerica Life Insurance Company	AA-
277	$	2,000,000	Male		71		113.9	New York Life Insurance Company	AA+
278	$	2,000,000	Male		71		113.9	New York Life Insurance Company	AA+

- 45 -

	Face Value		Gender	Age (ALB)		LE (mo.)		Insurance Company	S&P Rating
279	$	2,500,000	Male		71		129.4	Lincoln National Life Insurance Company	AA-
280	$	2,500,000	Male		71		129.4	John Hancock Life Insurance Company (U.S.A)	AA-
281	$	600,000	Male		71		97.1	AXA Equitable Life Insurance Company	A+
282	$	1,500,000	Male		71		123.4	Metropolitan Life Insurance Company	AA-
283	$	3,000,000	Male		70		87.1	John Hancock Life Insurance Company (U.S.A)	AA-
284	$	500,000	Male		70		104.9	Transamerica Life Insurance Company	AA-
285	$	500,000	Male		70		104.9	North American Company for Life And Health Insurance	A+
286	$	2,000,000	Male		68		126.7	Transamerica Life Insurance Company	AA-
287	$	1,000,000	Male		68		126.7	Genworth Life Insurance Company	BBB-
288	$	1,000,000	Male		68		73.5	Protective Life Insurance Company	AA-
289	$	156,538	Female		67		119.2	New York Life Insurance Company	AA+
290	$	2,000,000	Male		67		60.0	MetLife Investors USA Insurance Company	AA-
291	$	2,000,000	Male		67		60.0	MetLife Investors USA Insurance Company	AA-
292	$	1,000,000	Male		65		57.3	Lincoln National Life Insurance Company	AA-
293	$	1,000,000	Male		65		91.4	Transamerica Life Insurance Company	AA-
		754,942,235

(1)	The insured’s age is current as of the measurement date.
(2)	The insured’s life expectancy estimate, other than for a small face value insurance policy benefit, is the average of two life expectancy estimates provided by independent third-party medical actuarial underwriting firms at the time of purchase, actuarially adjusted through the measurement date.

ITEM 4.      CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in our reports filed pursuant to the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance the objectives of the control system are met.

As of December 31, 2014, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of our disclosure controls and procedures as such term is defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934 as amended, as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Securities Exchange Act of 1934 during the period covered by this report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

- 46 -

Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only with proper authorizations; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management, under the supervision of and with the participation of the Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2014 based on criteria for effective control over financial reporting set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), 2013 framework in “Internal Control—Integrated Framework.” Based on this assessment, our management concluded that, as of the evaluation date, we maintained effective internal control over financial reporting.

- 47 -

PART II. OTHER INFORMATION

ITEM 2.      UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Use of Proceeds – L Bonds

As indicated above, in June 2011, we filed a registration statement for a $250.0 million debt offering of Renewable Secured Debentures (subsequently renamed L Bonds) with the SEC, which registration statement was declared effective on January 31, 2012. The offering conducted under that registration statement was concluded in January 2015. The actual use of proceeds from the sale of L Bonds from January 31, 2012 to January 31, 2015 (excluding renewals), is as follows:

Gross Offering Proceeds	$	211,491,000
Net Offering Proceeds		199,031,000
Held in Short-Term Investments		24,903,000
Net Offering Proceeds Used	$	174,128,000	100	%
Purchase Policies		69,445,000	40	%
Payment of Premiums		32,352,000	18	%
Payment of Principal and Interest		53,280,000	31	%
Other Expenditures		19,051,000	11	%

- 48 -

ITEM 6.      EXHIBITS

Exhibit
31.1	Section 302 Certification of the Chief Executive Officer (filed herewith).
31.2	Section 302 Certification of the Chief Financial Officer (filed herewith).
32.1	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
99.1	Letter from Model Actuarial Pricing Systems, dated April 23, 2015 (filed herewith).

- 49 -

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GWG HOLDINGS, INC.
Date:  May 14, 2015	By:	/s/ Jon R. Sabes
		Chief Executive Officer
Date:  May 14, 2015	By:	/s/ William B. Acheson
		Chief Financial Officer

- 50 -

EX-31.1

Exhibit 31.1

SECTION 302 CERTIFICATION

I, Jon R. Sabes, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2015	/s/ Jon R. Sabes
	Chief Executive Officer

EX-31.2

Exhibit 31.2

SECTION 302 CERTIFICATION

I, William B. Acheson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GWG Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 14, 2015	By:	/s/ William B. Acheson
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of GWG Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon R. Sabes, Chief Executive Officer of the Company, and I, William B. Acheson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jon R. Sabes

Jon R. Sabes

Chief Executive Officer

May 14, 2015

/s/ William B. Acheson

WILLIAM B. ACHESON

Chief Financial Officer

May 14, 2015

EX-99.1

Exhibit 99.1

1232 W. Northwest Hwy
Palatine, IL 60067 +1 (847) 483-9402

April 23, 2015

Steven Sabes

Chief Operating Officer

GWG Life

220 South Sixth Street, Suite 1200

Minneapolis, MN 55402

Steven:

You have asked that we prepare a quarterly valuation of a GWG portfolio of life insurance settlements. The valuations were prepared under the assumptions described below, which you provided in phone conversations and e-mails. We utilized the revised policy portfolio data you provided on 4/16/2015 to project potential cash flows monthly following the 3/31/2015 valuation date, based on the premiums and other values in the policy records provided.

Data Reliance

In preparing these valuations, we relied upon:

· Policy Data – We have relied on the portfolio data file as provided to us by GWG Life. This file and the policy data contained in it are assumed to have been prepared accurately and reflect current company supported product performance. The 3/31/2015 file had 293 policies with total face amounts of $754,942,235, a net increase of 2 policies and net decrease of $24,156,802 in face amount over the prior quarter. The 12/31/2014 file had 291 policies with total face amounts of $779,099,037.

· Future Premiums Data – We have relied on GWG Life’s data regarding the future premiums to be paid on each policy. It is our understanding that GWG Life uses the MAPS software package along with data gathered from the actual premium payments to the life insurance carriers for each policy for projecting future minimum premium streams.

· Life Expectancy, Values, plus any adjustments – We have relied on the life expectancy values provided by GWG Life. It is our understanding that GWG Life obtained these LE values using the following industry experts: 21^st Services, AVS Underwriting, EMSI, Fasano Associates, and/or ISC Services.

Results

Using the assumptions stated below, we calculated the net present values as of the valuation dates using the specified discount rates of 11.38% and 7.16%. These results will be e-mailed to you in the Excel reports generated, including a Portfolio Summary and List of Policies, from the MAPS Portfolio valuation model.

	GWG Portfolio as of 3/31/2015
Number of Policies		293
Total Net Death Benefit ($)		754,942,235
Discount Rate		11.38	%	7.16	%	12.00	%	15.00	%
Expected Net Present Value ($)		278,395,045		341,866,555		270,763,833		238,485,125
Stochastic Analysis – 10,000 Scenarios
95th Percentile Net Present Value ($)		250,098,511		313,183,984		242,510,294		210,603,786
95% CTE Net Present Value ($)		243,128,382		305,959,505		235,628,513		204,067,551

The Expected Net Present Value is the probabilistic average value of the portfolio. These values are calculated actuarially; assuming that the amount of premiums paid and death benefits received are proportional to the probabilities of survival. Since death will occur at an unknown discrete point in time, the actual return for a policy, and a portfolio of policies, may vary significantly from the Expected Value.

Model Actuarial Pricing Systems, LP

1232 W. Northwest Hwy
Palatine, IL 60067 +1 (847) 483-9402

The Stochastic analysis can return information about the range of values that might be achieved along with probabilities that the results might be better or worse than the Expected or a specified level. The Stochastic analysis creates random scenarios where a discrete date of death is independently projected for each life based on its mortality curve. The net present value of the portfolio for each scenario is calculated as the present value of projected death benefits minus the present value of projected premiums. The scenarios are ranked by value. The 95th Percentile Net Present Value is the portfolio value exceeded by 95% of the stochastic scenarios. The 95% CTE is the Contingent Tail Expectation for the 95th percentile, and is the average of the 5% of scenarios with the lowest net present value.

The valuations (1) do not include premiums paid before the valuation date, and (2) assume that the insured remains alive at the valuation date. The valuations also assume that the policy COIs and policy expense charges remain at current levels in the future. If these charges are increased, the projected values would decrease. The above values do not consider any federal income or other taxes.

Summary of MAPS Model Settings and Assumptions

We used the following assumptions as discussed with you:

· Insurance Policy Characteristics. Per portfolio data file as provided.

· Policy Issue Date: Per portfolio data file as provided.

· Insured Date of Birth and Gender: Per portfolio data file as provided.

· Extended Death Benefit After Policy Maturity Age: Per portfolio data file as provided.

· Optimized Premium Levels and Timing: Monthly premiums unadjusted per the portfolio data file as provided.

· Per Policy and Portfolio Administrative Expenses: None, per the portfolio data file as provided.

· Collection of Death Benefit Delay: 0 months, with 0.00% statutory interest credited.

· Mortality: 2008 VBT Select & Ultimate Primary tables, by Age, Sex, and Tobacco Use.

· Age Basis: Age Nearest Birthday.

· Mortality Improvement: None.

· Life Expectancy: One blended LE and corresponding UW effective date per life in the portfolio data file as provided.

· Adjustment Applied to Stated LE: None.

· Improvement Used by Underwriters: No.

· Valuation Discount Interest Rates: 11.38% and 7.16% as specified, plus 12% and 15%.

· Number of Stochastic Scenarios: 10,000.

· Stochastic Random Seed input: 1234567

· Stochastic Percentile Ranks and Contingent Tail Expectations: 95%, with additional reporting at 75%, 85%, 90%, 97%, and 99%.

Notice on Mortality and Volatility

Parties engaged in life settlements commonly obtain and use "life expectancies" in their considerations. While life expectancies are provided for individuals, they are developed from expected patterns of mortality of large groups of similar individuals. No one knows exactly when any one individual will die, nor is a life expectancy intended to suggest the time until death will be near the life expectancy. Any one individual may live much longer than his or her estimated life expectancy or that projected by applying a mortality rating to any particular mortality table. Even for a large group of lives, the actual mortality for the group may be less than expected for a variety of reasons (such as improvements in medical technology, unanticipated general mortality improvement, or incorrect estimation of the life expectancy). Stochastic simulation and sensitivity testing can help to quantify these risks, but such tests should not be interpreted as a guarantee of any particular financial outcome. Investors will earn less than expected on the policy of any individual who lives longer than his life expectancy.

Model Actuarial Pricing Systems, LP

1232 W. Northwest Hwy
Palatine, IL 60067 +1 (847) 483-9402

Background

Model Actuarial Pricing Systems, LP is a subsidiary of Cantor Fitzgerald (a leading global financial services firm) providing life settlement software and services worldwide to a variety of customers including life settlement brokers, providers, consultants and investors.

Since its inception in late 1990s, the MAPS Single Policy Valuation Model has been the industry standard life settlement valuation model for both single life and joint life insurance contracts. Incorporating sophisticated analysis and valuation algorithms, the MAPS Model transformed the life settlements industry by providing actuarially correct valuation of the premium and death benefit cash flows associated with a life settlement transaction.

Very truly yours,

 

Brad McGee

Model Actuarial Pricing Systems, LP

Model Actuarial Pricing Systems, LP

XML

Fair value definition and hierarchy (Details 1) (Life Insurance policies [Member], USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Life Insurance policies [Member]
Summary of inputs utilized in estimating the fair value
Weighted average age of insured	82 years 10 months 24 days		82 years 9 months 18 days
Weighted average life expectancy, months*	77 years 9 months 18 days	[1]	78 years 4 months 24 days	[1]
Average face amount per policy	$ 2,577,000		$ 2,677,000
Discount rate	11.38%		11.43%

[1] * Standard life expectancy as adjusted for insured's specific circumstances.

XML

Commitments (Details) (USD $)	3 Months Ended
	Mar. 31, 2015 sqft	Mar. 31, 2014
Commitments (Textual)
Office space in square feet	11,695
Rent expenses	$ 67,000	$ 52,000
Minimum lease payments	$ 70,000

XML

Convertible, Redeemable Preferred Stock (Details) (USD $)	3 Months Ended	12 Months Ended	0 Months Ended	1 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Sep. 02, 2012	Jul. 31, 2011
Convertible Preferred Stock (Textual)
Exercise price of warrants	$ 12.50
Exercise period	3 years
Maturity period of warrant	3 years
Conversion of Series A preferred stock into common stock, description	One share of common stock for every 40 shares of Series A Preferred Stock purchased.
Preferred stock redemption terms	The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time.
Preferred stock, liquidation preference per share	$ 7.50
Redemption price of preferred shares	$ 7.50
Series A preferred stock outstanding	2,765,000
Gross consideration from convertible preferred stock	$ 20,712,000
Series A preferred stock issuance costs	2,838,000
Warrant outstanding	431,954	431,954
Weighted average remaining life of warrants outstanding	2 years 2 months 5 days	2 years 5 months 5 days
Accrued preferred dividend	518,000
Payable date of accrued preferred dividends	Apr. 15, 2015
Percentage of unredeemed shares redeemed one year after issuance	33.00%
Percentage of unredeemed shares redeemed two year after issuance	66.00%
Percentage of unredeemed shares redeemed three year after issuance	100.00%
Redeemed shares of Series A preferred stock	145,000
Minimum gross proceeds from common stock offering	5,000,000
Maximum offering price of common stock	$ 11.00
Fair value of outstanding warrants attached to Series A preferred stock	428,000
Term of redemption of warrants prior to expiration	The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.
Declared and accrued dividends	537,000	634,000
Preferred stock issued in lieu of cash dividend	26,000	27,000
Cash dividend rate, per share	$ 7
Common Stock [Member]
Convertible Preferred Stock (Textual)
Series A Preferred Stock conversion, Shares	508,000
Initial public offering [Member]
Convertible Preferred Stock (Textual)
Convertible preferred stock, shares issued upon conversion	678,000
Conversion of stock, shares converted into common stock	508,000
Series A 10 % convertible Preferred Stock [Member]
Convertible Preferred Stock (Textual)
Company offering shares of convertible redeemable preferred stock				3,333,333
Series A preferred stock shares sold for cash			3,278,000
Consideration received on sale of Series A preferred stock			24,582,000
Series A preferred stock shares issued in conversion of dividends	303,000
Series A preferred stock value issued in conversion of dividends	$ 2,121,000
Offering price of series A preferred stock		$ 7.50
Series A preferred stock, Dividend rate	10.00%
Conversion term for series A preferred stock	Each share has the right to convert into 0.75 shares of the Company's common stock.
Convertible preferred stock, shares issued upon conversion	678,000
Conversion of stock, shares converted into common stock	508,000

XML

Contingencies (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Contingencies (Textual)
Loaned to Opportunity Finance, LLC	$ 1,000,000
Repayments of loan	$ 177,000

XML

L Bonds (formerly Renewable Secured Debentures)) (Details) (Renewable Secured Debentures [Member], USD $)	Mar. 31, 2015
Renewable Secured Debentures [Member]
Summary of future contractual maturities of L Bonds
2015	$ 56,626,000
2016	59,311,000
2017	36,939,000
2018	23,355,000
2019	14,342,000
Thereafter	18,156,000
Total	208,729,000
Summary of amortization of deferred financing costs of L Bonds
2015	611,000
2016	1,487,000
2017	1,434,000
2018	1,130,000
2019	639,000
Thereafter	967,000
Total	$ 6,268,000

XML

Restrictions on cash (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Restrictions on Cash (Textual)
Restricted cash	$ 11,334,000	$ 4,296,000

XML

Guarantees of secured debt (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
REVENUE
Contract servicing fees
Gain on life settlements, net	16,783,409	5,516,205
Interest and other income	49,296	7,367
TOTAL REVENUE	16,832,705	5,523,572
EXPENSES
Origination and servicing fees
Employee compensation and benefits	1,727,917	968,746
Legal and professional fees	578,144	325,298
Interest expense	7,176,534	6,326,548
Other expenses	1,478,848	759,008
TOTAL EXPENSES	10,961,443	8,379,600
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	5,871,262
EQUITY IN INCOME OF SUBSIDIARY
NET INCOME (LOSS) BEFORE INCOME TAXES	5,871,262	(2,856,028)
INCOME TAX EXPENSE	2,609,371	(954,858)
NET INCOME (LOSS)	3,261,891	(1,901,170)
Parent [Member]
REVENUE
Contract servicing fees
Gain on life settlements, net
Interest and other income	7,543	6,929
TOTAL REVENUE	7,453	6,929
EXPENSES
Origination and servicing fees
Employee compensation and benefits	1,305,801	590,584
Legal and professional fees	477,351	266,159
Interest expense	5,249,962	4,216,528
Other expenses	951,362	421,243
TOTAL EXPENSES	7,984,476	5,494,514
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(7,976,933)	(5,487,585)
EQUITY IN INCOME OF SUBSIDIARY	(13,848,196)	2,631,557
NET INCOME (LOSS) BEFORE INCOME TAXES	5,871,262	(2,856,028)
INCOME TAX EXPENSE	2,609,371	(954,858)
NET INCOME (LOSS)	3,261,891	(1,901,170)
Guarantor Sub [Member]
REVENUE
Contract servicing fees	357,486	966,056
Gain on life settlements, net
Interest and other income	6,450	169,615
TOTAL REVENUE	363,936	1,135,671
EXPENSES
Origination and servicing fees
Employee compensation and benefits	422,116	378,162
Legal and professional fees	100,793	59,139
Interest expense	774,086	778,567
Other expenses	514,902	325,255
TOTAL EXPENSES	1,811,897	1,541,123
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	(1,447,961)	(405,452)
EQUITY IN INCOME OF SUBSIDIARY	(15,296,104)	3,037,009
NET INCOME (LOSS) BEFORE INCOME TAXES	13,848,144	2,631,557
INCOME TAX EXPENSE
NET INCOME (LOSS)	13,848,144	2,631,557
Non-Guarantor Sub [Member]
REVENUE
Contract servicing fees
Gain on life settlements, net	16,783,409	5,516,205
Interest and other income	35,303	44
TOTAL REVENUE	16,818,712	5,516,249
EXPENSES
Origination and servicing fees	357,486	966,056
Employee compensation and benefits
Legal and professional fees
Interest expense	1,152,486	1,331,453
Other expenses	12,584	181,731
TOTAL EXPENSES	1,522,556	2,479,240
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES	15,296,156	3,037,009
EQUITY IN INCOME OF SUBSIDIARY
NET INCOME (LOSS) BEFORE INCOME TAXES	15,296,156	3,037,009
INCOME TAX EXPENSE
NET INCOME (LOSS)	15,296,156	3,037,009
Eliminations [Member]
REVENUE
Contract servicing fees	(357,486)	(966,056)
Gain on life settlements, net
Interest and other income		(169,221)
TOTAL REVENUE	(357,486)	(1,135,277)
EXPENSES
Origination and servicing fees	(357,486)	(966,056)
Employee compensation and benefits
Legal and professional fees
Interest expense
Other expenses		(169,221)
TOTAL EXPENSES	(357,486)	(1,135,277)
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES
EQUITY IN INCOME OF SUBSIDIARY	(29,144,300)	(5,668,566)
NET INCOME (LOSS) BEFORE INCOME TAXES	(29,144,300)	(5,668,566)
INCOME TAX EXPENSE
NET INCOME (LOSS)	$ (29,144,300)	$ (5,668,566)

XML

Fair value definition and hierarchy (Tables)

3 Months Ended

Mar. 31, 2015

Fair Value Definition and Hierarchy [Abstract]

Reconciliation of investments in life insurance policies

	2015			2014
Beginning balance	$	282,883,000		$	234,673,000
Purchases		1,016,000			8,472,000
Maturities (cost basis)		(3,610,000	)		-
Gross unrealized gains (losses)		(1,894,000	)		11,359,000
Ending balance	$	278,395,000		$	254,504,000

Summary of inputs utilized in estimating the fair value

	As of   March 31, 2015			As of  December 31, 2014
Weighted average age of insured		82.9			82.8
Weighted average life expectancy, months*		77.8			78.4
Average face amount per policy	$	2,577,000		$	2,677,000
Discount rate		11.38	%		11.43	%

Fair value sensitivity analysis on the investment in life insurance policies

		Change in life expectancy estimates
		plus 8 months			minus 8 months		plus 4 months			minus  4 months
March 31, 2015	$	(37,287,000	)	$	38,921,000	$	(18,864,000	)	$	19,320,000
December 31, 2014	$	(38,864,000	)	$	40,634,000	$	(19,664,000	)	$	20,130,000

		Change in discount rate
		plus 2%			minus 2%		plus 1%			minus 1%
March 31, 2015	$	(23,373,000	)	$	27,333,000	$	(12,131,000	)	$	13,118,000
December 31, 2014	$	(24,085,000	)	$	28,179,000	$	(12,502,000	)	$	13,522,000

Warrants Level 3 instruments and measured at fair value upon issuance

issued	Warrants issued		Fair value per share		Risk free  rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%		5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%		5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%		5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%		5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%		5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%		5 years
		431,954

XML

Income taxes (Detail Textuals) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Taxes (Textual)
Federal net operating loss carryforwards	$ 537,000
Current income taxes	$ (427,000)

XML

Fair value definition and hierarchy (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015
Fair Value Definition and Hierarchy (Textual)
Estimated fair value of Series I Secured notes payable	$ 237,950,000
Weighted average market interest rate of Secured notes payable	7.17%
Face value of notes	$ 235,654,000
Description for change in discount factor	If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables are held constant.
Increase decrease in life expectancy	Four and eight months
Increase decrease in discount rate	1% and 2

XML

Investment in life insurance policies (Details Textual) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Investment in Life Insurance Policies (Textual)
Realized gains from life insurance policy	$ 25,014,000	$ 0
Benefit recognized from insurance policy	28,625,000	0
Carrying value of life insurance policy	$ 3,611,000	$ 0
Life Insurance policies [Member]
Investment in Life Insurance Policies (Textual)
Discount rate applied to portfolio	11.38%		11.43%

XML

Stock Incentive Plan (Details)	3 Months Ended
	Mar. 31, 2015
Outstanding stock options
Beginning Balance	1,000,101
Granted during the quarter	86,250
Vested during the quarter
Exercised during the quarter	(3,833)
Forfeited during the quarter	(9,417)
Ending Balance	1,073,101
Vested [Member]
Outstanding stock options
Beginning Balance	314,288
Granted during the quarter	43,500
Vested during the quarter	10,002
Exercised during the quarter	(3,833)
Forfeited during the quarter
Ending Balance	363,957
Un-vested [Member]
Outstanding stock options
Beginning Balance	685,813
Granted during the quarter	42,750
Vested during the quarter	(10,002)
Exercised during the quarter
Forfeited during the quarter	(9,417)
Ending Balance	709,144

XML

Concentrations (Details 1)	Mar. 31, 2015	Dec. 31, 2014
California [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	28.33%	28.87%
Florida [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	18.77%		[1]
New York [Member]
Summary of the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company
Percentage of insurance contracts held in specific states	9.56%	18.56%

[1] * percentage does not exceed 10% of the total face value.

XML

L Bonds (formerly Renewable Secured Debentures) (Details Textual) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Jan. 09, 2015
Renewable Secured Debentures (Textual)
Debentures offer for sale	$ 235,654,000
Weighted average market interest rate of Secured notes payable	7.17%
Renewable Secured Debentures [Member]
Renewable Secured Debentures (Textual)
Debentures offer for sale	250,000,000		1,000,000,000
Interest rates, minimum	4.25%
Interest rates, maximum	9.50%
Description of interest payment	Interest is payable monthly, annually or at maturity depending on the terms of the debenture.
Weighted average market interest rate of Secured notes payable	7.32%	7.45%
Amount outstanding under L Bonds	208,729,000	186,377,000
Amortization of deferred issuance costs	974,000	847,000
Future expected amortization of deferred financing costs	6,268,000
Maturity period of debentures, Minimum	6 months
Maturity period of debentures, Maximum	7 years
Conditions for proceed from issuance of debenture	(1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.
Publicly registered L Bond offering	1,000,000,000
Minimum increments	$ 25,000

XML

Fair value definition and hierarchy

3 Months Ended

Mar. 31, 2015

Fair Value Definition and Hierarchy [Abstract]

Fair value definition and hierarchy

(4)       Fair value definition and hierarchy

ASC 820 establishes a hierarchical disclosure framework which prioritizes and ranks the level of market price observability used in measuring assets and liabilities at fair value. Market price observability is affected by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace, including the existence and transparency of transactions between market participants. Assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices in an orderly market generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. ASC 820 establishes a three-level valuation hierarchy for inputs used in measuring fair value, which hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an arms-length and orderly transaction between market participants at the measurement date. An “orderly transaction” is a non-distressed transaction in which neither the seller nor the buyer is compelled to engage in the transaction.

The hierarchy is broken down into three levels based on the observability of inputs as follows:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.  Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

● Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary by types of assets and liabilities and is affected by a wide variety of factors, including, for example, whether an instrument is established in the marketplace, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for assets and liabilities categorized in Level 3.

Level 3 Valuation Process

The estimated fair value of the Company’s portfolio of life settlements is determined on a quarterly basis by the Company’s portfolio management committee, taking into consideration changes in discount rate assumptions, estimated premium payments and life expectancy estimate assumptions, as well as any changes in economic and other relevant conditions. These inputs are then used to estimate the discounted cash flows using the Model Actuarial Pricing System (MAPS), probabilistic portfolio price model, which estimates the cash flows using various probabilities and scenarios. The valuation process includes a review by senior management as of each valuation date. Management has also engaged a third party expert to independently test the accuracy of the valuations using the inputs provided by management on a quarterly basis.

Life insurance policies represent financial instruments recorded at fair value on a recurring basis. The following table reconciles the beginning and ending fair value of the Company’s Level 3 investments in life insurance policies for the three month periods ending March 31, as follows:

	2015			2014
Beginning balance	$	282,883,000		$	234,673,000
Purchases		1,016,000			8,472,000
Maturities (cost basis)		(3,610,000	)		-
Gross unrealized gains (losses)		(1,894,000	)		11,359,000
Ending balance	$	278,395,000		$	254,504,000

The fair value of a portfolio of life insurance policies is based on information available to the Company at the reporting date. Fair value is based upon a discounted cash flow model that incorporates life expectancy estimate assumptions. Life expectancy estimates are obtained from independent, third-party widely accepted life expectancy estimate providers at policy acquisition. The life expectancy values of each insured, as determined at policy acquisition, are rolled down monthly for the passage of time by the MAPS actuarial software the Company uses for ongoing valuation of its portfolio of life insurance policies. The discount rate incorporates current information about discount rate applied by other reporting companies owning portfolios of life insurance policies, discount rates observed in the life insurance secondary market, market interest rates, the credit exposure to the insurance company that issued the life insurance policy and management’s estimate of the risk premium a purchaser would require to receive the future cash flows derived from our portfolio of life insurance policies.

On September 15, 2014, 21st Services announced changes to its mortality tables primarily for insureds age 90 and older, as well as updated adjustment factors designed to better underwrite seniors with multiple impairments. These changes represent small portions of 21st Services’ historical underwritings. We expect medical-actuarial underwriting firms to continue improving and refining their underwriting methodology.

The fair value of life insurance policies is estimated using present value calculations of estimated cash flows based on the data specific to each individual life insurance policy. Estimated future policy premium payments are calculated based on the terms of the policy and the premium payment history. The following summarizes the unobservable inputs utilized in estimating the fair value of the portfolio of life insurance policies:

	As of   March 31, 2015			As of  December 31, 2014
Weighted average age of insured		82.9			82.8
Weighted average life expectancy, months*		77.8			78.4
Average face amount per policy	$	2,577,000		$	2,677,000
Discount rate		11.38	%		11.43	%

* Standard life expectancy as adjusted for insured’s specific circumstances.

These assumptions are, by their nature, inherently uncertain and the effect of changes in estimates may be significant. The techniques used in estimating the present value of estimated cash flows are derived from valuation techniques generally used in the industry and include inputs for the asset that are not based on observable market data. The extent to which the fair value could reasonably vary in the near term has been quantified by evaluating the effect of changes in significant underlying assumptions used to estimate the fair value. If the life expectancy estimates were increased or decreased by four and eight months on each outstanding policy and the discount factors were increased or decreased by 1% and 2%, while all other variables were held constant, the fair value of the investment in life insurance policies would increase or (decrease) by the amounts summarized below:

		Change in life expectancy estimates
		plus 8 months			minus 8 months		plus 4 months			minus  4 months
March 31, 2015	$	(37,287,000	)	$	38,921,000	$	(18,864,000	)	$	19,320,000
December 31, 2014	$	(38,864,000	)	$	40,634,000	$	(19,664,000	)	$	20,130,000

		Change in discount rate
		plus 2%			minus 2%		plus 1%			minus 1%
March 31, 2015	$	(23,373,000	)	$	27,333,000	$	(12,131,000	)	$	13,118,000
December 31, 2014	$	(24,085,000	)	$	28,179,000	$	(12,502,000	)	$	13,522,000

Other Fair Value Considerations

Carrying value of receivables, prepaid expenses, accounts payable and accrued expenses approximate fair value due to their short-term maturities and low credit risk. The estimated fair value of the Company’s Series I Secured Notes payable and L Bonds is approximately $237,950,000 based on a weighted-average market interest rate of 7.17% based on an income approach, the combined face value of these notes is $235,654,000 as of March 31, 2015. The carrying value of the revolving credit facility reflects interest charged at the commercial paper rate plus an applicable margin. The margin represents our credit risk, and the strength of the portfolio of life insurance policies collateralizing the debt. The overall rate reflects market, and the carrying value of the revolver approximates fair value. All of the financial instruments are Level 3 fair value measurements.

The Company has issued warrants to purchase common stock in connection with the issuance of its convertible, redeemable preferred stock. Warrants were determined by the Company as permanent equity. The fair value measurements associated with the warrants, measured at issuance, represent Level 3 instruments.

As of March 31, 2015:

Month issued	Warrants issued		Fair value per share		Risk free  rate			Volatility			Term
December 2011		68,937	$	0.22		0.42	%		25.25	%		5 years
March 2012		38,130	$	0.52		0.38	%		36.20	%		5 years
June 2012		161,840	$	1.16		0.41	%		47.36	%		5 years
July 2012		144,547	$	1.16		0.41	%		47.36	%		5 years
September 2012		2,500	$	0.72		0.31	%		40.49	%		5 years
September 2014		16,000	$	1.26		1.85	%		17.03	%		5 years
		431,954

Volatility is based upon the weekly percentage change in the stock price of selected comparable insurance companies. The percentage change is calculated on the average price of those selected stocks at the weekly close of business for the year preceding the balance sheet date. We compare annual volatility based on this weekly information.

XML

Concentrations (Details Textual)	3 Months Ended
	Mar. 31, 2015
Concentration (Textual)
Description of issuance contracts with specific life insurance companies and contracts held in specific states	Exceeding 10% of the total face value

XML

Credit facilities (Details) (USD $)	0 Months Ended		3 Months Ended	12 Months Ended
	Jan. 29, 2013	Jul. 15, 2008	Mar. 31, 2015	Dec. 31, 2014
Credit Facilities (Textual)
Maximum borrowing amount under line of credit facility		$ 100,000,000
Expiry date of line of credit		Jul. 15, 2013
Amount outstanding under line of credit facility			72,161,000	72,161,000
Effective rate of interest			6.22%	6.24%
Total funds available for additional borrowings under the borrowing base formula criteria			3,751,000	20,585,000
Extended date of line of credit facility	Dec. 31, 2014
Weighted average effective interest rate			6.20%	6.22%
Minimum tangible net worth to be maintained by company			15,000,000
Consolidated net income under credit and security agreement			98,775,000
Consolidated tangible net worth under credit and security agreement			$ 45,553,000

XML

Stock Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2015

Stock Incentive Plan [Abstract]

Schedule of outstanding stock options

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the quarter		43,500			42,750			86,250
Vested during the quarter		10,002			(10,002	)		-
Exercised during the quarter		(3,833	)		-			(3,833	)
Forfeited during the quarter		-			(9,417	)		(9,417	)
Balance as of March 31, 2015		363,957			709,144			1,073,101

XML

Income taxes (Tables)

3 Months Ended

Mar. 31, 2015

Income Taxes [Abstract]

Components of deferred income tax expense

Three months ended:	March 31,			March 31,
	2015			2014
Income tax provision:
Current:
Federal	$	(324,000	)	$	-
State		(103,000	)		-
Total current tax expense		(427,000	)		-
Deferred:
Federal	$	(1,654,000	)	$	802,000
State		(528,000	)		153,000
Total deferred tax expense		(2,182,000	)		955,000
Total income tax expense	$	(2,609,000	)	$	955,000

XML

Guarantees of secured debt (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
A S S E T S
CASH AND CASH EQUIVALENTS	$ 36,190,527	$ 30,662,704	$ 28,083,299	$ 33,449,793
Restricted cash	11,333,617	4,296,053
Policy Loans Receivable	19,640,000	1,750,000
Investment in life settlements, at fair value	278,395,047	282,883,010
Other assets	5,753,383	3,478,762
Investment in subsidiaries
TOTAL ASSETS	351,312,574	323,070,529
LIABILITIES
Revolving credit facility	72,161,048	72,161,048
Series I Secured Notes payable	26,498,511	27,616,578
L Bonds	205,038,330	182,782,884
Interest payable	11,404,195	11,128,519
Accounts payable and other accrued expenses	2,886,070	1,203,575
Other accrued expenses		514,434
Deferred taxes	7,455,806	5,273,555
TOTAL LIABILITIES	325,443,960	300,680,593
STOCKHOLDERS EQUITY
Member capital
Convertible preferred stock	20,712,073	20,527,866
Common stock	5,870	5,870
Additional paid-in capital	16,290,266	16,257,686
Accumulated deficit	(11,139,595)	(14,401,486)
TOTAL STOCKHOLDERS' EQUITY	25,868,614	22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	351,312,574	323,070,529
Parent [Member]
A S S E T S
CASH AND CASH EQUIVALENTS	34,762,097	30,446,473	26,466,468	32,711,636
Restricted cash
Policy Loans Receivable
Investment in life settlements, at fair value
Other assets	1,814,859	1,673,728
Investment in subsidiaries	210,207,072	185,636,417
TOTAL ASSETS	246,784,028	217,756,618
LIABILITIES
Revolving credit facility
Series I Secured Notes payable
L Bonds	205,038,330	182,782,884
Interest payable	7,242,071	6,598,250
Accounts payable and other accrued expenses	1,179,207	410,895
Other accrued expenses		301,098
Deferred taxes	7,455,806	5,273,555
TOTAL LIABILITIES	220,915,414	195,366,682
STOCKHOLDERS EQUITY
Member capital
Convertible preferred stock	20,712,073	20,527,866
Common stock	5,870	5,870
Additional paid-in capital	16,290,266	16,257,686
Accumulated deficit	(11,139,595)	(14,401,486)
TOTAL STOCKHOLDERS' EQUITY	25,868,614	22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	246,784,028	217,756,618
Guarantor Sub [Member]
A S S E T S
CASH AND CASH EQUIVALENTS	1,278,378	216,231	1,616,831	738,157
Restricted cash	1,862,500	82,500
Policy Loans Receivable
Investment in life settlements, at fair value
Other assets	1,756,731	1,777,534
Investment in subsidiaries	236,319,121	215,124,779
TOTAL ASSETS	241,216,730	217,201,044
LIABILITIES
Revolving credit facility
Series I Secured Notes payable	26,498,511	27,616,578
L Bonds
Interest payable	3,559,004	3,513,615
Accounts payable and other accrued expenses	1,102,196	242,680
Other accrued expenses		191,753
Deferred taxes
TOTAL LIABILITIES	31,159,711	31,564,626
STOCKHOLDERS EQUITY
Member capital	210,057,019	185,636,418
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY	210,057,019	185,636,418
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	241,216,730	217,201,044
Non-Guarantor Sub [Member]
A S S E T S
CASH AND CASH EQUIVALENTS	150,052
Restricted cash	9,471,117	4,213,553
Policy Loans Receivable	19,640,000
Investment in life settlements, at fair value	278,395,047	282,883,010
Other assets	2,181,793	1,777,500
Investment in subsidiaries
TOTAL ASSETS	309,838,009	288,874,063
LIABILITIES
Revolving credit facility	72,161,048	72,161,048
Series I Secured Notes payable
L Bonds
Interest payable	603,120	1,016,654
Accounts payable and other accrued expenses	604,667	550,000
Other accrued expenses		21,583
Deferred taxes
TOTAL LIABILITIES	73,368,835	73,749,285
STOCKHOLDERS EQUITY
Member capital	236,469,174	215,124,778
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY	236,496,174	215,124,778
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	309,838,009	288,874,063
Eliminations [Member]
A S S E T S
CASH AND CASH EQUIVALENTS
Restricted cash
Policy Loans Receivable
Investment in life settlements, at fair value
Other assets
Investment in subsidiaries	(446,526,193)	(400,761,196)
TOTAL ASSETS	(446,526,193)	(400,761,196)
LIABILITIES
Revolving credit facility
Series I Secured Notes payable
L Bonds
Interest payable
Accounts payable and other accrued expenses
Other accrued expenses
Deferred taxes
TOTAL LIABILITIES
STOCKHOLDERS EQUITY
Member capital	(446,526,193)	(400,761,196)
Convertible preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY	(446,526,193)	(400,761,196)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ (446,526,193)	$ (400,761,196)

XML

Series I Secured Notes Payable (Details) (Series I Secured Notes Payable [Member], USD $)	Mar. 31, 2015
Series I Secured Notes Payable [Member]
Summary of future contractual maturities of notes payable
2015	$ 9,426,000
2016	10,060,000
2017	5,873,000
2018	802,000
2019	347,000
Thereafter	418,000
Total	26,926,000
Summary of amortization of deferred financing costs of notes payable
2015	51,000
2016	168,000
2017	158,000
2018	30,000
2019	8,000
Thereafter	12,000
Total	$ 427,000

XML

Guarantees of secured debt (Tables)

3 Months Ended

Mar. 31, 2015

Guarantees of L Bonds [Abstract]

Condensed Consolidating Balance Sheets

Condensed Consolidating Balance Sheets

March 31, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	34,762,097		$	1,278,378	$	150,052	$	-		$	36,190,527
Restricted cash		-			1,862,500		9,471,117		-			11,333,617
Policy benefits receivable		-			-		19,640,000		-			19,640,000
Investment in life settlements, at fair value		-			-		278,395,047		-			278,395,047
Other assets		1,814,859			1,756,731		2,181,793		-			5,753,383
Investment in subsidiaries		210,207,072			236,319,121		-		(446,526,193	)		-
TOTAL ASSETS	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			26,498,511		-		-			26,498,511
L Bonds		205,038,330			-		-		-			205,038,330
Interest payable		7,242,071			3,559,004		603,120		-			11,404,195
Accounts payable and other accrued expenses		1,179,207			1,102,196		604,667		-			2,886,070
Deferred taxes		7,455,806			-		-		-			7,455,806
TOTAL LIABILITIES		220,915,414			31,159,711		73,368,835		-			325,443,960
STOCKHOLDERS’ EQUITY
Member capital		-			210,057,019		236,469,174		(446,526,193	)		-
Convertible preferred stock		20,712,073										20,712,073
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,290,266			-		-		-			16,290,266
Accumulated deficit		(11,139,595	)		-		-		-			(11,139,595	)
TOTAL STOCKHOLDERS’ EQUITY		25,868,614			210,057,019		236,496,174		(446,526,193	)		25,868,614
TOTAL LIABILITIES AND EQUITY	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		1,777,500		-			5,228,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y  (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Accounts payable		410,895			242,680		550,000		-			1,203,575
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Other accrued expenses		301,098			191,753		21,583		-			514,434
Deferred taxes		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

Condensed Consolidating Statements of Operations

Condensed Consolidating Statements of Operations

For the three months ended March 31, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	357,486		$	-	$	(357,486	)	$	-
Gain on life settlements, net		-			-			16,783,409		-			16,783,409
Interest and other income		7,543			6,450			35,303		-			49,296
TOTAL REVENUE		7,453			363,936			16,818,712		(357,486	)		16,832,705
EXPENSES
Origination and servicing fees		-			-			357,486		(357,486	)		-
Employee compensation and benefits		1,305,801			422,116			-		-			1,727,917
Legal and professional fees		477,351			100,793			-		-			578,144
Interest expense		5,249,962			774,086			1,152,486		-			7,176,534
Other expenses		951,362			514,902			12,584		-			1,478,848
TOTAL EXPENSES		7,984,476			1,811,897			1,522,556		(357,486	)		10,961,443
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(7,976,933	)		(1,447,961	)		15,296,156		-			5,871,262
EQUITY IN INCOME OF SUBSIDIARY		13,848,195			15,296,105			-		(29,144,300	)		-
NET INCOME BEFORE INCOME TAXES		5,871,262			13,848,144			15,296,156		(29,144,300	)		5,871,262
INCOME TAX EXPENSE		2,609,371			-			-		-			2,609,371
NET INCOME	$	3,261,891		$	13,848,144		$	15,296,156	$	(29,144,300	)	$	3,261,891

For the three months ended March 31, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	966,056		$	-	$	(966,056	)	$	-
Gain on life settlements, net		-			-			5,516,205		-			5,516,205
Interest and other income		6,929			169,615			44		(169,221	)		7,367
TOTAL REVENUE		6,929			1,135,671			5,516,249		(1,135,277	)		5,523,572
EXPENSES
Origination and servicing fees		-			-			966,056		(966,056	)		-
Employee compensation and benefits		590,584			378,162			-		-			968,746
Legal and professional fees		266,159			59,139			-		-			325,298
Interest expense		4,216,528			778,567			1,331,453		-			6,326,548
Other expenses		421,243			325,255			181,731		(169,221	)		759,008
TOTAL EXPENSES		5,494,514			1,541,123			2,479,240		(1,135,277	)		8,379,600
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,487,585	)		(405,452	)		3,037,009		-			(2,856,028	)
EQUITY IN INCOME OF SUBSIDIARY		2,631,557			3,037,009			-		(5,668,566	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(2,856,028	)		2,631,557			3,037,009		(5,668,566	)		(2,856,028	)
INCOME TAX BENEFIT		(954,858	)		-			-		-			(954,858	)
NET INCOME (LOSS)	$	(1,901,170	)	$	2,631,557		$	3,037,009	$	(5,668,566	)	$	(1,901,170	)

Condensed Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows

For the three months ended March 31, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	3,261,891		$	13,848,144		$	15,296,156		$	(29,144,300	)	$	3,261,891
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(13,848,196	)		(15,296,104	)		-			29,144,300			-
Gain on life settlements		-			-			1,893,845			-			1,893,845
Amortization of deferred financing and issuance costs		43,475			130,188			(722,693	)		-			(549,030	)
Deferred income taxes		2,182,251			-			-			-			2,182,251
Preferred stock issued for dividends		188,812			-			-			-			188,812
Increase in operating assets:
Policy benefits receivable		-			-			17,890,000			-			17,890,000
Other assets		(10,874,436	)		(5,877,435	)		-			16,620,698			(131,173	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		2,279,652			738,084			382,049			-			2,635,687
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(16,766,551	)		(6,457,123	)		(1,804,741	)		16,620,698			(8,407,717	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,446,477	)		-			(2,446,477	)
Proceeds from settlement of life settlements		-			-			3,610,595			-			3,610,595
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			1,164,118			-			1,164,118
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(1,273,189	)		-			-			(1,273,189	)
Proceeds from issuance of L Bonds		27,960,297			-			-			-			27,960,297
Payments from issuance of L Bonds		(1,340,583	)		-			-			-			(1,340,583	)
Payments from redemption of L Bonds		(5,537,539	)		-			-			-			(5,537,539	)
Proceeds from restricted cash		-			(1,780,000	)		(5,257,564	)		-			(7,073,564	)
Issuance of member capital		-			10,572,459			6,048,239			(16,620,698	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		21,082,175			7,519,270			790,675			(16,620,698	)		12,771,422
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,315,624			1,062,147			150,052			-			5,527,823
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		30,446,473			216,231			-			-			30,662,704
END OF THE YEAR	$	34,762,097		$	1,278,378		$	150,052		$	-		$	36,190,527

For the three months ended March 31, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(1,901,170	)	$	2,631,557		$	3,037,009		$	(5,668,566	)	$	(1,901,170	)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(2,631,557	)		(3,037,009	)		-			5,668,566			-
Gain on life settlements		-			-			(11,358,913	)		-			(11,358,913	)
Amortization of deferred financing and issuance costs		847,236			166,946			(660,525	)		-			353,657
Deferred income taxes		(954,858	)		-			-			-			(954,858	)
Preferred stock issued for dividends		192,340			-			-			-			192,340
Increase in operating assets:
Other assets		(15,947,713	)		(15,248,357	)		-			30,944,224			(251,846	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		713,785			229,443			334,598			-			1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(19,681,937	)		(15,257,420	)		(8,647,831	)		30,944,224			(12,642,964	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(8,271,203	)		-			(8,271,203	)
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(8,271,203	)		-			(8,271,203	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(868,303	)		-			-			(868,303	)
Proceeds from issuance of debentures		18,365,657			-			-			-			18,365,657
Payments from issuance of debentures		(1,057,763	)		-			-			-			(1,057,763	)
Payments from redemption of debentures		(3,871,125	)		-			-			-			(3,871,125	)
Proceeds from restricted cash		-			1,070,000			1,909,207			-			2,979,207
Issuance of member capital		-			15,934,397			15,009,827			(30,944,224	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		13,436,769			16,136,094			16,919,034			(30,944,224	)		15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(6,245,168	)		878,674			-			-			(5,366,494	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		32,711,636			738,157			-			-			33,449,793
END OF THE YEAR	$	26,466,468		$	1,616,831		$	-		$	-		$	28,083,299

XML

Concentrations (Tables)

3 Months Ended

Mar. 31, 2015

Concentration [Abstract]

Summary of the face value of insurance contracts

	March 31,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		15.02		14.55
John Hancock		12.03		11.48
Transamerica		10.32		*

* percentage does not exceed 10% of the total face value.

Summary of the number of insurance contracts

	March 31,		December 31,
	2015		2014
State of residence	%		%
California		28.33		28.87
Florida		18.77		18.56
New York		9.56		*

* percentage does not exceed 10% of the total face value.

XML

Investment in life insurance policies

3 Months Ended

Mar. 31, 2015

Investment in Life Insurance Policies [Abstract]

Investment in life insurance policies

(3)       Investment in life insurance policies

The life insurance policies (Level 3 fair value measurements) are valued based on unobservable inputs that are significant to the overall fair value measurement. Changes in the fair value of these instruments are recorded in gain or loss on life insurance policies in the consolidated statements of operations (net of the cash premiums paid on the policies). The fair value is determined on a discounted cash flow basis that incorporates life expectancy assumptions. Life expectancy reports have been obtained from widely accepted life expectancy providers. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy, and our estimate of the risk premium an investor in the policy would require. As a result of management’s analysis, discount rates of 11.38% and 11.43% were applied to the portfolio as of March 31, 2015 and December 31, 2014, respectively.

A summary of the Company’s life insurance policies accounted for under the fair value method and their estimated maturity dates, based on remaining life expectancy, is as follows:

		As of March 31, 2015						As of December 31, 2014
Years Ending December 31,		Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015			-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016			8		11,626,000		14,750,000		7		8,144,000		11,550,000
2017			15		14,104,000		20,357,000		17		21,916,000		35,542,000
2018			28		39,094,000		68,717,000		30		41,994,000		76,206,000
2019			43		46,749,000		101,110,000		45		47,303,000		106,973,000
2020			44		45,825,000		103,674,000		41		43,429,000		102,614,000
2021			39		32,011,000		93,970,000		36		29,789,000		90,921,000
Thereafter			116		88,986,000		352,364,000		112		85,245,000		349,293,000
	Totals		293		278,395,000		754,942,000		291	$	282,883,000	$	779,099,000

The Company recognized insurance benefits of $28,625,000 and $0 during the three months ended March 31, 2015 and 2014, respectively, related to policies with a carrying value of $3,611,000 and $0, respectively. The Company recorded realized gains of $25,014,000 and $0 on such policies.

Reconciliation of gain on life settlements:

Three Months Ended:	March 31, 2015			March 31, 2014
Change in fair value	$	(1,894,000	)	$	11,359,000
Premiums and other annual fees		(6,337,000	)		(5,843,000	)
Policy maturities		25,014,000			-
Gain on life settlements, net	$	16,783,000		$	5,516,000

The estimated expected premium payments and servicing fees to maintain the above life insurance policies in force for the next five years, assuming no mortalities, are as follows:

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Nine months ending December 31, 2015	$	18,635,000	$	352,000	$	18,987,000
2016		26,899,000		352,000		27,251,000
2017		30,098,000		352,000		30,450,000
2018		32,813,000		352,000		33,165,000
2019		36,454,000		352,000		36,806,000
2020		40,389,000		352,000		40,741,000
	$	185,288,000	$	2,112,000	$	187,400,000

Management anticipates funding the estimated premium payments as noted above with proceeds from the DZ Bank revolving credit facility and through additional debt and equity financing, as well as from cash proceeds from maturities of life insurance policies. The proceeds of these capital sources are also intended to be used for the purchase, financing, and maintenance of additional life insurance policies.

XML

Nature of business and summary of significant accounting policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Nature Of Business And Summary Of Significant Accounting Policies
Deposits and direct cost advances	$ 1,459,000		$ 27,000
Amortization of deferred financing costs	$ 0	$ 89,000
Redemption period for amortization of discount related to financing cost	3 years

XML

Fair value definition and hierarchy (Details 2) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Plus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ (37,287,000)	$ (38,864,000)
Minus 8 months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	38,921,000	40,634,000
Plus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(18,864,000)	(19,664,000)
Minus 4 Months [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	19,320,000	20,130,000
Plus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(23,373,000)	(24,085,000)
Minus 2% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	27,333,000	28,179,000
Plus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	(12,131,000)	(12,502,000)
Minus 1% [Member]
Fair value sensitivity analysis on the investment in life insurance policies
Investment in life policies	$ 13,118,000	$ 13,522,000

XML

Stock Incentive Plan (Details Textual) (USD $)	3 Months Ended	12 Months Ended	0 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Mar. 27, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares issued to employees, officers and directors	86,250
Options vesting period		3 years
Forfeited during the quarter	(9,417)
Compensation expense related to un-vested options not yet recognized	$ 608,000
Compensation expense related to un-vested options, period of recognition	3 years
Ownership Percentage	10.00%
Compensation Expense in 2015	217,000
Compensation Expense in 2016	217,000
Compensation Expense in 2017	166,000
Compensation Expense in 2018	$ 8,000
Exercised during the quarter	(3,833)
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$ 9.01
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$ 8.20
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares issued to employees, officers and directors		755,101
Number of options vested	363,957
Others [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$ 10.25
Others [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise Price	$ 7.46
2013 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares issuable			2,000,000
Stock based compensation, Method used	The expected volatility used in the Black-Scholes model valuation of options issued during the year was 17.03% annualized.] The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks.
Expected volatility rate	17.03%
2013 Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option period			10 years
2013 Stock Incentive Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares for an employee		53,000
Employee granting right purchase of common stock		318,000
Number of options vested		159,000
Exercise Price		12.50
Options vesting period		1 year
2013 Stock Incentive Plan [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares for an employee			400,000
Forfeited during the quarter	72,583
Forfeited during the year, Percent	15.00%
Exercised during the quarter	4,167

XML

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
A S S E T S
CASH AND CASH EQUIVALENTS	$ 36,190,527	$ 30,662,704
Restricted cash	11,333,617	4,296,053
Policy benefits receivable	19,640,000	1,750,000
Investment in life settlements, at fair value	278,395,047	282,883,010
Other assets	5,753,383	3,478,762
TOTAL ASSETS	351,312,574	323,070,529
LIABILITIES
Revolving credit facility	72,161,048	72,161,048
Series I Secured Notes payable	26,498,511	27,616,578
L Bonds	205,038,330	182,782,884
Interest payable	11,404,195	11,128,519
Accounts payable and accrued expenses	2,886,070	1,718,009
Deferred taxes, net	7,455,806	5,273,555
TOTAL LIABILITIES	325,443,960	300,680,593
STOCKHOLDERS' EQUITY
CONVERTIBLE PREFERRED STOCK (par value $0.001; shares authorized 40,000,000; shares outstanding 2,765,281 and 2,738,966; liquidation preference of $20,740,000 and $20,542,000, respectively)	20,712,073	20,527,866
COMMON STOCK Common stock (par value $0.001: shares authorized 210,000,000; shares issued and outstanding is 5,870,193 on both March 31, 2015 and December 31, 2014)	5,870	5,870
Additional paid-in capital	16,290,266	16,257,686
Accumulated deficit	(11,139,595)	(14,401,486)
TOTAL STOCKHOLDERS' EQUITY	25,868,614	22,389,936
TOTAL LIABILITIES & EQUITY	$ 351,312,574	$ 323,070,529

XML

Series I Secured Notes Payable (Details Textual) (USD $)	3 Months Ended		0 Months Ended	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 14, 2011	Dec. 31, 2014
Series I Secured Notes Payable (Textual)
Weighted average market interest rate of Secured notes payable	7.17%
Amortization of deferred financing and issuance costs	$ 0	$ 89,000
Series I Secured Notes Payable [Member]
Series I Secured Notes Payable (Textual)
Interest rate on secured notes, Minimum			5.65%
Interest rate on secured notes, Maximum			9.55%
Description of interest payment	Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note.
Weighted average market interest rate of Secured notes payable	8.39%			8.37%
principal amount outstanding under Series I Secured notes	26,926,000			28,047,000
Amortization of deferred financing and issuance costs	130,000			167,000
Future expected amortization of deferred financing costs	$ 427,000
Minimum maturity period of secured notes			6 months
Maximum maturity period of secured notes			7 years
Amortizatoin period of deferred financing cost	6 years

XML

Nature of business and summary of significant accounting policies

3 Months Ended

Mar. 31, 2015

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business and summary of significant accounting policies

(1)       Nature of business and summary of significant accounting policies

Nature of business - GWG Holdings, Inc. (GWG Holdings) and subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life, LLC (GWG Life), and GWG Life’s own subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II), and GWG DLP Funding III, LLC (DLP III). All of these entities are legally organized in Delaware. Unless the context otherwise requires or we specifically so indicate, all references in this report to "we", "us", "our", "our Company", "GWG", or the "Company" refer to these entities collectively. References to particular entities, such as “GWG Holdings” or “GWG Life”, are meant to refer only to the particular entity referenced.

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1) Receipt of death notice or verified obituary of insured; or

2) Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $1,459,000 and $27,000 at March 31, 2015 and December 31, 2014, respectively.

Deferred financing and issuance costs - Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $0 and $89,000 for the three months ended March 31, 2015 and 2014, respectively. As of December 31, 2014 those costs have been fully amortized. The Series I Secured Notes payable, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements - Pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

XML

Guarantees of secured debt (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 31, 2015	Jan. 09, 2015
Guarantees of L Bonds (Textual)
Debentures offer for sale		$ 235,654,000
Maximum rate of return on equity fund amount	18.00%
Guarantees of L Bonds [Member]
Guarantees of L Bonds (Textual)
Debentures offer for sale		$ 250,000,000	$ 1,000,000,000

XML

Investment in life insurance policies (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Summary of reconciliation of gain on life settlements
Change in fair value	$ (1,894,000)	$ 11,359,000
Premiums and other annual fees	(6,337,000)	(5,843,000)
Policy maturities	25,014,000
Gain on life settlements, net	$ 16,783,000	$ 5,516,000

XML

Subsequent events

3 Months Ended

Mar. 31, 2015

Subsequent events [Abstract]

Subsequent events

(17) Subsequent events

Subsequent to March 31, 2015, one policy has matured. The insurance benefits of this policy were $750,000 and the carrying value of the policy was 132,000. The Company recorded realized gains of $618,000 on this policy.

Subsequent to March 31, 2015, the Company has issued approximately an additional $9.6 million in principal amount of L Bonds.

Amended and Restated Credit Facility

Effective May 11, 2015, GWG Holdings, together with certain of its subsidiaries, entered into an Second Amended and Restated Credit and Security Agreement with Autobahn Funding Company LLC, as the conduit lender, and DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as the committed lender and as the agent on behalf of secured parties under such agreement.  The Second Amended and Restated Credit and Security Agreement extends the maturity date of borrowings made by the Company’s subsidiaries, GWG DLP Funding II, LLC and GWG DLP Funding III, LLC, to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance, or at the lender’s cost of borrowing plus 4.75 percent, which is 1.75 percent less than under the previous Credit and Security Agreement executed on January 25, 2013.  In addition to the extended term and decreased interest rate and borrowing cost, the Second Amended and Restated Credit and Security Agreement also removes the requirement that the Company maintain a reserve for certain projected expenditures (including anticipated premium payments required to service its life insurance portfolio), thereby allowing for the Company’s full use of the credit facility up to its limit of $105,000,000.

In connection with the Second Amended and Restated Credit and Security Agreement, GWG Holdings and its subsidiaries entered into certain other agreements and amendments and restatements of earlier agreements entered into in connection with the original and renewal Credit and Security Agreements.  Included among these other agreements was an Amended and Restated Performance Guaranty affirming the performance guaranty that GWG Holdings earlier provided in connection with the original and first amended and related Credit and Security Agreements to DZ Bank AG Deutsche Zentral-Genossenschaftsbank, as agent.

XML

Investment in life insurance policies (Details 2) (USD $)	Mar. 31, 2015
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Nine months ending December 31 ,2015	$ 18,987,000
2016	27,251,000
2017	30,450,000
2018	33,165,000
2019	36,806,000
2020	40,741,000
Estimated expected premium payments	187,400,000
Premiums
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Nine months ending December 31 ,2015	18,635,000
2016	26,899,000
2017	30,098,000
2018	32,813,000
2019	36,454,000
2020	40,389,000
Estimated expected premium payments	185,288,000
Servicing
Summary of estimated expected premium payments to maintain the above life insurance policies assuming no mortalities
Nine months ending December 31 ,2015	352,000
2016	352,000
2017	352,000
2018	352,000
2019	352,000
2020	352,000
Estimated expected premium payments	$ 2,112,000

XML

Investment in life insurance policies (Tables)

3 Months Ended

Mar. 31, 2015

Investment in Life Insurance Policies [Abstract]

Summary of life insurance policies, under the fair value method and estimated maturity dates, based on remaining life expectancy

		As of March 31, 2015						As of December 31, 2014
Years Ending December 31,		Number of Contracts		Estimated Fair Value		Face Value		Number of Contracts		Estimated Fair Value		Face Value
2015			-	$	-	$	-		3	$	5,063,000	$	6,000,000
2016			8		11,626,000		14,750,000		7		8,144,000		11,550,000
2017			15		14,104,000		20,357,000		17		21,916,000		35,542,000
2018			28		39,094,000		68,717,000		30		41,994,000		76,206,000
2019			43		46,749,000		101,110,000		45		47,303,000		106,973,000
2020			44		45,825,000		103,674,000		41		43,429,000		102,614,000
2021			39		32,011,000		93,970,000		36		29,789,000		90,921,000
Thereafter			116		88,986,000		352,364,000		112		85,245,000		349,293,000
	Totals		293		278,395,000		754,942,000		291	$	282,883,000	$	779,099,000

Reconciliation of gain on life settlements

Three Months Ended:	March 31, 2015			March 31, 2014
Change in fair value	$	(1,894,000	)	$	11,359,000
Premiums and other annual fees		(6,337,000	)		(5,843,000	)
Policy maturities		25,014,000			-
Gain on life settlements, net	$	16,783,000		$	5,516,000

Estimated expected premium payments to maintain the above life insurance policies assuming no mortalities

Years Ending December 31,	Premiums		Servicing		Premiums and Servicing Fees
Nine months ending December 31, 2015	$	18,635,000	$	352,000	$	18,987,000
2016		26,899,000		352,000		27,251,000
2017		30,098,000		352,000		30,450,000
2018		32,813,000		352,000		33,165,000
2019		36,454,000		352,000		36,806,000
2020		40,389,000		352,000		40,741,000
	$	185,288,000	$	2,112,000	$	187,400,000

XML

Restrictions on cash

3 Months Ended

Mar. 31, 2015

Restrictions on Cash [Abstract]

Restrictions on cash

(2)       Restrictions on cash

The Company is required by its lenders to maintain collection and escrow accounts. These accounts are used to fund the acquisition of insurance policies, pay annual premiums of insurance policies, pay interest and other charges under the revolving credit facility, and collect policy benefits. DZ Bank AG, as agent for Autobahn Funding Company, LLC, the lender for the revolving credit facility described in note 5, authorizes the disbursements from these accounts. At March 31, 2015 and December 31, 2014, there were balances of $11,334,000, and $4,296,000, respectively, maintained in these restricted cash accounts.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Balance Sheets [Abstract]
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	40,000,000	40,000,000
Convertible preferred stock, shares issued	2,765,281	2,738,966
Convertible preferred stock, liquidation preference	$ 20,740,000	$ 20,542,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	210,000,000	210,000,000
Common stock, shares issued	5,870,193	5,870,193
Common stock, shares outstanding	5,870,193	5,870,193

XML

Net income per common share

3 Months Ended

Mar. 31, 2015

Net loss per common share [Abstract]

Net loss per common share

(12)     Net income per common share

The Company began issuing Series A Preferred Stock on September 1, 2011, as described in note 8. The Series A Preferred Stock is dilutive to the net loss per common share calculation at March 31, 2015 and anti-dilutive at March 31, 2014. The Company has also issued warrants to purchase common stock in conjunction with the sale of convertible preferred stock, discussed in note 8. The warrants and vested stock options are anti-dilutive at March 31, 2015 and March 31, 2014 and have not been included in the fully diluted net loss per common share calculation.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	May 14, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	GWG Holdings, Inc.
Entity Central Index Key	0001522690
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,870,193

XML

Commitments

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies [Abstract]

Commitments

(13)     Commitments

The Company entered into an office lease with U.S. Bank National Association as the landlord. The lease was effective April 22, 2012 with a term through August 31, 2015. The lease is for 11,695 square feet of office space located at 220 South Sixth Street, Minneapolis, Minnesota. The Company is obligated to pay base rent plus common area maintenance and a share of the building operating costs. Rent expenses under this agreement were $67,000 and $52,000 during the three month ended March 31, 2015 and 2014, respectively. The minimum lease payments for 2015 under the lease agreement are $70,000.

XML

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
REVENUE
Gain on life settlements, net	$ 16,783,409	$ 5,516,205
Interest and other income	49,296	7,367
TOTAL REVENUE	16,832,705	5,523,572
EXPENSES
Employee compensation and benefits	1,727,917	968,746
Legal and professional fees	578,144	325,298
Interest expense	7,176,534	6,326,548
Other expenses	1,478,848	759,008
TOTAL EXPENSES	10,961,443	8,379,600
INCOME (LOSS) BEFORE INCOME TAXES	5,871,262	(2,856,028)
INCOME TAX EXPENSE (BENEFIT)	2,609,371	(954,858)
NET INCOME (LOSS)	3,261,891	(1,901,170)
Loss attributable to preferred shareholders	(353,155)	(125,714)
INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ 3,615,046	$ (2,026,884)
NET INCOME (LOSS) PER COMMON SHARE
Basic	$ 0.62	$ (0.44)
Diluted	$ 0.46	$ (0.44)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic	5,870,193	4,562,000
Diluted	7,940,645	4,562,000

XML

L Bonds (formerly Renewable Secured Debentures)

3 Months Ended

Mar. 31, 2015

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures (subsequently renamed L Bonds) [Abstract]

Formerly Renewable Secured Debentures (subsequently renamed L Bonds)

(7)       L Bonds (formerly Renewable Secured Debentures)

The Company registered with the SEC, effective January of 2012, the offer and sale of $250,000,000 of Renewable Secured Debentures (subsequently renamed “L Bonds”). The debentures are secured by assets of GWG Holdings and GWG Life and are subordinate to our revolving credit facility (see note 5). L Bonds have maturity dates ranging from six months to seven years with fixed interest rates varying from 4.25% to 9.50% depending on the term of the note. Interest is payable monthly, annually or at maturity depending on the terms of the debenture. Effective January 9, 2015, The Company launched a $1 billion follow-on to our publicly registered L Bond offering. The Company is offering L Bonds on a continuous basis and there is no minimum amount of L Bonds that must be sold before The Company can use proceeds from the sale of L Bonds. The Company plans to use the net proceeds from the offering of the L Bonds primarily to purchase and finance additional life insurance assets, and to service and retire other outstanding debt obligations. Emerson Equity LLC is serving as the managing broker-dealer for the offering, which is being sold through a network of participating dealers and licensed financial advisors and representatives in minimum increments of $25,000. At March 31, 2015 and December 31, 2014, the weighted-average interest rate of L Bonds was 7.32% and 7.45%, respectively. The amount outstanding under these L Bonds was $208,729,000 and $186,377,000 at March 31, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the L Bonds and the carrying amount on the consolidated balance sheets is due to netting of unamortized deferred issuance costs and cash receipts for new issuances in process. Amortization of deferred issuance costs was $974,000 and $847,000 for the three months ended March 31, 2015 and 2014, respectively. Future expected amortization of deferred financing costs as of March 31, 2015 is $6,268,000 in total over the next seven years.

The use of proceeds from the issuances of L Bonds is limited to the following: (1) payment of commissions on sales of L Bonds, (2) payment of offering expenses, (3) purchase of life insurance policies, (4) payment of premiums on life insurance policies, (5) payment of principal and interest on L Bonds, (6) payment of portfolio operations expenses, and (7) general working capital.

Future contractual maturities of L Bonds and future amortization of their deferred financing costs at March 31, 2015 are as follows: 

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	56,626,000	$	611,000
2016		59,311,000		1,487,000
2017		36,939,000		1,434,000
2018		23,355,000		1,130,000
2019		14,342,000		639,000
Thereafter		18,156,000		967,000
	$	208,729,000	$	6,268,000

The Company entered into an Indenture effective October 19, 2011 with Holdings as obligor, GWG Life as guarantor, and Bank of Utah as trustee for the benefit of the debenture holders. The Indenture has certain financial and non-financial covenants. The Company was in compliance with these covenants at December 31, 2014 and 2013.

XML

Series I Secured Notes payable

3 Months Ended

Mar. 31, 2015

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures (subsequently renamed L Bonds) [Abstract]

Series I Secured Notes payable

(6)       Series I Secured Notes payable

Series I Secured Notes are secured by assets of GWG Life and are subordinate to our revolving credit facility (see note 5). On June 14, 2011, the Company closed the offering to additional investors; however, existing investors may elect to continue advancing amounts outstanding upon maturity subject to the Company’s option to repay such notes. Series I Secured Notes have maturity dates ranging from six months to seven years with fixed interest rates varying from 5.65% to 9.55% depending on the term of the note. Interest is payable monthly, quarterly, annually or at maturity depending on the terms of the note. At March 31, 2015 and December 31, 2014, the weighted-average interest rate of Series I Secured Notes was 8.39% and 8.37%, respectively. The notes are secured by assets of GWG Life. The principal amount outstanding under these Series I Secured Notes was $26,926,000 and $28,047,000 at March 31, 2015 and December 31, 2014, respectively. The difference between the amount outstanding on the Series I Secured Notes and the carrying amount on the consolidated balance sheet is due to netting of unamortized deferred issuance costs. Overall, interest expense includes amortization of deferred financing and issuance costs of $130,000 and $167,000 for the three months ended March 31, 2015 and 2014, respectively. Future expected amortization of deferred financing costs is $427,000 in total over the next six years.

Future contractual maturities of Series I Secured Notes payable and future amortization of their deferred financing costs at March 31, 2015 are as follows: 

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	9,426,000	$	51,000
2016		10,060,000		168,000
2017		5,873,000		158,000
2018		802,000		30,000
2019		347,000		8,000
Thereafter		418,000		12,000
	$	26,926,000	$	427,000

XML

Nature of business and summary of significant accounting policies (Policies)

3 Months Ended

Mar. 31, 2015

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business

Nature of business - GWG Holdings, Inc. (GWG Holdings) and subsidiaries, located in Minneapolis, Minnesota, facilitates the purchase of life insurance policies for its own investment portfolio through its wholly owned subsidiary, GWG Life, LLC (GWG Life), and GWG Life’s own subsidiaries, GWG Trust (Trust), GWG DLP Funding II, LLC (DLP II) and its wholly owned subsidiary, GWG DLP Master Trust II (the Trust II), and GWG DLP Funding III, LLC (DLP III). All of these entities are legally organized in Delaware. Unless the context otherwise requires or we specifically so indicate, all references in this report to "we", "us", "our", "our Company", "GWG", or the "Company" refer to these entities collectively. References to particular entities, such as “GWG Holdings” or “GWG Life”, are meant to refer only to the particular entity referenced.

Use of estimates

Use of estimates - The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The most significant estimates with regard to these consolidated financial statements relates to (1) the determination of the assumptions used in estimating the fair value of the investment in life insurance policies, and (2) the value of deferred tax assets and liabilities.

Cash and cash equivalents

Cash and cash equivalents - The Company considers cash in demand deposit accounts and temporary investments purchased with an original maturity of three months or less to be cash equivalents. The Company maintains its cash and cash equivalents with highly rated financial institutions. From time to time, the Company’s balances in its bank accounts exceed Federal Deposit Insurance Corporation limits. The Company periodically evaluates the risk of exceeding insured levels and may transfer funds as it deems appropriate. The Company has not experienced any losses with regards to balances in excess of insured limits or as a result of other concentrations of credit risk.

Life settlements

Life settlements - ASC 325-30, Investments in Insurance Contracts, allows a reporting entity the election to account for its investments in life settlements using either the investment method or the fair value method. The election shall be made on an instrument-by-instrument basis and is irrevocable. Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs. Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized. Under the fair value method, an investor shall recognize the initial investment at the purchase price. In subsequent periods, the investor shall re-measure the investment at fair value in its entirety at each reporting period and shall recognize the change in fair value in current period income net of premiums paid. The Company uses the fair value method to account for all life settlements.

The Company recognizes realized gains (revenue) from life settlement contracts upon one of the two following events:

1) Receipt of death notice or verified obituary of insured; or

2) Sale of policy and filing of change of ownership forms and receipt of payment

The Company recognizes the difference between the death benefits and carrying values of the policy when an insured event has occurred and the Company determines that settlement and ultimate collection of the death benefits is realizable and reasonably assured. Revenue from a transaction must meet both criteria in order to be recognized. In an event of a sale of a policy, the Company recognizes gain or loss as the difference between the sale price and the carrying value of the policy on the date of the receipt of payment on such sale.

Deposits and initial direct costs advanced on unsettled policy acquisitions are recorded as other assets until policy ownership has been transferred to the Company.  Such deposits and direct cost advances were $1,459,000 and $27,000 at March 31, 2015 and December 31, 2014, respectively.

Deferred financing and issuance costs

Deferred financing and issuance costs - Costs incurred to obtain financing under the revolving credit facility, as described in note 5, have been capitalized and are amortized using the straight-line method over the term of the revolving credit facility. Amortization of deferred financing costs was $0 and $89,000 for the three months ended March 31, 2015 and 2014, respectively. As of December 31, 2014 those costs have been fully amortized. The Series I Secured Notes payable, as described in note 6, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The L Bonds, as described in note 7, are reported net of issuance costs, sales commissions and other direct expenses, which are amortized using the interest method over the term of each respective borrowing. The Series A Preferred Stock, as described in note 8, is reported net of issuance costs, sales commissions, including the fair value of warrants issued, and other direct expenses, which are amortized using the interest method as interest expense over the three-year redemption period.

Earnings (loss) per share

Earnings (loss) per share - Basic per share earnings (loss) attributable to non-redeemable interests is calculated using the weighted-average number of shares outstanding during the period. Diluted earnings per share is calculated based on the potential dilutive impact, if any, of the Company’s convertible, redeemable preferred stock, and outstanding warrants, and stock options.

Subsequent events

Subsequent events - Subsequent events are events or transactions that occur after the balance sheet date but before consolidated financial statements are issued. The Company recognizes in the consolidated financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing the consolidated financial statements. The Company’s consolidated financial statements do not recognize subsequent events that provide evidence about conditions that did not exist at the date of the balance sheet but arose after the balance sheet date and before the consolidated financial statements are available to be issued. The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are filed for potential recognition or disclosure.

Recently adopted pronouncements

Recently adopted pronouncements - Pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or are not expected to be significant to the Company.

XML

Contingencies

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies [Abstract]

Contingencies

(14)    Contingencies

Litigation - In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Opportunity Finance, LLC, owned by Jon Sabes and Steven Sabes (Company directors and officers), is subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments that may have been deemed preference payments. In addition, Jon Sabes and Steven Sabes are subject to litigation clawback claims by the bankruptcy trustee for third-party matters for payments received from Opportunity Finance that may have been deemed preference payments. If the parties are unsuccessful in defending against these claims, their equity ownership in the Company may be sold or transferred to other parties to satisfy such claims. In addition, the Company loaned $1,000,000 to Opportunity Finance, LLC, and was repaid in full plus interest of $177,000. This investment amount may also be subject to clawback claims by the bankruptcy court.

XML

Common Stock

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Common Stock

(10)    Common Stock

On September 24, 2014, GWG consummated an initial public offering of its common stock which resulted in the sale of 800,000 shares of common stock at $12.50 per share. The sale resulted in net proceeds of approximately $8.6 million after the deduction of underwriting commissions, discounts and expense reimbursements. In connection with this offering, the Company listed its common stock on The NASDAQ Capital Market under the ticker symbol “GWGH” effective September 25, 2014. The Company used the net proceeds from the offering to promote and advertise the opportunities for consumers owning life insurance and investors to profit from participating in the secondary market for life insurance policies, purchase additional life insurance policies in the secondary market, pay premiums on the Company’s life insurance policy assets, fund its portfolio operations, and for working capital purposes.

Stock split— On June 24, 2014, the Company’s Board of Directors and majority stockholders approved a joint resolution to effect an amendment to the Company’s Certificate of Incorporation to effect a reverse split of the issued and outstanding common stock on a 2-for-1 basis. The effective date of the amendment and reverse stock split was June 24, 2014. In lieu of fractional shares, stockholders received cash payments in an amount equal to the fraction to which the stockholder would otherwise be entitled multiplied by the price of the common stock, as determined by the Board of Directors of the Company, but adjusted so as to give effect to the reverse stock split. The par value of the common stock remained at $0.001 per share.

XML

Concentrations (Details)	Mar. 31, 2015	Dec. 31, 2014
AXA Equitable [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	15.02%	14.55%
John Hancock [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	12.03%	11.48%
Transamerica [Member]
Summary of the face value of insurance contracts with specific life insurance companies
Face value percentage of insurance contracts with specific life insurance companies	10.32%		[1]

[1] * percentage does not exceed 10% of the total face value.

XML

Convertible, Redeemable Preferred Stock

3 Months Ended

Mar. 31, 2015

Equity [Abstract]

Convertible, Redeemable Preferred Stock

(8)       Convertible, Redeemable Preferred Stock

The Company offered 3,333,333 shares of convertible redeemable preferred stock (Series A Preferred Stock) for sale to accredited investors in a private placement on July 31, 2011. The offering of Series A Preferred Stock concluded on September 2, 2012 and resulted in 3,278,000 shares being issued for gross consideration of $24,582,000. As of March 31, 2015, 303,000 shares have been issued as a result of the payment of $2,121,000 in dividends in the form of shares of Series A Preferred Stock and 678,000 shares have been converted to 508,000 shares of the Company’s common stock. The Series A Preferred Stock was sold at an offering price of $7.50 per share. Series A Preferred Stock has a preferred yield of 10% per annum, and each share has the right to convert into 0.75 shares of the Company’s common stock. Series A preferred shareholders also received three-year warrants to purchase, at an exercise price per share of $12.50, one share of common stock for every 40 shares of Series A Preferred Stock purchased. The warrants are exercisable immediately. Upon their original issuance, these warrants had a three-year exercise period. Effective August 1, 2014, the Board of Directors authorized the extension of the warrant exercise period for an additional two years. In the Certificate of Designations for the Series A Preferred Stock dated July 31, 2011, the Company agreed to permit preferred shareholders to sell their shares back to the Company for the stated value of $7.50 per share, plus accrued dividends, according to the following schedule: 

● Up to 33% of the holder’s unredeemed shares one year after issuance:

● Up to 66% of the holder’s unredeemed shares two years after issuance; and

● Up to 100% of the holder’s unredeemed shares three years after issuance.

The Company’s obligation to redeem its Series A Preferred Stock terminated upon the Company completing a registration of its common stock with the SEC which occurred on September 24, 2014 (See Note 10). As such, the convertible redeemable preferred stock was reclassified from temporary equity to permanent equity. The Company may redeem the Series A preferred shares at a price equal to 110% of their liquidation preference ($7.50 per share) at any time. As of March 31, 2015, the Company had redeemed an aggregate of 145,000 shares of Series A Preferred Stock.The Series A Preferred Stock shares (i) were convertible, at the election of the Company, into common stock of the Company in the event of either a registered offering of the Company’s common stock with the SEC aggregating gross proceeds of at least $5.0 million and at a price equal to or greater than $11.00 per share; (ii) remain convertible at the option of each holder; and (iii) are required to be converted upon the consent of shareholders holding at least a majority of the then-outstanding Series A Preferred Stock. In connection with the Company’s initial public offering, the Company elected to cause the conversion of 678,000 shares of preferred stock into 508,000 shares of common stock. As of March 31, 2015, the Company had 2,765,000 shares of Series A Preferred Stock outstanding with gross consideration of $20,712,000 (including cash proceeds, conversion of Series I Secured Notes and accrued interest on Series I, and conversion of preferred dividends payable). The Company incurred Series A Preferred Stock issuance costs of $2,838,000, all of which was included as a component of additional paid in capital as of December 31, 2014.

The Company determined that the grant date fair value of the outstanding warrants attached to the Series A Preferred Stock was $428,000 for warrants outstanding as of March 31, 2015. The Company may redeem outstanding warrants prior to their expiration, at a price of $0.01 per share upon 30 days written notice to the investors at any time after (i) the Company has completed a registration of its common stock with the SEC and (ii) the volume of weighted-average sale price per share of common stock equals or exceeds $14.00 per share for ten consecutive trading days ending on the third business day prior to proper notice of such redemption.

Total warrants outstanding as of both March 31, 2015 and December 31, 2014, were 431,954 with a weighted-average remaining life of 2.18 and 2.43 years, respectively. As of March 31, 2015, none of these warrants have been exercised.

Dividends on the Series A Preferred Stock may be paid in either cash or additional shares of Series A Preferred Stock at the election of the holder and approval of the Company. The dividends are reported as an expense and included in the caption interest expense in the consolidated statements of operations. The Company declared and accrued dividends of $537,000 and $634,000 for the three months ended March 31, 2015 and 2014, respectively, pursuant to a board resolution declaring the dividend. 26,000 and 27,000 shares of Series A Preferred Stock were issued in lieu of cash dividends in the three months ended March 31, 2015 and 2014, respectively. The shares issued in lieu of cash dividends were issued at $7.00 per share. As of March 31, 2015, GWG Holdings has $518,000 of accrued preferred dividends which were paid or converted to shares of Series A Preferred Stock on April 15, 2015.

XML

Income taxes

3 Months Ended

Mar. 31, 2015

Income Taxes [Abstract]

Income taxes

(9)       Income taxes

The Company has a $427,000 and $0 of current income tax liability as of March 31, 2015 and December 31, 2014. The components of current and deferred income tax expense for the three month ended March 31, 2015 and income tax benefit for the three month ended March 31, 2014, consisted of the following:

Three months ended:	March 31,			March 31,
	2015			2014
Income tax provision:
Current:
Federal	$	(324,000	)	$	-
State		(103,000	)		-
Total current tax expense		(427,000	)		-
Deferred:
Federal	$	(1,654,000	)	$	802,000
State		(528,000	)		153,000
Total deferred tax expense		(2,182,000	)		955,000
Total income tax expense	$	(2,609,000	)	$	955,000

The primary differences between the Company’s March 31, 2015 effective tax rate and the statutory federal rate are the accrual of nondeductible preferred stock dividend expense of $537,000, state taxes, and other non-deductible expenses. The most significant temporary differences between GAAP net income and taxable net income are the treatment of interest costs with respect to the acquisition of the life insurance policies and revenue recognition with respect to the mark-to-market of life insurance portfolio.

XML

Stock Incentive Plan

3 Months Ended

Mar. 31, 2015

Stock Incentive Plan [Abstract]

Stock Incentive Plan

(11)     Stock Incentive Plan

The Company adopted the GWG Holdings, Inc. 2013 Stock Incentive Plan on March 27, 2013. The plan was subsequently revised on March 4, 2015. The plan is administered by Compensation Committee of the Board of Directors of the Company. The Company’s Chief Executive Officer may, on a discretionary basis and without committee review or approval, grant incentives to new employees of the Company who are not officers of the Company. Incentives under the plan may be granted in one or a combination of the following forms: (a) incentive stock options and non-statutory stock options; (b) stock appreciation rights; (c) stock awards; (d) restricted stock; (e) restricted stock units; and (f) performance shares. Eligible participants include officers and employees of the company, members of the Board of Directors, and consultants or other independent contractors. 2,000,000 shares are issuable under the plan. No person shall receive grants of stock options and SARs under the plan that exceed, in the aggregate 400,000 shares of common stock in any one year. The term of each stock option shall be determined by the committee but shall not exceed ten years. Vested stock options may be exercised in whole or part by the holder giving notice to the Company. The holder of the option may provide payment for the exercise price or surrender shares equal to the exercise price.

The Company issued stock options for 755,101 shares of common stock to employees, officers, and directors of the Company through December 31, 2014. Options for 363,957 shares have vested, and the remaining options will vest over three years. The options were issued with an exercise price between $8.20 and $9.01 for those owning more than 10% of the Company’s stock and between $7.46 and $10.25 for others, which is equal to the estimated market price of the shares on the date of grant valued using Black-Scholes binomial option pricing model. The expected volatility used in the Black-Scholes model valuation of options issued during the year was 17.03% annualized. The annual volatility rate is based on the standard deviation of the average continuously compounded rate of return of five selected comparable companies over the previous 52 weeks. Forfeiture rate of 15% is based on historical Company information and expected future trend. As of March 31, 2015, stock options for 72,583 shares were forfeited and stock options for 4,167 shares were exercised.

In September 2014, we entered into a stock option agreement (the Agreement) with a new management employee (the Employee) granting the Employee the right to purchase up to 318,000 of the Company’s common stock at an exercise price of $12.50. The grant of such rights to purchase the Company’s common stock was treated as an inducement grant and was issued outside the GWG Holdings Inc. 2013 Stock Incentive Plan. The Agreement specifies that, among other things, options to purchase 159,000 shares of the Company’s common stock will vest with the Employee ratably on the first, second and third anniversary of the date of the Agreement. The remaining 159,000 options will vest quarterly using a formula based upon the closing price of the Company’s common stock on the last business day of such quarter. The maximum number of these remaining options that will vest with the Employee is 53,000 in each successive one-year period beginning on the date of the Agreement.

Outstanding stock options:

	Vested			Un-vested			Total
Balance as of December 31, 2014		314,288			685,813			1,000,101
Granted during the quarter		43,500			42,750			86,250
Vested during the quarter		10,002			(10,002	)		-
Exercised during the quarter		(3,833	)		-			(3,833	)
Forfeited during the quarter		-			(9,417	)		(9,417	)
Balance as of March 31, 2015		363,957			709,144			1,073,101

Compensation expense related to un-vested options not yet recognized is $608,000. We expect to recognize this compensation expense over the next three years ($217,000 in 2015, $217,000 in 2016, $166,000 in 2017, and 8,000 in 2018). The Company issues new common stock for options exercised.

XML

Subsequent events (Details) (Subsequent Event [Member], USD $)	3 Months Ended	0 Months Ended
	Mar. 31, 2015 Policy	May 11, 2015
Subsequent events (Textual)
Number of policies	1
Insurance benefit amount	$ 750,000
Realized gains of policies	618,000
Additional principal amount of L bonds	9,600,000
Carrying value	132,000
Subsidiaries [Member]
Subsequent events (Textual)
Credit facility use by company		$ 105,000,000
Credit facility bear interest, Description		The maturity date of borrowings made by the Company's subsidiaries, GWG DLP Funding II, LLC and GWG DLP Funding III, LLC, to June 30, 2018. Advances under the credit facility made after May 11, 2015 will bear interest at the commercial paper rate of the lender at the time of the advance, or at the lender's cost of borrowing plus 4.75 percent, which is 1.75 percent less than under the previous Credit and Security Agreement executed on January 25, 2013.
Maturity date of borrowings		Jun. 30, 2018

XML

Investment in life insurance policies (Details) (USD $)	Mar. 31, 2015 INF	Dec. 31, 2014 INF
Summary of Company's life insurance policies accounted for under fair value method and their estimated maturity dates, based on remaining life expectancy
Number of Contracts, 2015		3
Number of Contracts, 2016	8	7
Number of Contracts, 2017	15	17
Number of Contracts, 2018	28	30
Number of Contracts, 2019	43	45
Number of Contracts, 2020	44	41
Number of Contracts, 2021	39	36
Number of Contracts, Thereafter	116	112
Life Settlement Contracts, Number of Contracts, Total	293	291
Estimated Fair Value, 2015		$ 5,063,000
Estimated Fair Value, 2016	11,626,000	8,144,000
Estimated Fair Value, 2017	14,104,000	21,916,000
Estimated Fair Value, 2018	39,094,000	41,994,000
Estimated Fair Value, 2019	46,749,000	47,303,000
Estimated Fair Value, 2020	45,825,000	43,429,000
Estimated Fair Value, 2021	32,011,000	29,789,000
Estimated Fair Value, Thereafter	88,986,000	85,245,000
Life Settlement Contracts, Estimated Fair Value, Total	278,395,000	282,883,000
Face Value, 2015		6,000,000
Face Value, 2016	14,750,000	11,550,000
Face Value, 2017	20,357,000	35,542,000
Face Value, 2018	68,717,000	76,206,000
Face Value, 2019	101,110,000	106,973,000
Face Value, 2020	103,674,000	102,614,000
Face Value, 2021	93,970,000	90,921,000
Face Value, Thereafter	352,364,000	349,293,000
Life Settlement Contracts, Face Value, Total	$ 754,942,000	$ 779,099,000

XML

Common Stock (Details) (USD $)	1 Months Ended	0 Months Ended
	Jun. 24, 2014	Sep. 24, 2014	Mar. 31, 2015	Dec. 31, 2014
Common Stock Disclosure [Textual]
Common stock, par value			$ 0.001	$ 0.001
Reverse stock split	2-for-1
GWG (Member)
Common Stock Disclosure [Textual]
Shares of common stock issued		800,000
Common stock, par value		$ 12.50

XML

Concentrations

3 Months Ended

Mar. 31, 2015

Concentration [Abstract]

Concentration

(16)     Concentrations

GWG purchases life insurance policies written by life insurance companies having investment grade ratings by independent rating agencies.  As a result there may be certain concentrations of contracts with life insurance companies.  The following summarizes the face value of insurance contracts with specific life insurance companies exceeding 10% of the total face value held by the Company.

	March 31,		December 31,
	2015		2014
Life insurance company	%		%
AXA Equitable		15.02		14.55
John Hancock		12.03		11.48
Transamerica		10.32		*

* percentage does not exceed 10% of the total face value.

The following summarizes the number of insurance contracts held in specific states exceeding 10% of the total face value held by the Company:

	March 31,		December 31,
	2015		2014
State of residence	%		%
California		28.33		28.87
Florida		18.77		18.56
New York		9.56		*

* percentage does not exceed 10% of the total face value.

XML

Series I Secured Notes payable (Tables)

3 Months Ended

Mar. 31, 2015

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures (subsequently renamed L Bonds) [Abstract]

Future contractual maturities of series I secured notes payable

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	9,426,000	$	51,000
2016		10,060,000		168,000
2017		5,873,000		158,000
2018		802,000		30,000
2019		347,000		8,000
Thereafter		418,000		12,000
	$	26,926,000	$	427,000

XML

Income taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Federal	$ (324,000)
State	(103,000)
Total current tax expense	(427,000)
Deferred:
Federal	(1,654,000)	802,000
State	(528,000)	153,000
Total deferred tax expense	(2,182,000)	955,000
Total income tax expense	$ 2,609,371	$ (954,858)

XML

Fair value definition and hierarchy (Details 3) (Level 3 [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued	431,954
December 2011 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Dec. 31, 2011
Warrants issued	68,937
Fair value per share	0.22
Risk free rate	0.42%
Volatility rate	25.25%
Term	5 years
March 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Mar. 31, 2012
Warrants issued	38,130
Fair value per share	0.52
Risk free rate	0.38%
Volatility rate	36.20%
Term	5 years
June 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Jun. 30, 2012
Warrants issued	161,840
Fair value per share	1.16
Risk free rate	0.41%
Volatility rate	47.36%
Term	5 years
July 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Jul. 31, 2012
Warrants issued	144,547
Fair value per share	1.16
Risk free rate	0.41%
Volatility rate	47.36%
Term	5 years
September 2012 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Sep. 30, 2012
Warrants issued	2,500
Fair value per share	0.72
Risk free rate	0.31%
Volatility rate	40.49%
Term	5 years
September 2014 [Member]
Warrants Level 3 instruments and measured at fair value upon issuance
Warrants issued date	Sep. 30, 2014
Warrants issued	16,000
Fair value per share	1.26
Risk free rate	1.85%
Volatility rate	17.03%
Term	5 years

XML

Condensed Consolidated Statement of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 3,261,891	$ (1,901,170)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Gain on life settlements	1,893,845	(11,358,913)
Amortization of deferred financing and issuance costs	(549,030)	353,657
Deferred income taxes	2,182,251	(954,858)
Convertible, redeemable preferred stock dividends payable	188,812	192,340
Increase in operating liabilities:
Policy benefits receivable	(17,890,000)
Other assets	(131,173)	(251,846)
Increase in operating liabilities:
Accounts payable and other accrued expenses	2,635,687	1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(8,407,717)	(12,642,964)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,446,477)	(8,271,203)
Proceeds from settlement of life settlements	3,610,595
NET CASH FLOWS USED IN INVESTING ACTIVITIES	1,164,118	(8,271,203)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable	(1,273,189)	(868,303)
Proceeds from issuance of L Bonds	27,960,297	18,365,657
Payments for issuance and redemption of L Bonds	(6,878,122)	(4,928,888)
Proceeds (payments) from restricted cash	(7,037,564)	2,979,207
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	12,771,422	15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	5,527,823	(5,366,494)
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR	30,662,704	33,449,793
END OF YEAR	36,190,527	28,083,299
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and preferred dividends paid	6,102,000	4,250,000
Series I Secured Notes:
Accrued interest and commissions payable added to principal	41,000	65,000
L Bonds:
Accrued interest and commissions payable added to principal	218,000	119,000
Convertible, Redeemable Preferred Stock:
Accretion of Convertible, Redeemable Preferred Stock to redemption value		126,000
Conversion of dividends payable	$ 184,000	$ 188,000

XML

Credit facilities

3 Months Ended

Mar. 31, 2015

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures (subsequently renamed L Bonds) [Abstract]

Credit facilities

(5)       Credit facilities

Revolving credit facility – Autobahn Funding Company LLC

On July 15, 2008, DLP II and United Lending entered into a revolving credit facility pursuant to a Credit and Security Agreement (Agreement) with Autobahn Funding Company LLC (Autobahn), providing the Company with a maximum borrowing amount of $100,000,000. Autobahn is a commercial paper conduit that issues commercial paper to investors in order to provide funding to DLP II. DZ Bank AG Deutsche Zentral-Genossenschaftsbank (DZ Bank) acts as the agent for Autobahn. The original Agreement was to expire on July 15, 2013. On January 29, 2013, GWG Holdings, together with GWG Life and DLP II, entered into an Amended and Restated Credit and Security Agreement with Autobahn, extending the facility expiration date to December 31, 2014. On May 29, 2014, GWG Holdings, together with GWG Life and DLP II, entered into an Amendment No. 1 to Amended and Restated Credit and Security Agreement with Autobahn and DZ Bank (as committed lender and Agent). The amendment was entered into for the purpose of extending the maturity date for borrowings under the Agreement to December 31, 2016. The amount outstanding under this facility as of both March 31, 2015 and December 31, 2014 was $72,161,000.

The Agreement requires DLP II to pay, on a monthly basis, interest at the commercial paper rate plus an applicable margin, as defined in the Agreement. The effective rate was 6.22% at March 31, 2015 and 6.24% at December 31, 2014. The Agreement also requires payment of an unused line fee on the unfunded amount under the revolving credit facility. The weighted-average effective interest rate (excluding the unused line fee) was 6.20% and 6.22% for the three months ended March 31, 2015 and 2014, respectively. The note is secured by substantially all of DLP II’s assets, which consist primarily of life insurance policies.

The Agreement has certain financial and non-financial/operational covenants. The Company was in compliance with these covenants at March 31, 2015 and December 31, 2014. The Agreement generally prohibits the Company from:

● changing its corporate name, offices, and jurisdiction of incorporation

● changing any deposit accounts or payment instructions to insurers;

● changing any operating policies and practices such that it would be reasonably likely to adversely affect the collectability of any asset in any material respect;

● merging or consolidating with, or selling all or substantially all of its assets to, any third party;

● selling any collateral or creating or permitting to exist any adverse claim upon any collateral;

● engaging in any other business or activity than that contemplated by the Agreement;

● incurring or guaranteeing any debt for borrowed money;

● amending the Company’s certificate of incorporation or bylaws, making any loans or advances to, investments in, or paying any dividends to, any person unless both before and after any such loan, advance, investment or dividend there exists no actual event of default, potential event of default or termination event;

● removing an independent director on the board of directors except for cause or with the consent of the lender; or

● making payment on or issuing any Series I Secured Notes or L Bonds, or amending any agreements respecting such notes or debentures, if an event of default, potential event of default or termination event exists or would arise from any such action.

In addition, the Company has agreed to maintain (i) a positive consolidated net income on a non-GAAP basis (as defined and calculated under the Agreement) for each complete fiscal year; (ii) a tangible net worth on a non-GAAP basis (as defined and calculated under the Agreement) of not less than $15 million; and (iii) maintain a borrowing base surplus or cash cushion sufficient to pay 12 months of premiums and facility fees.

Consolidated tangible net worth and net income as of and for the four quarters ended March 31, 2015, as calculated under the agreement, was $98,775,000 and $45,553,000 respectively.

Advances under the Agreement are subject to a borrowing base formula, which limits the availability of advances based on attributes of policies pledged to the facility. Over-concentration of policies by insurance carrier, over-concentration of policies by insurance carriers with ratings below a AA- rating, and the premiums and facility fees reserve are the three primary factors which may limit availability of funds on the facility. Total funds available for additional borrowings under the borrowing base formula criteria at March 31, 2015 and December 31, 2014, were $3,751,000 and $20,585,000 respectively.

On July 15, 2008, GWG Holdings delivered a performance guaranty in favor of Autobahn pursuant to which it guaranteed the obligations of GWG Life, in its capacity as the seller and master servicer, under the Credit and Security Agreement and related documents. In January 2013 and May 2014 in connection with the Amended and Restated Credit and Security Agreement and Amendment No. 1 to Amended and Restated Credit and Security Agreement, GWG Holdings delivered a reaffirmation of its performance guaranty. The obligations of GWG Holdings under the performance guaranty and subsequent reaffirmation do not extend to the principal and interest owed by DLP II as the borrower under the credit facility.

XML

Guarantees of secured debt (Details 2) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 3,261,891	$ (1,901,170)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries
Gain on life settlements	(1,893,845)	11,358,913
Amortization of deferred financing and issuance costs	(549,030)	353,657
Deferred income taxes	2,182,251	(954,858)
Preferred stock issued for dividends	188,812	192,340
Increase in operating assets:
Policy benefits receivable	17,890,000
Other assets	(131,173)	(251,846)
Increase in operating liabilities:
Accounts payable and other accrued expenses	2,635,687	1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(8,407,717)	(12,642,964)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,446,477)	(8,271,203)
Proceeds from settlement of life settlements	3,610,595
NET CASH FLOWS USED IN INVESTING ACTIVITIES	1,164,118	(8,271,203)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable	(1,273,189)	(868,303)
Proceeds from issuance of L Bonds	27,960,297	18,365,657
Payments from issuance of L Bonds	(1,340,583)	1,057,763
Payments from redemption of L Bonds	(5,537,539)	(3,871,125)
Proceeds from restricted cash	(7,037,564)	2,979,207
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	12,771,422	15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	5,527,823	(5,366,494)
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR	30,662,704	33,449,793
END OF YEAR	36,190,527	28,083,299
Parent [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	3,261,891	(1,901,170)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries	(13,848,196)	2,631,557
Gain on life settlements
Amortization of deferred financing and issuance costs	43,475	847,236
Deferred income taxes	2,182,251	(954,858)
Preferred stock issued for dividends	188,812	192,340
Increase in operating assets:
Policy benefits receivable
Other assets	(10,874,436)	(15,947,713)
Increase in operating liabilities:
Accounts payable and other accrued expenses	2,279,652	713,785
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(16,766,551)	(19,681,937)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable
Proceeds from issuance of L Bonds	27,960,297	18,365,657
Payments from issuance of L Bonds	(1,340,583)	(1,057,763)
Payments from redemption of L Bonds	(5,537,539)	(3,871,125)
Proceeds from restricted cash
Issuance of member capital
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	21,082,175	13,436,769
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	4,315,624	(6,245,168)
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR	30,446,473	32,711,636
END OF YEAR	34,762,097	26,466,468
Guarantor Subsidiary [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	13,848,144	2,631,557
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries	(15,296,104)	3,037,009
Gain on life settlements
Amortization of deferred financing and issuance costs	130,188	166,946
Deferred income taxes
Preferred stock issued for dividends
Increase in operating assets:
Policy benefits receivable
Other assets	(5,877,435)	(15,248,357)
Increase in operating liabilities:
Accounts payable and other accrued expenses	738,084	229,443
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(6,457,123)	(15,257,420)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable	(1,273,189)	(868,303)
Proceeds from issuance of L Bonds
Payments from issuance of L Bonds
Payments from redemption of L Bonds
Proceeds from restricted cash	(1,780,000)	1,070,000
Issuance of member capital	10,572,459	15,934,397
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	7,519,270	16,136,094
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,062,147	878,674
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR	216,231	738,157
END OF YEAR	1,278,378	1,616,831
Non-Guarantor Subsidiaries [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	15,296,156	3,037,009
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries
Gain on life settlements	1,893,845	(11,358,913)
Amortization of deferred financing and issuance costs	(722,693)	(660,525)
Deferred income taxes
Preferred stock issued for dividends
Increase in operating assets:
Policy benefits receivable	17,890,000
Other assets
Increase in operating liabilities:
Accounts payable and other accrued expenses	382,049	334,598
NET CASH FLOWS USED IN OPERATING ACTIVITIES	(1,804,741)	(8,647,831)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements	(2,446,477)	(8,271,203)
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES	1,164,118	(8,271,203)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable
Proceeds from issuance of L Bonds
Payments from issuance of L Bonds
Payments from redemption of L Bonds
Proceeds from restricted cash	(5,257,564)	1,909,207
Issuance of member capital	6,048,239	15,009,827
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	790,675	16,919,034
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	150,052
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR
END OF YEAR	150,052
Eliminations [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	(29,144,300)	(5,668,566)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries	(29,144,300)	(5,668,566)
Gain on life settlements
Amortization of deferred financing and issuance costs
Deferred income taxes
Preferred stock issued for dividends
Increase in operating assets:
Policy benefits receivable
Other assets	16,620,698	30,944,224
Increase in operating liabilities:
Accounts payable and other accrued expenses
NET CASH FLOWS USED IN OPERATING ACTIVITIES	16,620,698	30,944,224
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements
Proceeds from settlement of life settlements
NET CASH FLOWS USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable
Proceeds from issuance of L Bonds
Payments from issuance of L Bonds
Payments from redemption of L Bonds
Proceeds from restricted cash
Issuance of member capital	(16,620,698)	(30,944,224)
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	(16,620,698)	(30,944,224)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS
BEGINNING OF YEAR
END OF YEAR

XML

L Bonds (formerly Renewable Secured Debentures) (Tables)

3 Months Ended

Mar. 31, 2015

Credit facilities and Series I Secured Notes Payable and Renewable Secured Debentures (subsequently renamed L Bonds) [Abstract]

Schedule of future contractual maturities of L Bonds

Years Ending December 31,	Contractual Maturities		Amortization of Deferred Financing Costs
Nine months ending December 31 ,2015	$	56,626,000	$	611,000
2016		59,311,000		1,487,000
2017		36,939,000		1,434,000
2018		23,355,000		1,130,000
2019		14,342,000		639,000
Thereafter		18,156,000		967,000
	$	208,729,000	$	6,268,000

XML

Fair value definition and hierarchy (Details) (Life Insurance policies [Member], USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2012
Life Insurance policies [Member]
Summary of reconciliation of investments in life insurance policies
Beginning balance	$ 282,883,000	$ 234,673,000	$ 254,504,000	$ 234,673,000
Purchases	1,016,000	8,472,000
Maturities (cost basis)	(3,610,000)
Gross unrealized gains (losses)	(1,894,000)	11,359,000
Ending balance	$ 278,395,000	$ 254,504,000	$ 254,504,000	$ 234,673,000

XML

Guarantees of secured debt

3 Months Ended

Mar. 31, 2015

Guarantees of L Bonds [Abstract]

Guarantees of L Bonds

(15)    Guarantees of secured debt

GWG Holdings has registered with the SEC the offer and sale $250,000,000 of L Bonds, and effective January 9, 2015, launched a $1 billion follow-on to its publicly registered L Bond offering as described in note 7. The L Bonds are secured by the assets of Holdings as described in note 7 and a pledge of all the common stock held by the largest individual shareholders. Obligations under the L Bonds are guaranteed by GWG Life. This guarantee involves the grant of a security interest in all the assets of GWG Life. The payment of principal and interest on the L Bonds is fully and unconditional guaranteed by GWG Life. Substantially all of the Company’s life insurance policies are held by DLP II, DLP III and the Trust. The policies held by DLP II are not collateral for the L Bond obligations as such policies serve as collateral for the credit facility.

The consolidating financial statements are presented in lieu of separate financial statements and other related disclosures of the subsidiary guarantors and issuer because management does not believe that separate financial statements and related disclosures would be material to investors. There are currently no significant restrictions on the ability of Holdings or GWG Life, the guarantor subsidiary, to obtain funds from its subsidiaries by dividend or loan, except as follows. DLP II is a borrower under a credit agreement with Autobahn, with DZ Bank AG as agent, as described in note 5. The significant majority of insurance policies owned by the Company are subject to a collateral arrangement with DZ Bank AG described in notes 2 and 5. Under this arrangement, collection and escrow accounts are used to fund premiums of the insurance policies and to pay interest and other charges under the revolving credit facility. DZ Bank AG and Autobahn must authorize all disbursements from these accounts, including any distributions to GWG Life. Distributions are limited to an amount that would result in the borrowers (DLP II, GWG Life and Holdings) realizing an annualized rate of return on the equity funded amount for such assets of not more than 18%, as determined by DZ Bank AG. After such amount is reached, the credit agreement requires that excess funds be used for repayments of borrowings before any additional distributions may be made.

The following represents consolidating financial information as of March 31, 2015 and December 31, 2014, with respect to the financial position, and for the three months ended March 31, 2015 and 2014 with respect to results of operations and cash flows of Holdings and its subsidiaries. The parent column presents the financial information of Holdings, the primary obligor of the L Bonds. The guarantor subsidiary column presents the financial information of GWG Life, the guarantor subsidiary of the L Bonds, presenting its investment in DLP II, DLP III and Trust under the equity method. The non-guarantor subsidiaries column presents the financial information of all non-guarantor subsidiaries including DLP II, DLP III and Trust.

Condensed Consolidating Balance Sheets

March 31, 2015	Parent			Guarantor Sub		Non-Guarantor Sub		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	34,762,097		$	1,278,378	$	150,052	$	-		$	36,190,527
Restricted cash		-			1,862,500		9,471,117		-			11,333,617
Policy benefits receivable		-			-		19,640,000		-			19,640,000
Investment in life settlements, at fair value		-			-		278,395,047		-			278,395,047
Other assets		1,814,859			1,756,731		2,181,793		-			5,753,383
Investment in subsidiaries		210,207,072			236,319,121		-		(446,526,193	)		-
TOTAL ASSETS	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			26,498,511		-		-			26,498,511
L Bonds		205,038,330			-		-		-			205,038,330
Interest payable		7,242,071			3,559,004		603,120		-			11,404,195
Accounts payable and other accrued expenses		1,179,207			1,102,196		604,667		-			2,886,070
Deferred taxes		7,455,806			-		-		-			7,455,806
TOTAL LIABILITIES		220,915,414			31,159,711		73,368,835		-			325,443,960
STOCKHOLDERS’ EQUITY
Member capital		-			210,057,019		236,469,174		(446,526,193	)		-
Convertible preferred stock		20,712,073										20,712,073
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,290,266			-		-		-			16,290,266
Accumulated deficit		(11,139,595	)		-		-		-			(11,139,595	)
TOTAL STOCKHOLDERS’ EQUITY		25,868,614			210,057,019		236,496,174		(446,526,193	)		25,868,614
TOTAL LIABILITIES AND EQUITY	$	246,784,028		$	241,216,730	$	309,838,009	$	(446,526,193	)	$	351,312,574

December 31, 2014	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries		Eliminations			Consolidated
A S S E T S
Cash and cash equivalents	$	30,446,473		$	216,231	$	-	$	-		$	30,662,704
Restricted cash		-			82,500		4,213,553		-			4,296,053
Investment in life settlements, at fair value		-			-		282,883,010		-			282,883,010
Other assets		1,673,728			1,777,534		1,777,500		-			5,228,762
Investment in subsidiaries		185,636,417			215,124,779		-		(400,761,196	)		-
TOTAL ASSETS	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529
L I A B I L I T I E S  &  S T O C K H O L D E R S'  E Q U I T Y  (D E F I C I T)
LIABILITIES
Revolving credit facility	$	-		$	-	$	72,161,048	$	-		$	72,161,048
Series I Secured Notes payable		-			27,616,578		-		-			27,616,578
L Bonds		182,782,884			-		-		-			182,782,884
Accounts payable		410,895			242,680		550,000		-			1,203,575
Interest payable		6,598,250			3,513,615		1,016,654		-			11,128,519
Other accrued expenses		301,098			191,753		21,583		-			514,434
Deferred taxes		5,273,555			-		-		-			5,273,555
TOTAL LIABILITIES		195,366,682			31,564,626		73,749,285		-			300,680,593
STOCKHOLDERS’ EQUITY
Member capital		-			185,636,418		215,124,778		(400,761,196	)		-
Convertible preferred stock		20,527,866			-		-		-			20,527,866
Common stock		5,870			-		-		-			5,870
Additional paid-in capital		16,257,686			-		-		-			16,257,686
Accumulated deficit		(14,401,486	)		-		-		-			(14,401,486	)
TOTAL STOCKHOLDERS’ EQUITY		22,389,936			185,636,418		215,124,778		(400,761,196	)		22,389,936
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	217,756,618		$	217,201,044	$	288,874,063	$	(400,761,196	)	$	323,070,529

Condensed Consolidating Statements of Operations

For the three months ended March 31, 2015	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	357,486		$	-	$	(357,486	)	$	-
Gain on life settlements, net		-			-			16,783,409		-			16,783,409
Interest and other income		7,543			6,450			35,303		-			49,296
TOTAL REVENUE		7,453			363,936			16,818,712		(357,486	)		16,832,705
EXPENSES
Origination and servicing fees		-			-			357,486		(357,486	)		-
Employee compensation and benefits		1,305,801			422,116			-		-			1,727,917
Legal and professional fees		477,351			100,793			-		-			578,144
Interest expense		5,249,962			774,086			1,152,486		-			7,176,534
Other expenses		951,362			514,902			12,584		-			1,478,848
TOTAL EXPENSES		7,984,476			1,811,897			1,522,556		(357,486	)		10,961,443
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(7,976,933	)		(1,447,961	)		15,296,156		-			5,871,262
EQUITY IN INCOME OF SUBSIDIARY		13,848,195			15,296,105			-		(29,144,300	)		-
NET INCOME BEFORE INCOME TAXES		5,871,262			13,848,144			15,296,156		(29,144,300	)		5,871,262
INCOME TAX EXPENSE		2,609,371			-			-		-			2,609,371
NET INCOME	$	3,261,891		$	13,848,144		$	15,296,156	$	(29,144,300	)	$	3,261,891

For the three months ended March 31, 2014	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries		Eliminations			Consolidated
REVENUE
Contract servicing fees	$	-		$	966,056		$	-	$	(966,056	)	$	-
Gain on life settlements, net		-			-			5,516,205		-			5,516,205
Interest and other income		6,929			169,615			44		(169,221	)		7,367
TOTAL REVENUE		6,929			1,135,671			5,516,249		(1,135,277	)		5,523,572
EXPENSES
Origination and servicing fees		-			-			966,056		(966,056	)		-
Employee compensation and benefits		590,584			378,162			-		-			968,746
Legal and professional fees		266,159			59,139			-		-			325,298
Interest expense		4,216,528			778,567			1,331,453		-			6,326,548
Other expenses		421,243			325,255			181,731		(169,221	)		759,008
TOTAL EXPENSES		5,494,514			1,541,123			2,479,240		(1,135,277	)		8,379,600
INCOME (LOSS) BEFORE EQUITY IN INCOME OF SUBSIDIARIES		(5,487,585	)		(405,452	)		3,037,009		-			(2,856,028	)
EQUITY IN INCOME OF SUBSIDIARY		2,631,557			3,037,009			-		(5,668,566	)		-
NET INCOME (LOSS) BEFORE INCOME TAXES		(2,856,028	)		2,631,557			3,037,009		(5,668,566	)		(2,856,028	)
INCOME TAX BENEFIT		(954,858	)		-			-		-			(954,858	)
NET INCOME (LOSS)	$	(1,901,170	)	$	2,631,557		$	3,037,009	$	(5,668,566	)	$	(1,901,170	)

Condensed Consolidating Statements of Cash Flows

For the three months ended March 31, 2015	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	3,261,891		$	13,848,144		$	15,296,156		$	(29,144,300	)	$	3,261,891
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(13,848,196	)		(15,296,104	)		-			29,144,300			-
Gain on life settlements		-			-			1,893,845			-			1,893,845
Amortization of deferred financing and issuance costs		43,475			130,188			(722,693	)		-			(549,030	)
Deferred income taxes		2,182,251			-			-			-			2,182,251
Preferred stock issued for dividends		188,812			-			-			-			188,812
Increase in operating assets:
Policy benefits receivable		-			-			17,890,000			-			17,890,000
Other assets		(10,874,436	)		(5,877,435	)		-			16,620,698			(131,173	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		2,279,652			738,084			382,049			-			2,635,687
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(16,766,551	)		(6,457,123	)		(1,804,741	)		16,620,698			(8,407,717	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(2,446,477	)		-			(2,446,477	)
Proceeds from settlement of life settlements		-			-			3,610,595			-			3,610,595
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			1,164,118			-			1,164,118
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(1,273,189	)		-			-			(1,273,189	)
Proceeds from issuance of L Bonds		27,960,297			-			-			-			27,960,297
Payments from issuance of L Bonds		(1,340,583	)		-			-			-			(1,340,583	)
Payments from redemption of L Bonds		(5,537,539	)		-			-			-			(5,537,539	)
Proceeds from restricted cash		-			(1,780,000	)		(5,257,564	)		-			(7,073,564	)
Issuance of member capital		-			10,572,459			6,048,239			(16,620,698	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		21,082,175			7,519,270			790,675			(16,620,698	)		12,771,422
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		4,315,624			1,062,147			150,052			-			5,527,823
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		30,446,473			216,231			-			-			30,662,704
END OF THE YEAR	$	34,762,097		$	1,278,378		$	150,052		$	-		$	36,190,527

For the three months ended March 31, 2014	Parent			Guarantor Sub			Non-Guarantor Sub			Eliminations			Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(1,901,170	)	$	2,631,557		$	3,037,009		$	(5,668,566	)	$	(1,901,170	)
Adjustments to reconcile net loss to cash:
(Equity) loss of subsidiaries		(2,631,557	)		(3,037,009	)		-			5,668,566			-
Gain on life settlements		-			-			(11,358,913	)		-			(11,358,913	)
Amortization of deferred financing and issuance costs		847,236			166,946			(660,525	)		-			353,657
Deferred income taxes		(954,858	)		-			-			-			(954,858	)
Preferred stock issued for dividends		192,340			-			-			-			192,340
Increase in operating assets:
Other assets		(15,947,713	)		(15,248,357	)		-			30,944,224			(251,846	)
Increase in operating liabilities:
Accounts payable and other accrued expenses		713,785			229,443			334,598			-			1,277,826
NET CASH FLOWS USED IN OPERATING ACTIVITIES		(19,681,937	)		(15,257,420	)		(8,647,831	)		30,944,224			(12,642,964	)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in life settlements		-			-			(8,271,203	)		-			(8,271,203	)
NET CASH FLOWS USED IN INVESTING ACTIVITIES		-			-			(8,271,203	)		-			(8,271,203	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for redemption of Series I Secured Notes payable		-			(868,303	)		-			-			(868,303	)
Proceeds from issuance of debentures		18,365,657			-			-			-			18,365,657
Payments from issuance of debentures		(1,057,763	)		-			-			-			(1,057,763	)
Payments from redemption of debentures		(3,871,125	)		-			-			-			(3,871,125	)
Proceeds from restricted cash		-			1,070,000			1,909,207			-			2,979,207
Issuance of member capital		-			15,934,397			15,009,827			(30,944,224	)		-
NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		13,436,769			16,136,094			16,919,034			(30,944,224	)		15,547,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(6,245,168	)		878,674			-			-			(5,366,494	)
CASH AND CASH EQUIVALENTS
BEGINNING OF THE YEAR		32,711,636			738,157			-			-			33,449,793
END OF THE YEAR	$	26,466,468		$	1,616,831		$	-		$	-		$	28,083,299